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Background: Around 19% of people screened by UK cardiac rehabilitation programmes report having
moderate or severe symptoms of depression. These individuals are at an increased risk of cardiac mortality
and morbidity, reduced quality of life and increased use of health resources compared with their
non-depressed counterparts. Maximising psychological health is a goal of cardiac rehabilitation, but
psychological care is patchy.
Objective(s): To examine the feasibility and acceptability of embedding enhanced psychological care (EPC)
within cardiac rehabilitation, we tested the feasibility of developing/implementing EPC and documented
the key uncertainties associated with undertaking a definitive evaluation.
Design: A two-stage multimethods study; a feasibility study and a qualitative evaluation, followed by an
external pilot cluster randomised controlled trial (RCT) with a nested qualitative study.
Setting: UK comprehensive cardiac rehabilitation teams.
Participants: Adults eligible for cardiac rehabilitation following an acute coronary syndrome with
new-onset depressive symptoms on initial nurse assessment. Patients who had received treatment for
depression in the preceding 6 months were excluded.
Interventions: The EPC intervention comprised nurse-led mental health-care co-ordination and
behavioural activation within cardiac rehabilitation. The comparator was usual cardiac rehabilitation care.
Main outcome measures: Measures at baseline, and at the 5- (feasibility and pilot) and 8-month
follow-ups (pilot only). Process measures related to cardiac team and patient recruitment, and participant
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retention. Outcomes included depressive symptoms, cardiac mortality and morbidity, anxiety, health-related
quality of life and service resource use. Interviews explored participant and nurses’ views and experiences.
Results: Between September 2014 and May 2015, five nurses from four teams recruited participants
into the feasibility study. Of the 203 patients screened, 30 were eligible and nine took part (the target was
20 participants). At interview, participants and nurses gave valuable insights into the EPC intervention
design and delivery. Although acceptable, the EPC delivery was challenging for nurses (e.g. the ability to
allocate sufficient time within existing workloads) and the intervention was modified accordingly. Between
December 2014 and February 2015, 8 out of 20 teams approached agreed to participate in the pilot RCT
[five were randomised to the EPC arm and three were randomised to the usual-care (UC) arm]. Of the
614 patients screened, 55 were eligible and 29 took part (the target was 43 participants). At baseline,
the trial arms were well matched for sex and ethnicity, although the EPC arm participants were younger,
from more deprived areas and had higher depression scores than the UC participants. A total of 27 out
of 29 participants were followed up at 5 months. Interviews with 18 participants (12 in the EPC arm and
six in the UC arm) and seven nurses who delivered EPC identified that both groups acknowledged the
importance of receiving psychological support embedded within routine cardiac rehabilitation. For those
experiencing/delivering EPC, the intervention was broadly acceptable, albeit challenging to deliver within
existing care.
Limitations: Both the feasibility and the pilot studies encountered significant challenges in recruiting
patients, which limited the power of the pilot study analyses.
Conclusions: Cardiac rehabilitation nurses can be trained to deliver EPC. Although valued by both patients
and nurses, organisational and workload constraints were significant barriers to implementation in participating
teams, suggesting that future research may require a modified approach to intervention delivery within current
service arrangements. We obtained important data informing definitive research regarding participant
recruitment and retention, and optimal methods of data collection.
Future research: Consideration should be given to the delivery of EPC by dedicated mental health
practitioners, working closely with cardiac rehabilitation services.
Trial registration: Current Controlled Trials ISRCTN34701576.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 22, No. 30.
See the NIHR Journals Library website for further project information.
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Glossary
Acute coronary syndrome A set of signs and symptoms arising from decreased blood flow to the heart,
usually attributable to one of three problems: ST elevation myocardial infarction, non-ST elevation
myocardial infarction or unstable angina.
Behavioural activation A psychological therapy applied to the management of depression, which applies
a functional-analytic approach, which asks the client to develop an understanding of the relationships
between actions and emotions, and to alter behaviours that reduce low mood.
Comprehensive cardiac rehabilitation programme A structured rehabilitation programme aimed at
supporting people recovering from an acute cardiac event. Core components include education, exercise
and physical activity, diet and weight management, medical management and psychological support.
Mental health-care co-ordination The systematic monitoring of patient mood by a designated
health-care professional, combined with the offering of evidence-based therapies designed to
modify/manage the patient’s underlying mental health condition.
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Plain English summary
A fter an acute heart problem, around 20% of people eligible for NHS cardiac rehabilitation havemoderate or severe symptoms of depression. Although psychological health is part of cardiac
rehabilitation, access to psychological care is patchy. Our aim was to develop and implement enhanced
psychological care (EPC) to be delivered by nurses within cardiac rehabilitation teams. Nurses identified
patients with depressive symptoms and offered them behavioural activation – an established treatment
for depression that focuses on helping people with depression change the way they act. Nurses were also
trained in how to monitor/manage the patient’s mental health-care needs.
First, we tested the practicality and acceptability of EPC from the patients’ and the nurses’ perspectives.
After refinement, we then undertook a pilot study to further test EPC and to clarify uncertainties around
the participant recruitment and retention needed to design a future randomised controlled trial (RCT) that
would compare a group of people who receive EPC to a group who receive usual care. Preliminary testing
of EPC (four teams, nine patients) found EPC to be acceptable, although nurses found it difficult to deliver
within their existing workload. The intervention was refined to reduce workload, and then tested in a small
pilot version of a potential RCT. Five teams were randomly allocated to deliver EPC and three teams to
deliver usual care. Patients completed assessments at the beginning of the RCT and at 5 and 8 months
after that. Measures assessed included mood, cardiac events, health-related quality of life and resource
use. Twenty-nine patients participated in the trial (15 in the EPC arm and 14 in the usual-care arm).
Nurses and patients were also asked to take part in interviews.
Our pilot study showed that 93% of participants completed the 5-month follow-up assessment, but
participant recruitment was challenging. At interview, patients and nurses acknowledged the importance
of embedding psychological support within routine rehabilitation. However, significant organisational and
workload constraints meant that EPC was not practical in routine care.
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Scientific summary
Background
Depression is common in people with coronary heart disease (CHD), affecting up to 20% of such
individuals, and is approximately four times more common than in the general population. Such depression
is associated with a doubling of the risk of subsequent morbidity and mortality. The detection and
appropriate management of depression among people with CHD is a policy priority.
Routine clinical care for people with CHD who have experienced acute coronary syndrome [(ACS) including
myocardial infarction, non-ST elevation myocardial infarction (NSTEMI) and unstable angina] includes the
provision of cardiac rehabilitation. Cardiac rehabilitation in the UK is conceptualised as a seven-stage
model beginning from when the patient presents with ACS, and incorporates education, exercise, weight
management, medical management and psychological support. Psychological support can include the
assessment of symptoms of anxiety and depression, and the provision of relaxation or stress management.
Only a minority of services have direct access to specialist psychological support. Thus, despite the
availability of evidence-based interventions for depression in primary and secondary care, the majority of
people attending cardiac rehabilitation do not receive adequate psychological care.
Our research aimed to address this gap in the provision of psychological support for people with
depression by developing and evaluating enhanced psychological care (EPC), a complex intervention
embedded within routine cardiac rehabilitation. In line with the funding brief, our research focused on
people with new-onset depression.
Our research comprised:
l the development of clinical and training materials to support cardiac rehabilitation nurses in the delivery
of EPC, involving a maximum of eight sessions of behavioural activation (BA) for depression and mental
health-care co-ordination to ensure adequate monitoring of depression, and the assessment and
management of any associated risk and onwards referral, where appropriate
l an uncontrolled pre–post feasibility study, which aimed to determine the feasibility and acceptability of
implementing/experiencing EPC from the perspective of cardiac rehabilitation nurses and patients,
modifying the intervention when indicated
l a pilot cluster randomised controlled trial (RCT), which aimed to identify the methods and procedures
required to undertake a fully powered evaluation of the clinical effectiveness and cost-effectiveness of
EPC for depression delivered within routine cardiac rehabilitation compared with usual care (UC).
Objectives
The objectives of the feasibility study were to:
l develop and refine the EPC intervention for implementation by cardiac rehabilitation nurses
l describe the psychological support routinely offered by cardiac rehabilitation services
l determine the feasibility and acceptability of implementing/experiencing EPC
l determine (1) the proportion of patients with new-onset depression attending cardiac rehabilitation
assessment, (2) participant attendance at, and adherence with, the cardiac rehabilitation programme
with EPC and (3) the psychological care co-ordination provided within usual cardiac rehabilitation care
l develop and undertake preliminary testing of the study methods required to implement a pilot trial.
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The objectives of the pilot cluster RCT were to:
l quantify the flow of patients from the cardiac event to the 8-month follow-up, and to document the
flow of those participants who agreed to take part in the pilot trial
l collect participant outcome data to estimate the standard deviation (SD) for outcomes
l establish the data collection methods required to support a definitive economic evaluation
l gather qualitative evidence from patients and nurses on the acceptability of receiving/implementing
EPC, of study methods and procedures and on the content of usual psychological care.
Methods
Intervention development
Behavioural activation is an evidence-based treatment for depression that is suitable for the training of,
and delivery by, non-psychologically trained clinical practitioners. Using mental health expertise within our
team, we developed materials to support the delivery of BA, tailored to the needs of people with CHD and
suitable for delivery within cardiac rehabilitation services. The mental health-care co-ordination components
of the intervention were based on current National Institute for Health and Care Excellence guidance,
targeting the recognition and management of depression in adults with chronic physical health problems.
Consistent with the Medical Research Council’s guidance for the development and evaluation of complex
interventions, we conducted a two-phase study.
Feasibility study
We conducted a multimethods study to determine the feasibility and acceptability of implementing/
experiencing EPC from the perspective of cardiac rehabilitation nurses and patients.
Five nurses from participating cardiac rehabilitation services received 2 days of training in EPC. Of the five
nurses trained, four engaged in the recruitment of participants; one nurse attended training but did not
participate in patient recruitment or EPC delivery.
In the preliminary observational study, we aimed to recruit 20 patients with depression, referred by nurses
from three operationally distinct cardiac rehabilitation teams in Devon, UK. Adult patients referred to
cardiac rehabilitation services following an episode of ACS, and scoring in the depressed range [Patient
Health Questionnaire-9 (PHQ-9) score of 10 or more], were eligible for inclusion. Patients were excluded if
they had received treatment for depression in the previous 6 months, if they experienced alcohol or drug
dependency, if they were actively suicidal or if they had uncontrolled bipolar disorder or schizophrenia.
Patient research assessments were conducted at baseline and at 5 months. Nurses recorded a screening
log to record patient throughput, and maintained clinical notes to record patient engagement with EPC.
We conducted qualitative interviews with nurses before the intervention development, again within
4 weeks of completing training and, finally, towards the end of the EPC delivery. We also gauged
nurses’ experiences through observations of nurse training and nurse/clinical supervisor meetings,
clinical supervisors’ supervision summaries and field notes. Patients were interviewed once they had
completed EPC.
Pilot study
We conducted a pilot cluster RCT to test the methods, and procedures, needed to facilitate the planning
and design of a subsequent fully powered evaluation of EPC for depression among individuals attending
cardiac rehabilitation compared with UC. UC was standard NHS cardiac rehabilitation (including
psychological care), as delivered in the locality of the teams randomised to that arm.
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Quantitative assessments were conducted at baseline, 5 months and 8 months. At baseline, data were
recorded on demographic characteristics, medical/cardiac status and psychiatric diagnostic status. At
baseline and follow-up, assessments were made of depression severity [using the Beck Depression
Inventory, version 2 (BDI-II)], anxiety [using the Beck Anxiety Inventory (BAI)], health-related quality of life
[using the EuroQol-5 Dimensions (EQ-5D) and the Heart Quality Of Life scale (HeartQoL)], degree of BA
[using the Behavioural Activation for Depression Scale – Short Form (BADS-SF)] and satisfaction with
treatment [using the Client Satisfaction Questionnaire – 8 (CSQ-8)]. A preliminary economic evaluation was
conducted to pilot methods to collect data on costs.
Qualitative data were collected during observations of staff training and during interviews with nurses who
had delivered EPC, and with patients in both trial arms (after the 5-month assessment) and patients who
had been offered, but had declined, trial participation.
Results
Feasibility study
At a pre-training meeting with cardiac rehabilitation nurses, it became apparent that there was considerable
variation in the way in which different cardiac rehabilitation services were organised, which affected how
nurses conducted their rehabilitation programmes.
At interviews following training, nurses reported that they liked the content and format of training and the
supporting materials provided, and were positive about the prospect of using BA. Nurses commented that
the training had given them the confidence to discuss and manage risk issues with patients, and that care
co-ordination provided them with options over where to direct patients. Nurses raised concerns about how
they would fit in the BA sessions around the rest of their workload.
Between September 2014 and March 2015, of the 203 patients screened for study eligibility, 30 met the
inclusion criteria, of whom nine agreed to take part. The mean age of patients participating in the study
was 60.4 years; 78% were male and all self-reported their ethnicity as white and their preferred language
as English. Of those recruited, 22% met the diagnostic criteria for a ‘mild’ depressive episode and 22% for
a ‘severe’ depressive episode.
Data collected from nurse notes indicated that the nine recruited patients attended between 1 and
18 sessions of cardiac rehabilitation. Nurses discussed a mental health referral for four individuals.
Of the nine patients interviewed after receiving EPC, most felt that EPC had helped their mood, and valued
the opportunity to discuss their feelings, although participants remembered little about the contents of the
intervention materials.
Feedback on study procedures indicated that most participants reported that assessments were of ‘the right
length’ and had ‘the right number of questions’. Eight out of nine participants completed the participant-
reported outcome data.
Transition between the feasibility study and the pilot study
We modified the research procedures for the pilot study based on findings from the feasibility study,
including broadening the eligibility criteria to include all patients referred for cardiac rehabilitation, and
reducing our recruitment target from 64 to 43 participants.
We modified the EPC intervention based on the feasibility study findings. We increased the emphasis on
care co-ordination and, to reduce the burden on nurses, shifted from nurse-delivered to patient-led/
nurse-supported BA. Treatment and training materials were modified to reflect these changes.
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Pilot study
Between December 2014 and February 2015, 8 out of 20 teams approached agreed to participate,
and were then randomised: five to the EPC arm and three to the UC arm. One team from the EPC arm
dropped out post randomisation, but was replaced with a matched team. NHS governance (research and
development) approvals in two areas took < 2 months from the initial contact; in five areas, it took
between 2.5 and 3.5 months and, in the final area, it took > 5 months, which led to some delays in
participant recruitment.
Fifty-five of the 614 patients screened were eligible for recruitment, and 29 patients took part (67% of the
revised target sample size of 43). Trial arms were well matched for sex, ethnicity and preferred language.
Patients in the EPC arm were younger than those in the UC arm (mean age 62.7 vs. 68.1 years), with
higher depression scores at baseline (BDI-II scores: 18.4 vs. 12.5).
Summary of the quantitative results
At 5 months, the mean BDI-II score was reduced from baseline in the EPC and UC groups, and the mean
between-group difference (adjusting for baseline score) was 1.7 [95% confidence interval (CI) –3.8 to 7.3].
Reductions in BDI-II scores at 5 months were observed in 5 out of 12 patients (42%) in the EPC arm and
7 out of 14 patients (50%) in the UC arm. Of the participants with a BDI-II score of > 14 (caseness) at
baseline who attended the 5-month follow-up, 3 out of 7 patients (43%) in the EPC arm and 6 out of
7 patients (86%) in the UC arm were in remission (i.e. a BDI-II score of < 14).
At 5 months, the mean BAI score improved in the EPC and UC arms, and the between-group mean difference
(adjusting for baseline score) was 4.6 (95% CI –0.8 to 10.0); heart-related quality of life (HeartQoL) improved
in both treatment arms (adjusted between-group mean difference of –8.2, 95% CI –14.9 to –1.4), and generic
health-related quality of life [EuroQol-5 Dimensions, five-level version (EQ-5D-5L)] remained largely unchanged
in both treatment arms (adjusted between-group mean difference of 0.05, 95% CI –0.02 to 0.11).
All of the participants in the EPC arm, and most of the participants in the UC arm, were extremely satisfied
with the amount of help they received (11/11 and 8/13 participants, respectively).
Economic evaluation
We successfully gathered information on the use of health services (clinical notes) across the period of
involvement for 27 out of 29 participants. Apart from a difference at baseline between the two groups in
EQ-5D-5L scores, there were no notable differences or changes over time. If a definitive trial were to be
conducted, these health-related quality-of-life estimates could be used to determine a trial sample size
based on the expected cost-effectiveness of the intervention.
The total estimated cost of providing EPC (n = 15) was £13,384 (i.e. an estimated cost per participant of
£959). A substantial proportion (93%) of the overall cost was attributable to nurse training, with the
estimated length of time nurses spent to deliver EPC contributing a relatively small amount (£63 of the
estimated £959 per participant).
Case note review
The manual case note review of general practitioner (GP) records and cardiac nurse records proved to be
satisfactory. Good or very good agreement between patient and either set of records was observed for
information regarding accident and emergency attendance or hospital admission, but agreement was poor
in respect to information on primary care resource use (when compared with GP records). The availability of
physiological and biochemical information varied among participants, generally with greater availability of
physiological data in GP or cardiac rehabilitation notes than that of biochemical data.
Summary of the qualitative results
Eighteen patient participants (twelve in the EPC arm and six in the UC arm) were interviewed, as well as
three patients who declined trial entry. Trial participants described the major impact that their cardiac
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event had had on both their mental and physical health. EPC participants described the one-to-one
dedicated time they had received from nurses to focus on their mental health as vital to their recovery, and
felt that embedding EPC in cardiac rehabilitation was timely and appropriate. UC participants felt that they
had not discussed their mental well-being with their nurse in any depth or at all. Individuals who declined
EPC reported that they did so because they did not feel low, were not keen to discuss mood and/or they
felt overloaded with information following a cardiac event.
Seven cardiac nurses were interviewed from four intervention teams. The provision of psychological
support was viewed as a key part of their role. Training in best-practice mental health-care co-ordination
and managing risk was universally valued, and nurses felt that some patients had benefited from BA.
Nurses commented that it was helpful that EPC had been integrated within cardiac rehabilitation, as many
patients declined referrals to other services; they felt able to deliver the intervention, but had struggled to
implement it within their existing workloads.
Conclusions
Implications for health care
l Patients and nurses acknowledged the importance, and recognised the value, of having psychological
support embedded within routine cardiac rehabilitation, rather than having it provided elsewhere.
l The patient-focused format of EPC, as modified for our pilot trial, was acceptable to both patients
and nurses.
l Cardiac rehabilitation nurses can be trained to deliver EPC. Although valued by both patients and
nurses, organisational and workload constraints were significant barriers to implementation.
l Consideration should be given to delivering EPC by dedicated mental health workers, such as
psychological well-being practitioners (PWPs), working closely with cardiac rehabilitation services.
Recommendations for research
l Enhanced psychological care, as delivered by dedicated PWPs working closely with cardiac
rehabilitation services, should be considered for further evaluation in a large-scale clinical trial.
l The future definitive trial would require involvement of a substantial proportion of UK cardiac
rehabilitation teams.
l A future study should review the need for cluster randomisation, and explore the potential for an
individual randomised design.
l All depressed patients attending cardiac rehabilitation should be included, not just those with
new-onset depression.
l The BDI-II was suitable as a primary outcome measure.
l Assessment of the primary outcome at 5 months is viable, although a longer follow-up period
(12 months) is required to capture cardiac events, and to inform the health economic evaluation.
Trial registration
This trial is registered as ISRCTN34701576.
Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.
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Chapter 1 Background
Coronary heart disease
Globally, coronary heart disease (CHD) is the single leading cause of death. The World Health Organization
estimated that ischaemic heart disease accounted for 7.4 million deaths in 2012, which is around one-third
of all deaths globally.1 In the UK, 1 in 10 women and 1 in 7 men died from CHD in 2015 (around 70,000
deaths per annum), with most deaths caused by myocardial infarctions (MIs).2 However, the UK mortality
rate from CHD is falling, largely through the introduction of evidence-based treatments and lifestyle
changes leading to reductions in major cardiac risk factors (mostly smoking). The successful fall in mortality
rate means that many more people are living with heart disease and may need support to manage their
symptoms and prognosis. In 2015, around 2.3 million people in the UK were living with CHD, over 60% of
whom were male.
As a consequence, the need to address stress, psychosocial factors (e.g. lack of social support) and other
underlying mood disorders (such as depression or anxiety), has long been recognised as important within
conventional cardiac care in the UK,3 Europe4 and the USA.5
Depression and coronary heart disease
Among people who have experienced acute coronary syndromes [ACSs including ST elevation MI (STEMI),
non-STEMI (NSTEMI) and unstable angina], prevalence rates for major depression are estimated to be
around 20% in studies using structured clinical interview schedules.6 The rate of depression has also been
shown to be raised in individuals following coronary artery bypass grafting,7 people with unstable angina8
and those experiencing chronic heart failure.9 Irrespective of the underlying coronary condition, the rates of
depression greatly exceed the UK general population rate of 2.6%.10
Depression is important among people with CHD, as it predicts a range of negative medical outcomes,
including greater morbidity and mortality,11–15 poorer health-related quality of life (HRQoL),16–18 higher use
of routine and unscheduled health care19,20 and, therefore, increased health-care costs.21 The nature of the
association between depression and CHD is complex and the mechanisms underpinning this association are
unclear, but may include biological and behavioural processes (e.g. poorer adherence to cardiac risk factor
management), or may be confounded by shared genetic vulnerability, environmental stresses or perseverative
negative cognitive processes.22 New-onset depression is associated with an approximate doubling of the risk
of subsequent incident ACS,23,24 the worsening of associated heart failure25 and increased rates of cardiac
mortality.18 It remains unclear, however, whether new-onset depression is particularly ‘cardio-toxic’22 or
whether its apparent associations with poor cardiac outcomes is confounded by, for example, the severity of
the underlying cardiac disease.18
Depression that predates an ACS, on the other hand, differs from new-onset depression in that it is predicted
by risk factors that are similar to depression in the general population, including being of young age, lacking
social support, experiencing ongoing life difficulties and a past history of psychiatric disorder.22 Although such
depression is associated with poorer medical outcomes, compared with people who are not depressed, the
association with adverse medical outcomes appears to be less strong than that for new-onset depression.14
In light of the high prevalence of depression among people with CHD and its association with poor
medical outcomes, there is widespread national and international recognition that detection and treatment
of such depression is important.3–5
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Usual health care for people with cardiac heart disease and depression
Cardiac rehabilitation service provision
In the UK, the NHS routinely offers multidisciplinary cardiac rehabilitation to people who experience an
acute cardiac event. These are patients with CHD referred following admission with an ACS. The majority
will have had coronary revascularisation, usually percutaneous coronary intervention (PCI) for STEMI, or
coronary artery bypass graft (CABG) surgery. Many patients with heart failure may also be admitted with an
ACS, and are also eligible for cardiac rehabilitation. Some patients have concomitant valve surgery with
CABG, and others may have had a pacemaker or defibrillator in the context of CHD. Some patient groups,
such as people with heart failure, who might benefit from cardiac rehabilitation have historically been
excluded from cardiac rehabilitation. However, recent national audit data suggest that such exclusions are
diminishing and that the diversity of case mix is increasing. In the UK in 2014–15, an estimated 82,127
patients commenced cardiac rehabilitation, including individuals with a primary indication of MI (19.6%),
MI and PCI (28.1%), PCI (14.1%), CABG (14.8%), heart failure (4.4%), angina (3.6%), valve surgery (5.9%)
and other or unknown conditions (e.g. having a pacemaker, implantable cardioverter defibrillator; 9.6%).26
Guidance on the recommended content of usual cardiac rehabilitation care has been published by the
British Association for Cardiovascular Prevention and Rehabilitation (BACPR),3 the contents of which are
broadly comparable with that which is recommended across Europe4 and the USA.5 Core components
include education; exercise and physical activity; diet and weight management; medical management
and psychological support. Cardiac rehabilitation follows a seven-stage care pathway (stages 0–6), as
illustrated in Figure 1 and Box 1.27
The organisation and delivery of cardiac rehabilitation services are currently in a state of flux. In 2011–12,
in the UK, The National Audit of Cardiac Rehabilitation: Annual Statistical Report 201328 identified 290
operationally distinct, comprehensive cardiac rehabilitation programmes (stages 2–5); by 2014–15, 308
core programmes were identified.26 While working towards nationally agreed standards and a standardised
patient care pathway, there remains considerable regional variation in the staffing and skill mix of
individual services.
Patient attrition across the cardiac rehabilitation pathway also remains an area of significant challenge.
It has been estimated that, for people with one of the four most prevalent indicated conditions (MI, MI
and PCI, PCI or CABG) referred to cardiac rehabilitation in the UK, uptake is around 47% and varies
considerably by condition (38%, 54%, 40% and 59%, respectively).26 The number of individuals who go
on to attend a structured rehabilitation programme is strongly influenced by gender. It has been estimated
that around two-thirds of potentially eligible men start structured rehabilitation, compared with less than
one-third of women, and the reasons underlying these differences are not well understood.
As part of the initial cardiac rehabilitation assessment with a nurse specialist (stage 2), individuals are
usually asked to complete the Hospital Anxiety and Depression Scale (HADS)29 to assess mood. In
2014–15, it was estimated that 12% of patients exhibited borderline depressive symptoms (i.e. a HADS-D
score of 8–10) and 7% were depressed (i.e. a HADS-D score of ≥ 11) during this initial assessment. Of the
individuals who completed the final assessment of a structured cardiac rehabilitation programme (stage 5),
8% exhibited borderline depressive symptoms and 4% were depressed during this final assessment. There
was considerable regional variation observed in the change scores between localities.26 These findings
indicate that there is considerable scope to improve and standardise treatment for depression among
people undergoing cardiac rehabilitation.
Despite the burden of depression, in 2013, only 25 out of 260 cardiac rehabilitation services (10%)
reported receiving direct psychologist input.30 However there is recent evidence that psychologist input is
increasing, with 48 out of 261 programmes (18%) reporting such input in 2014.26 Notwithstanding this
progress, the evidence still suggests that patients’ depression usually remains untreated.31 Locally agreed
referral protocols providing for access to psychological care at either the tertiary (stage 1) or community
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FIGURE 1 Cardiac rehabilitation standard patient care pathway. CR, cardiac rehabilitation.
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(stages 2–5) levels may be agreed. However, the precise content of such protocols, and the consistency of
their implementation, is not clear from audit data.
Although it would appear that structured management of depression is not routinely provided within the
majority of cardiac rehabilitation programmes, individuals may access mental health care through existing
care pathways for depression provided by other mainstream NHS services.32–34 Notwithstanding this, there
is a need to deliver models of care to increase access to evidence-based depression treatments for people
undergoing cardiac rehabilitation.
Effectiveness of psychological care for people with depression
Effective care for people with depressive symptoms includes the provision of psychological and/or
pharmacological interventions, as well as the effective co-ordination of mental health-care services.32–34
Effectiveness of psychological therapies in the general population
Psychological treatments, such as cognitive behavioural therapy (CBT), interpersonal therapy and
antidepressant medication, are the mainstay evidence-based treatments for acute depression. Both are
BOX 1 Cardiac rehabilitation standard patient care pathway
Stage 0
The pathway commences when a patient presents after an acute coronary event, and is identified and referred
to a cardiac rehabilitation team by the hospital staff.
Stage 1
After the initial referral is received, it is managed by a cardiac nurse specialist who approaches the patient,
often on the hospital ward, to begin the rehabilitation process through the provision of clinical advice and
educational materials. Where appropriate, the individual is also offered a clinic appointment at a community-
based service after their discharge from hospital.
Stages 2 and 3
Individuals who elect to attend the clinic appointment with a cardiac nurse receive a multidimensional
assessment, covering both physical and mental health status (stage 2), and a care plan is developed to support
their rehabilitation needs (stage 3). Individuals deemed medically suitable for a cardiac rehabilitation are then
invited to attend the next available structured programme in their locality.
Stage 4
Structured cardiac rehabilitation programmes offer participants the opportunity to receive further education and
support in relation to cardiac risk factor modification and psychosocial health, as well as undertake a supervised
exercise programme. Current guidance recommends that programmes are delivered twice weekly over a period
of 8 to 12 weeks.27
Stages 5 and 6
On completion of the structured cardiac rehabilitation programme (or at the point the patient chooses to
withdraw from the care pathway), when possible, the cardiac nurse specialist conducts a final assessment of
the individual’s physical and mental health status (stage 5), before organising the discharge into existing
community services, making any referrals that are deemed appropriate (stage 6).
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recommended by the National Institute for Health and Care Excellence (NICE) as first-line treatments.33,34
However, there are problems with antidepressant medications, which include side effects, poor patient
adherence and relapse risk on cessation of prescribing. Service user organisations and mental health policy
advisors advocate greater availability of a range of psychological therapies, which many people prefer, in
part because of the problems with antidepressant medications, but also because patients can learn skills to
help manage depression.35
Cognitive behavioural therapy has been shown to be of similar efficacy to antidepressant medication.36
However, CBT offers two major advantages: (1) it is consistent with many service users’ preferences for
non-pharmacological treatment; and, (2) it modifies the illness trajectory, as its benefits continue post
treatment, by teaching skills to prevent depressive relapse in the long term. However, CBT may not suit
everyone, as not all individuals engage or adhere to it because of a combination of factors (e.g. the
investment of time, the burden of homework and the need to make cognitive and behavioural changes).37
In addition, CBT is typically offered only by specialist CBT therapists, because of the significant training
required; the high costs of training and employing sufficient therapists may therefore limit attempts to
access CBT. The Improving Access to Psychological Therapies (IAPT)38–40 programme in England has done
much to enhance access to psychological treatments (recovery rates are at approximately 50%), and
recently has extended its scope to people with depression and long-term conditions, including CHD.
However, the capacity of the IAPT programme to reach this patient group and its acceptability are as
yet untested.
Another psychological therapy that is a potential alternative to CBT is that of behavioural activation (BA).
BA alleviates depression by focusing directly on changing behaviour.41 Behavioural theory postulates that
depression is sustained by avoiding many usual activities, and as individuals withdraw and disrupt their
basic routines, they become isolated from positive reinforcement opportunities in their environment. Thus,
individuals may end up stuck in a cycle of depressed mood, decreased activity and avoidance of activities.41
BA systematically disrupts this cycle through encouraging individuals to initiate action despite the presence
of negative mood, counteracting their natural tendency to withdraw or avoid activities.42 Although CBT
also incorporates behavioural elements and may also increase activities, its primary techniques focus on
changing maladaptive beliefs43 by initiating behavioural experiments to test specific beliefs. BA also
explicitly prioritises the treatment of negatively reinforced avoidance and rumination. The rationale for BA
is simpler to understand and operationalise for both patients and mental health workers. The focus of BA
on context and functioning is also closely aligned to the ethos of cardiac rehabilitation services. The relative
simplicity of BA makes it more straightforward to train non-mental health nurses in its application.44–46
Evidence regarding the clinical effectiveness of BA for the treatment of depression in general populations is
available from two recent systematic reviews.47,48
Ekers et al.47 synthesised evidence from randomised controlled trials (RCTs) of BA for depression with either
control patients [waiting list, usual care (UC) or placebo] or participants taking antidepressant medication.
Data from 25 trials (1088 participants) were pooled in a meta-analysis, which reported post-treatment
depressive symptom levels to be significantly reduced with BA compared with controls [25 studies, n = 1088;
standardised mean difference (SMD) –0.74, 95% confidence interval (CI) –0.91 to –0.56]. Although far
fewer trials compared post-treatment outcomes for BA with those for antidepressant medication, the effect
size estimate favoured BA (four studies, 283 participants; SMD –0.42, 95% CI –0.83 to 0.00). However,
these data should be interpreted with some caution, as the upper boundary of the 95% CI bordered the
value of no effect.
A second review, by Shinohara et al.,48 compared the effectiveness of behavioural therapies for the
management of depression with other psychological therapies within five major categories (cognitive–
behavioural, third-wave cognitive–behavioural, psychodynamic, humanistic and integrative therapies).
Synthesising data from 18 trials (690 participants), the authors concluded that the treatment response
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rates of behavioural therapies were comparable to other psychological therapies [risk ratio (RR) 0.97,
95% CI 0.86 to 1.09] and were broadly acceptable to participants.
It is noteworthy that both review teams noted that the methodological quality of selected studies was low
and that there remains some uncertainty regarding the effectiveness of BA,47,48 particularly with regard
to the longer-term outcomes.47 However, a very recent National Institute for Health Research (NIHR)
Health Technology Assessment (HTA) programme-funded non-inferiority RCT [the Cost and Outcome of
Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA) trial]49 comparing
BA with CBT has shown that BA is not inferior to CBT for the treatment of depression.50 In this trial,
which randomised 440 participants to BA or CBT, 66% of participants receiving BA or CBT were recovered
from depression at 12 months post randomisation, with benefits extending to the same degree at the
long-term 18-month follow-up point. The COBRA trial also reported the costs of BA to be lower than
CBT (an incremental cost-effectiveness ratio of –£6865), with this difference largely attributable to BA
being delivered by people with less expertise in psychological therapies. This finding is consistent with
data reported from a small RCT of BA (n = 24) versus treatment as usual (n = 23), which reported an
incremental cost-effectiveness ratio of –£5756 in favour of BA.51 The evidence, therefore, is now much
clearer that BA is an effective, and less costly, front-line treatment for depression in general populations.
Clinical effectiveness of collaborative care approaches in the general population
Despite the proven clinical effectiveness of depression treatments, a number of studies have shown that
individuals often have difficulty accessing or maintaining contact with high-quality mental health care.
Under these circumstances, effective care for people with depression may require a system-level intervention
aimed at overcoming barriers to accessing services and increasing co-ordination of mental health care.
Such system-level interventions can be managed in primary care as part of a stepped-care algorithm to
ensure optimal access to, and co-ordination of, psychological or pharmacological interventions of proven
clinical effectiveness.32–34
Collaborative care is one example of such a system-level intervention aimed at overcoming barriers to
mental health care for people with depression. Collaborative care is a complex intervention52,53 in which a
number of health professionals work together to ensure the individual accesses appropriate, evidence-based
care to suit their mental health-care needs. In this model, a case manager trained in mental health-care
co-ordination works closely with a medical doctor [often the person’s general practitioner (GP)] and mental
health specialist services. The case manager is responsible for generating a structured management plan
to support the patient’s access to evidence-based treatment based on best-practice guidelines. The case
manager will then implement the care plan, providing the patient with scheduled follow-ups to monitor
their progress (in person or over the telephone/internet), provide specific interventions (or make the
appropriate referrals), encourage treatment adherence and monitor symptoms. Another core goal of such
a model is to enhance interprofessional communication across the wider care team.
A 2012 Cochrane review synthesised evidence from 79 RCTs (24,308 participants) comparing collaborative
care with either UC or alternative treatments for people with depression and anxiety.53 Although the
evidence was of variable quality, the primary analysis found collaborative care to be superior to the
comparator condition for reducing depressive symptoms in the short term (0–6 months, 30 studies,
5984 participants; SMD –0.34, 95% CI –0.41 to –0.27) and medium term (7–12 months, 13 studies,
4092 participants; SMD –0.28, 95% CI –0.41 to –0.15). Although one study observed long-term effects
(13–24 months) in favour of collaborative care, as these data were derived from only one study
(1379 participants; SMD –0.35, 95% CI –0.46 to –0.24), the generalisability of this finding should be
treated with caution. There was also some evidence of benefits in other outcomes including medication use,
mental HRQoL and participant satisfaction, although benefits in terms of physical quality of life remained
uncertain. Although many of the published trials are not from the UK, a recent large Medical Research
Council (MRC)/NIHR-funded two-arm cluster RCT (n = 581) found collaborative care to be clinically effective
(and cost-effective) for people with depression in UK primary care, and of particular note is that two-thirds
of this trial sample also had comorbid physical health problems.54 A second recent cluster RCT found similar
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results when testing collaborative care exclusively in a UK primary care-based population with depression
and a comorbid physical health problem (diabetes mellitus or CHD).55
Clinical effectiveness of psychological care for people with coronary heart disease
In the previous section, Effectiveness of psychological therapies in the general population, we reviewed the
evidence of clinical effectiveness of psychological therapies and mental health collaborative care models
tested in the general population samples of people with depressive symptoms. There is also a considerable
body of evidence regarding the clinical effectiveness of psychological therapies designed specifically for
use for people with CHD. Similar psychological techniques (e.g. CBT, BA) may be applied in isolation or
combined with other psychological interventions (e.g. stress management or problem-solving skills training)
as part of multifaceted treatment packages. The target population and setting can vary. Some interventions
target people with coronary disease irrespective of their baseline psychological health, whereas others adopt
a more selective approach, offering interventions only to those individuals screening positive for an existing
psychological condition.
Two systematic reviews56,57 have used meta-analytic techniques to synthesise evidence on the clinical
effectiveness of psychological interventions for people with CHD. Direct comparisons between these reviews
are problematic because of the important differences in the application of methods and definitions. Both
reviews selected studies in which the direct effects of psychological interventions were compared with a
comparator group (mostly usual medical care with or without cardiac rehabilitation) on measures of
depressive symptoms. However, Dickens et al.56 selected studies with any length of follow-up (ranging from
5 days to 12 months), and reported only psychological outcomes. In contrast, Richards et al.57 selected
studies that followed up participants for a minimum of 6 months (range 6 months to 10.7 years) and
reported evidence for clinical events (e.g. mortality, cardiac morbidity), as well as the psychological outcomes
of depressive symptoms and anxiety and stress levels. Both reviews also undertook metaregression analyses,
seeking to explore whether or not intervention effectiveness was mediated by their use in unselected
populations, as opposed to targeting people with existing psychological conditions. Although the studies
applied different taxonomies, both reviews also sought to identify potential explanatory components of
psychological interventions. Notwithstanding differences in study methods, there was some consistency in
the findings from these reviews.
Analysing data from 62 studies (17,397 participants), Dickens et al.56 observed a small but statistically
significant improvement in depression for psychological interventions compared with UC (SMD 0.18,
95% CI 0.12 to 0.24). Subgroup analysis identified certain treatment components with small beneficial
effects on depressive symptoms, including general education, problem-solving, skills training, exercise, CBT
and relaxation. In a subgroup analysis, there was also a small effect observed in favour of psychologically
based interventions (SMD 0.21; 12 trial arms), when targeted at people with coronary disease and clinical
depression, as compared with untargeted populations.
In the second review, Richards et al.57 synthesised data from 35 studies (10,703 participants), including
12 studies that recruited patients with an established psychopathology (eight studies selected people
with depression), and from 19 studies reporting some levels of psychopathology within their participant
samples. The interventions tested were mostly multifactorial in nature, designed to address a number of
different treatment goals (e.g. reducing stress levels, improving mood states, improving coping strategies,
emotional support), through combining psychological techniques (e.g. stress management, CBT or
behavioural therapies).
Richards et al.57 found no significant differences in the effects of psychological interventions versus the
comparator group in terms of total mortality (23 trials, 7776 participants; RR 0.90, 95% CI 0.77 to 1.05)
and the risk of subsequent revascularisation (13 trials, 6822 participants; RR 0.94, 95% CI 0.81 to 1.11)
or of a non-fatal infarction (13 trials, 7845 participants; 0.82, 0.64 to 1.05). However, there was some
evidence that cardiac mortality was reduced (11 trials, 4792 participants; 0.79, 95% CI 0.63 to 0.98).
When considering psychological outcomes, interventions based on psychological therapies resulted in
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significant improvements in the participant-reported levels of depressive symptoms (19 trials, 5825
participants; SMD –0.27, 95% CI –0.39 to –0.15), anxiety levels (12 trials, 3161 participants; SMD –0.24,
95% CI –0.38 to –0.09) and stress levels (eight trials, 1251 participants; SMD –0.56, 95% CI –0.88 to
–0.24). Metaregression exploring a limited number of intervention characteristics found no significant
predictors of intervention effects for the outcome of cardiac mortality. Unlike Dickens et al.,56 psychological
therapies combined with adjunct pharmacology (when deemed appropriate) prescribed for an underlying
psychological disorder were found to be more effective than interventions that did not combine
psychological and pharmacological therapies (difference in effect size β = –0.51; p = 0.003). For anxiety,
interventions recruiting participants with an underlying psychological disorder appeared to be more effective
than those delivered to unselected populations (β = –0.28; p = 0.03), although this finding was not
replicated for the outcome of depressive symptoms.
Although somewhat different in focus and methodology, both reviews consistently demonstrated that
providing psychological interventions for people with established CHD yields small, but statistically significant,
improvements in participant-reported levels of depressive symptoms. However, given the multicomponent
nature of the interventions tested, combined with the diverse patient groups and settings in which such
interventions were tested, it is not possible to ascertain which psychological treatment components may be
most effective and for whom.
Clinical effectiveness of collaborative care approaches for people with heart disease
More recently, rather than evaluating the clinical effectiveness of psychological interventions, research is
focusing on the clinical effectiveness of collaborative care for people with coronary disease and depression.
Consistent with the care models developed in general populations, the focus is not to evaluate the clinical
effectiveness of individual psychological therapies per se. Rather, the aim of collaborative care is to ensure
that individuals with heart disease and depressive symptoms receive best-practice psychological care
through appropriate assessment, symptom monitoring, referral to psychological therapists and, where
appropriate, the provision of pharmacological therapy. Psychological care is delivered by a care manager
and the wider clinical care team members, who work with the individual over a period of time to tailor
their preferences for care with recommendations based on their symptoms and previous experiences. In
some models, the care manager also provides elements of psychological therapy.
A recent systematic review by Tully and Baumiester58 synthesised data from six RCTs (1284 participants),
which randomised participants to either collaborative care or a UC comparator group. Although there was
no evidence of a sustained reduction in major adverse cardiac events (including mortality or morbidity)
arising from collaborative care, small reductions favouring collaborative care were found in the short term
(3–12 months) for depressive symptoms (six studies, 1277 participants; SMD –0.31, 95% CI –0.43 to
–0.19; p < 0.00001) and anxiety symptoms (four studies; SMD –0.36, CI –0.54 to –0.17; p < 0.0001),
and mental HRQoL improved (five studies; SMD 0.24, 95% CI 0.08 to 0.38; p = 0.003), although no
differences were observed for physical HRQoL.
Rationale for current research
This study was undertaken in response to a NIHR commissioning brief in 2013, which invited research
addressing the question: What is the clinical and cost-effectiveness of enhanced care for new onset
depression post cardiac event? The brief envisaged that the intervention would involve enhanced,
non-pharmacological care for depression tailored to adults with new-onset depression after an acute
cardiac event. The intervention was required to be easily deliverable in the NHS, and integrated within
existing NHS cardiac rehabilitation during the recovery phase.
In responding to this brief, our review of the literature regarding the clinical effectiveness of psychological
treatments was inconclusive. Recent systematic reviews56–58 report modest, but statistically significant,
reductions in depressive symptoms for patients with coronary disease receiving psychological treatments,
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although the methodological quality of studies selected is such that it precludes firm conclusions regarding
which treatment components are most effective and who should be targeted for intervention.
Most intervention studies have recruited participants immediately following an acute cardiac event, and the
complexity of depression in that period may have contributed to the lack of conclusive evidence regarding
the treatment response. The reasons for the limited benefits of conventional depression treatments in
patients with CHD are not clear, although three factors are noteworthy.
First, depression that starts after an ACS is different from depression in the general population.22 Post-ACS
depression does not have the usual risk factor profile as that observed for the general population; instead,
it is associated with ongoing cardiac symptoms and increased concerns about health,59,60 which may act to
reduce the response to conventional treatment.61 Second, established psychological treatments, such as
CBT, that encourage recall of past experience and challenge maladaptive thoughts may be too traumatic
for people who have suffered a recent life-threatening event. Finally, the psychological therapies available
through IAPT may not be widely available to people with CHD. Indeed, in 2013 a qualitative study of people
undergoing cardiac rehabilitation62 concluded that management of depression should be embedded within
cardiac rehabilitation teams, rather than as another source of onward referral. As UK cardiac rehabilitation
services experience significant patient attrition at each stage of the rehabilitation pathway (53% attrition
prior to commencing a structured programme), and 19%26 of individuals are found to have depressive
symptoms upon initial assessment, another outward referral for psychological care may be a barrier to
accessing timely care.
If a relatively simple psychological treatment of proven benefit in general populations of people with
depression, such as BA,47,50 has the potential to be safely and effectively embedded within the cardiac
rehabilitation service, this could holistically tackle the depressive symptoms at the same time as physical
rehabilitation, as part of patient case management. Similarly, acknowledging that attrition from rehabilitation
is high, we also believe that any attempt to enhance psychological care should include training cardiac
rehabilitation nurses (who routinely screen for depressive symptoms) to apply evidence-based mental health
referrals. Such a mental health collaborative care approach should also be in place for patients completing
structured cardiac rehabilitation programmes, but whose depressive symptoms do not respond to
psychological treatment.
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Chapter 2 Aims and objectives
Feasibility study aims
The overarching aim of the feasibility study was to design an enhanced psychological care (EPC) intervention
for the management of patients with new-onset depressive symptoms, composed of care co-ordination and
BA, and to test its implementation within routine cardiac rehabilitation settings. We also sought to specify
the psychological components within UC for patients with depressive symptoms using cardiac rehabilitation
services (NHS care pathway stages 2–5; see Figure 1) following an acute cardiac event. There were
five objectives:
(1a) To describe the content of psychological support routinely offered by cardiac rehabilitation services,
including active treatments offered by rehabilitation teams, or referral practices to existing NHS
mental health services.
(1b) To develop, and refine, the underlying intervention theory of a standardised EPC intervention
(including a supporting intervention manual and training package) for implementation by cardiac
rehabilitation nurses.
(1c) To determine the feasibility, and acceptability, of implementing/experiencing EPC from the
perspectives of cardiac rehabilitation staff and patients.
(1d) To describe process measures, including: (1) the number of patients with new-onset depressive
symptoms identified during the initial cardiac rehabilitation assessment (NHS care pathway stages 2–3);
(2) participant attendance at, and adherence with, the comprehensive cardiac rehabilitation programme
with an embedded EPC aimed at treating depression, and the time elapsed to the start of treatment;
and (3) the psychological care co-ordination activities provided to participants when exiting from the
cardiac rehabilitation care pathway.
(1e) To develop and undertake preliminary testing of study methods (cardiac rehabilitation team and
participant recruitment, data collection procedures) required to implement a pilot trial.
To address these objectives, a multimethod feasibility study was undertaken, including a qualitative study
involving cardiac rehabilitation staff and patient participants (addressing objectives 1a, 1b and 1c) and a
before-and-after observational study (addressing objectives 1b, 1d and 1e).
External pilot trial aims
The main aim of the pilot trial that followed the feasibility study was to test the methods and procedures
required to undertake a fully powered evaluation of the clinical effectiveness and cost-effectiveness of
cardiac rehabilitation teams implementing EPC for individuals with new-onset depressive symptoms using
cardiac rehabilitation services compared with cardiac rehabilitation delivering UC. There were four objectives:
(2a) To quantify the flow of patients from the cardiac event to the 8-month follow-up for patients
entering into the cardiac rehabilitation care pathway, and to document the flow of those
participants who agreed to take part in the pilot trial (i.e. eligibility, recruitment and attrition).
(2b) To collect participant outcome data in order to estimate the standard deviation (SD) for various
continuous outcomes to inform sample size calculations (number of cardiac rehabilitation teams and
participants) for a definitive trial.
(2c) To establish the data collection methods required to support a definitive economic evaluation.
(2d) To gather qualitative evidence from patient participants (including participants who did or did not
adhere to the EPC, and from those patients who declined to take part in the trial) and from nurses
on the acceptability of receiving/implementing EPC, on the appropriateness of study methods and
procedures, and on the content of usual psychological care within cardiac rehabilitation services.
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Chapter 3 Study methods
Consistent with MRC’s guidance for the development and evaluation of complex interventions,63a two-phase study was undertaken. The first phase included a multimethod feasibility study composed
of qualitative and observational methods, and the second phase entailed a pilot cluster RCT, which also
tested the methods for economic data collection and included a nested qualitative study.
Feasibility study design
The feasibility study was designed to support the development and preliminary testing of the EPC
intervention, and to undertake an early evaluation of study methods and procedures before undertaking
the pilot RCT. A before-and-after observational study was combined with observations of UC and
qualitative interviews with cardiac nurses and patient participants.
Observational study
Feasibility study intervention
Enhanced psychological care was a complex intervention, comprising nurse-led BA therapy and mental
health-care co-ordination. The intervention was developed and delivered by experts within the research team
who had used BA in other clinical trials conducted in general populations of patients with depression.44,50,54
Current UK NICE guidance33 was used as the basis for the mental health-care co-ordination component of
EPC. This guidance recommends the regular review of participants’ symptoms, including them in decisions
about their treatment and, when necessary, referring them to their GP and/or existing community or primary
care mental health services, either during or on their point of discharge from EPC.
Before taking part in the study, nurses from participating cardiac rehabilitation teams underwent a 2-day
training course covering the topics of BA, mental health-care co-ordination, managing mental health risk
issues (e.g. suicide ideation) and delivery of the intervention. Each nurse was given a manual (version 2,
20 August 2014; available on request from the study team) providing detailed information to support their
delivery of EPC. Once trained, nurses were asked to start consecutively screening all patients for depressive
symptoms during their initial cardiac rehabilitation assessment and to offer study entry to eligible
participants. Nurses delivering EPC to one or more patients received weekly supervision from a clinical
supervisor with mental health expertise working within the study team. Supervision was conducted by
telephone, with nurses receiving individual supervision.
In the UK, the NHS routinely offers multidisciplinary cardiac rehabilitation following a seven-stage standard
patient care pathway (see Figure 1).3,27 Cardiac rehabilitation programmes usually consist of an initial
assessment, with a structured 6- to 8-week programme with up to two sessions each week. However, the
precise content of a cardiac rehabilitation session can vary across sites, and could include a clinic appointment
during which the patient’s underlying cardiac condition would be monitored/discussed, a rehabilitation fitness
session would be overseen by a nurse or there would be a group education session. It was recommended
that nurses provide EPC once per week to participants, at a point in a rehabilitation session that was deemed
to be appropriate based on local circumstances.
At the start of rehabilitation, the nurse provided the participant with a CADENCE (enhanced psychological
CAre in carDiac rEhabilitatioN serviCEs for patients with new-onset depression compared with usual care)
participant handbook (version 2, 20 August 2014), and asked that they read it before the next session.
The nurse then provided an individually tailored treatment programme of BA and care co-ordination
(as appropriate) across the course of the rehabilitation programme. Although there was some flexibility in
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how EPC was delivered, some elements of the intervention were deemed to be central. The intervention
protocol advised that each EPC session should comprise:
1. The monitoring of depressive symptoms, using the Patient Health Questionnaire-9 (PHQ-9),64,65 and of
anxiety, using the Generalised Anxiety Disorder-7 (GAD-7)66 instrument; these tools replaced the HADS,
which cardiac nurses had previously used to monitor symptoms of anxiety and depression; this change
was implemented because both GPs and community mental health services routinely use the PHQ-9
and the GAD-7 to make treatment decisions/referrals; unlike the HADS, the PHQ-9 also asks individuals
to report any suicidal ideation, the identification of which is core to the safe and effective management
of depression. Thus, the change from the HADS to the PHQ-9 was intended to facilitate seamless
mental health-care co-ordination by ensuring that clinicians communicated the symptoms burden and
risk safely and effectively.
2. Monitoring of suicide and self-harm risk at every nurse–participant contact, and procedures to manage
such risks should they arise.
3. Participant self-monitoring through the completion of a mood–activity diary between rehabilitation
sessions; at each session, the participant and nurse undertook a functional analysis of the diary, aiming
to identify patterns of behaviour linked to high mood. Participants were encouraged to identify valued
activities, and triggers to ‘depressed behaviours’; after identifying different coping strategies, over the
following week, participants were encouraged to schedule other routine, pleasurable and necessary
activities to replace those behaviours associated with low mood.
4. Application of mental health-care co-ordination algorithms targeted at those individuals whose low
mood had not resolved during EPC (a PHQ-9 score of ≥ 10), or participants who elected not to continue
with BA as part of their rehabilitation programme. On completion of cardiac rehabilitation, the
participant’s GP was routinely informed of the psychological care provided, and of the last PHQ-9 and
GAD-7 scores recorded during symptom monitoring.
Nurses were asked to record patient participation with EPC in their nursing notes during the course of
cardiac rehabilitation attendance.
Settings and participants
The observational study aimed to recruit up to 20 eligible participants from three locality-based
comprehensive cardiac rehabilitation teams in Devon, south-west England. Early discussions with cardiac
rehabilitation specialists suggested that the study intervention would be delivered by cardiac nurse(s) from
locality-based teams that were operationally distinct (i.e. there was no crossover of staff) from neighbouring
teams. Thus, in some teams it might be necessary to train more than one nurse, particularly if two nurses
work interchangeably to provide continuity of care for individual patients within their locality.
Sample size
Consistent with the feasibility design, no formal sample size calculation was undertaken; rather, a target
sample (three teams, 20 participants) was deemed sufficient to provide the preliminary data required to
test our feasibility study aims; that is, ensuring that nurses had sufficient experience of delivering EPC
(circa eight or nine patients per team) to comment meaningfully on the intervention design.
Participant inclusion and exclusion criteria
Inclusion criteria
Adult patients (aged ≥ 18 years) referred for cardiac rehabilitation based on local clinical referral protocols
were eligible to take part in the observational study. The inclusion criteria included patients admitted with an
ACS (i.e. STEMI or NSTEMI and unstable angina), and/or following a coronary revascularisation procedure (i.e.
CABG or PCI). At the time this study commenced, this constituted the majority of patients referred for cardiac
rehabilitation services in the UK [the 2012 National Audit of Cardiac Rehabilitation (NACR)28]. Patients with
a new episode of depressive symptoms were identified through nurse screening during their initial cardiac
rehabilitation appointment. Those patients scoring ≥ 10 using the PHQ-9 were eligible for inclusion (note that
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this meant that participating teams changed their usual practice of monitoring mood using the HADS29 to
monitoring mood using the PHQ-9 and the GAD-7). This cut-off point was chosen to aid identification of
people with at least moderate depression,67 but also to maintain alignment with primary care psychological
services (IAPT), which offer treatment for people with PHQ-9 scores of ≥ 10 upon referral from GP-based
services.
Exclusion criteria
Patients who reported that they were actively treated for depression (psychological or drug therapy) in the
6 months before their acute cardiac event were excluded. The nurse also excluded patients for whom there
was evidence of alcohol or drug dependency, when the participant was acutely suicidal or when there was
evidence of poorly controlled bipolar disorder or psychosis/psychotic symptoms based on a clinical review
(and having sought external confirmation from the GP or other clinicians as required). Potential participants
also needed to have sufficiently good English-language skills to engage with both the mental health-care
co-ordination and BA components of the EPC intervention, or to be willing to work with a NHS translator if
required, and to provide informed consent to take part.
Participant recruitment procedure
All cardiac rehabilitation nurses were trained to apply a structured checklist to ascertain participant eligibility
based on the study’s inclusion/exclusion criteria. Eligible participants were identified by cardiac rehabilitation
nurses during their initial clinic appointment (NHS care pathway stage 2/3) before commencing the structured
rehabilitation programme (stage 4). Eligible patients were asked by the nurse to take part in the observational
study and associated qualitative interview study, and provided with brief study information to take away and
review. The nurse asked for patients’ permission to pass their contact details onto a researcher, who was
independent of the clinical team.
Within 2 working days of receipt of a completed ‘permission for release of personal details’ form from the
cardiac team, the researcher contacted the potential participant to discuss the study. During this initial
telephone call, the researcher confirmed that the patient was currently not receiving any form of active
treatment for their depressive symptoms. The individual was provided with the opportunity to ask any further
questions about the study. For those individuals who were happy to progress, the researcher agreed a date
for the face-to-face baseline home visit within 1 week, and sent a confirmation letter, which included a
detailed participant information sheet for their review. During the baseline visit, the researcher once again
briefly reviewed the study eligibility criteria to ensure that there had been no major changes in their
treatment for depression since referral. The researcher then went through the participant information sheet
and answered any remaining questions that the individual raised. The participant was reminded that their
involvement was entirely voluntary, that their usual health care would not be affected by their decision to
take part, and that they could withdraw from the study at any point without giving a reason. If the individual
was happy to proceed, written consent was obtained prior to completion of the baseline assessment. The
baseline assessment was typically conducted before the participant commenced their comprehensive cardiac
rehabilitation programme. Mental health-care co-ordination was implemented for participants who
subsequently elected not to attend the rehabilitation.
Data collection and analysis procedures
The aim of this feasibility study was to collect preliminary data regarding process measures relating to the
flow of participants in the study and the adequacy of data collection procedures. We therefore restricted
data collection to a baseline interview and a single 5-month follow-up, and a subset of process and
outcome measures was assessed.
Process measures
Process data were collected in relation to patient throughput and intervention fidelity. To ascertain study
eligibility and recruitment, cardiac rehabilitation nurses completed a screening log, recording the numbers
of patients attending an initial nurse assessment, the proportion identified with depressive symptoms
during this assessment, the prevalence of new-onset (as opposed to existing) depression and the number
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of patients who were deemed eligible for study participation. The nurse screening log also captured brief,
anonymised data on patient sociodemographic characteristics (e.g. age, sex, ethnicity/preferred language)
and on the clinical conditions resulting in the cardiac rehabilitation referral, allowing the characteristics
of our sampling frame to be described. For eligible patients, the nurse also recorded the number of
participants offered study entry and the number who later agreed to be contacted by a researcher.
The research team documented the number of individuals who subsequently consented to take part and
who underwent a baseline interview. Descriptive statistics documenting the flow of patients through the
study procedures are presented.
For this study, intervention fidelity was assessed through a review of cardiac nurse notes conducted by
the researcher. We documented the numbers of people recruited to the study who subsequently did not
attend the structured rehabilitation programme. For participants who commenced intensive rehabilitation
with EPC, we assessed adherence by recording the number of BA sessions offered and the number of
sessions attended. We reviewed the nursing notes for all participants, and recorded the number with
documentary evidence of mental health-care co-ordination on exiting cardiac rehabilitation and the type
of mental health referrals made (if appropriate).
Adequacy of data collection procedures
As this was a feasibility study, we restricted our focus to testing the completeness of data relating to
participant-reported outcome measures at baseline and the 5-month follow-up (i.e. excluding cardiac
morbidity and mortality, and health-care resource use). A full description of the participant-reported
outcome measures collected at both time points is provided under the description of the pilot trial methods
(see Data collection procedures). Descriptive statistics were presented on the number of participants
completing assessments and the completeness of data recorded therein. Descriptive summaries of the
baseline and 5-month outcomes were also calculated.
Qualitative study
Data collection procedures
Although broadly following the NHS cardiac care pathway, discussions with clinical co-applicants and
participating teams indicated that there was considerable variation between the cardiac teams on how
cardiac rehabilitation was delivered. Thus, before EPC was operationalised by participating teams/nurses,
the qualitative researcher conducted observations of UC within each study team to assess what variations
existed. These observations indicated that the study teams varied in terms of their patient waiting list times,
how cardiac rehabilitation was delivered, what room facilities were available to cardiac nurses and how
many cardiac rehabilitation sessions were offered to patients. These insights informed the development of
the intervention and the nurse training package prior to nurses being trained and EPC being implemented.
During the qualitative study, observations were also made of the nurse training. All observations were
recorded by the qualitative researcher using field notes. This researcher also took notes during the early
informal discussions held with participating nurse teams about the practicalities of, and barriers to,
EPC delivery.
Nurses were interviewed within 4 weeks of completing EPC training, and before they started to deliver
EPC, to ascertain their views of the training and to identify any problems they envisaged in delivering EPC
within their rehabilitation programme. Nurses were interviewed again towards the end of delivering EPC
to study participants to explore their views on the acceptability of the intervention and the study materials,
and the extent to which they thought EPC could be embedded within cardiac rehabilitation services.
Nurses’ experiences of delivering the intervention were also gauged through nurse/clinical supervisor sessions
being observed and field notes being taken. In addition, the clinical supervisors wrote an anonymised
summary of the nurses’ experiences, detailing the issues identified during supervisory sessions relevant to
EPC delivery.
STUDY METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
16
Patient participants were interviewed once they had completed their EPC to explore their views and
experiences of receiving it. The aim was to interview approximately 15 patients, having purposefully
sampled individuals to achieve variation in relation to participant age and gender, the recruiting team
and treatment adherence (including patients who refused any cardiac rehabilitation, participants who fully
engaged with EPC and individuals who undertook EPC but did not complete treatment).
Nurse and participant interviews were conducted by an experienced qualitative researcher. Topic guides
were used to ensure consistency across the interviews (see Appendix 1). The content of the guides was
informed by the aims of the study, the research team’s knowledge of the literature and the intervention
and the insights gained through observations and discussions held early on in the study with nurses and
the intervention developers. The nurse and patient interview topic guides were developed in parallel to
ensure that key areas were explored during both sets of interviews, allowing findings from participant
and nurse interviews to then be triangulated, increasing the confidence with which conclusions could be
drawn. All nurse and participant interviews were digitally recorded and transcribed verbatim. Prior to
analysis, the transcripts were checked against the audio-recordings for accuracy and anonymised, with
individual participants being allocated a numerical identification code.
Protocol changes when implementing the qualitative feasibility study
A number of methodological changes were made to the protocol for the qualitative elements for the
feasibility study. These were made during the course of the feasibility study in response to insights gained
as the work progressed.
l The original protocol stated that a focus group would be conducted with nurses directly following their
training in EPC. Once the training package had been developed, it was clear that nurses would be
expected to attend a 2-day training course and that there would be little time at the end of the second
day to complete a focus group with those attending. To reduce the burden on nurses, a decision was
made to replace the focus group with a brief one-to-one telephone interview conducted within
4 weeks of the training.
l We had originally planned to interview patients who were eligible for the study but who declined to
take up cardiac rehabilitation to ascertain the reasons behind their decision. However, it became
apparent that patients who refused cardiac rehabilitation usually did not attend the initial appointment
with the nurse. As this meant that we could not determine which of these patients would be eligible
for study participation (i.e. those who had low mood), these interviews were not conducted.
l Initially, we had planned to interview nurses on two occasions during the period in which they were
delivering EPC. The first interview was scheduled to be conducted early on in the delivery of EPC to
explore nurses’ initial experiences of delivering BA. The second interview was to be conducted once
they had finished providing EPC. The first interview was dropped, as issues relating to the early EPC
implementation formed the basis of clinical supervision sessions and, with the nurses’ consent, the
supervisors were willing to let the qualitative researcher sit in on the supervision sessions.
l The protocol stated that the qualitative researcher was to conduct observations of the nurses’ provision
of the intervention to assess implementation and integration of EPC into existing care. However, as
participant recruitment was much lower than anticipated (only one of the four nurses provided care to
more than one patient), we elected not to conduct these observations, as we anticipated that the nurses
would be uncomfortable with being observed at this early stage of delivering a new intervention.
l Finally, we aimed to invite staff from the wider cardiac rehabilitation teams to contribute to a focus
group discussion on whether or not the provision of EPC had affected them. However, it became
clear that the cardiac rehabilitation nurses were working in isolation, and thus it was unlikely that the
provision of EPC would impact upon other team members. Instead, a question was added to the nurse
topic guide to enquire as to whether or not the nurses were aware of anyone else from the immediate
clinical teams being affected by the intervention.
Our sponsors and funders were notified of all of these protocol changes.
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Qualitative data analysis
Notes taken during the observations were read and re-read by the qualitative researcher, who then fed
back key points that were relevant to the design and delivery of the intervention to the rest of the
research team.
Interview data were analysed thematically, focusing on how study materials and nurse training could be
improved in terms of making them more acceptable for nurses, and the intervention could be improved in
terms of its effective implementation in practice and its acceptability to nurses and participants.
Transcripts from the nurse and participant interviews were read and re-read by two members of the
research team to gain an overall understanding of the accounts given, to ascertain emerging themes and
to develop an initial coding frame. The two researchers then independently coded a sample of transcripts
and discussed their preliminary coding and interpretation of the data. The coding frame was then revised,
with new codes being developed and existing codes being defined more clearly or deleted. Once both
researchers had agreed the coding frame, transcripts were manually coded and data under each code
were summarised in a table, using an approach based on framework analysis.68 Having done this,
comparisons were then made within and across the data. When coding the nurse and patient interviews,
similar codes were used, when possible, to allow for triangulation of findings between data sets. Nurse
and patient data sets were analysed separately to ensure that a thorough understanding of each group’s
account was established before comparisons were made between the views held by patients and nurses.
The findings from the observations and interviews were fed back and discussed within the wider research
team throughout the feasibility study, so that changes could be made to the intervention and study
materials prior to undertaking the pilot trial.
Design of the pilot randomised controlled trial
The second phase of research included a pilot RCT, the testing of economic data collection procedures and
a nested qualitative study.
An external pilot cluster RCT69,70 was undertaken. We recruited eight comprehensive cardiac rehabilitation
teams (clusters) and randomised five of these to EPC plus UC embedded within cardiac rehabilitation
(intervention), and the other three to usual cardiac rehabilitation care (control). The decision to allocate
more clusters to the intervention arm was informed by data emerging from our feasibility study (see
Chapter 4, The transition between feasibility study and pilot study), which suggested that participant
recruitment would be slower than anticipated. We therefore sought to ensure that a sufficient number of
nurses and patient participants had exposure to EPC to support the aims of the qualitative study interviews
(i.e. recruiting enough participants with experience of EPC).
Randomisation and allocation concealment
A cluster randomised design was adopted in preference to individual randomisation to ameliorate concerns
around potential contamination between the intervention and control arms (i.e. intervention participants
coming into direct contact with control participants and sharing aspects of their treatment). Our EPC
intervention included training for cardiac rehabilitation nurses to provide mental health-care co-ordination to
participants with depressive symptoms. Once trained, we judged that it would be very difficult operationally
for the nurse to apply care co-ordination to only the subset of their patients randomised to receive EPC
(as would be required with individual randomisation).
Randomisation was carried out by the trial statistician (FCW), who was independent of the recruitment of
rehabilitation teams or patient participants. The allocation sequence was generated using computer-
generated random numbers. Cluster randomisation was balanced (to the extent possible) by team type
(community, hospital or mixed community and hospital teams) and patient throughput at the initial cardiac
rehabilitation assessment (NHS care pathway stage 2/3; categorised as low/high). The latter cut-off point
between low/high throughputs was determined post hoc after scrutinising the mean monthly throughput
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across cardiac rehabilitation teams, with ‘low’ being equivalent to ≤ 22 patients per month, and ‘high’ being
equivalent to > 22 patients per month (these cut-off points were based on a natural break in the distribution
of team throughput assessed during a preparatory audit collecting data for a 2-month period in January and
February 2015). The throughput of new patients assessed by cardiac rehabilitation teams was selected as a
stratifying variable, as this appeared to be a better predictor of team workload than staffing levels, and
would ensure that a sufficient number of patient participants were recruited into each trial arm. Team setting
was selected as a stratifying variable, as our feasibility study suggested that teams working in hospital or
community settings, or in a combination of both, may encounter different resource issues that could affect
the delivery of EPC.
Randomisation took place after all eight cardiac teams had been recruited. Each team was informed of its
allocation by the trial researcher.
Trial interventions
Usual care
Usual care is defined here as the standard NHS care pathway, commencing at the point of assessment
undertaken by a cardiac rehabilitation specialist nurse from a locality-based cardiac rehabilitation team
(see Figure 1).3,27 Of the people invited to attend an initial cardiac rehabilitation assessment, it is estimated
that less than half will attend a comprehensive rehabilitation programme offered within 2–10 weeks of
assessment (stage 4).28 Treatment as usual typically includes intensive rehabilitation for one or two sessions
per week for approximately 8 weeks. Sessions generally last around 2 hours, and include structured
exercise, education (e.g. managing lifestyle and cardiac risk) and some psychological input (e.g. relaxation,
stress management) in order to meet the core standards of care described by the BACPR.3 On exiting a
comprehensive rehabilitation programme, patients receive a final assessment (stage 5), and discharge
arrangements are made to community services (stage 6).
There is considerable debate as to what constitutes standard psychological care within cardiac rehabilitation.
Although most nurses will assess the patient’s mood using the HADS during the initial assessment, and on
completion of the rehabilitation programme, little is known about how this information is used as part of
care planning. National audit data found that psychological expertise within locality-based cardiac
rehabilitation teams is uncommon (< 10%),28 although some teams may refer patients onto specialist
mental health services if they have specific concerns regarding an individual’s mental well-being.
Enhanced psychological care
Based on our feasibility findings (see Chapter 4, Refinements to the enhanced psychological care intervention
prior to the pilot study), we made some important modifications to the EPC intervention before starting the
pilot study. The most fundamental changes in the delivery of EPC between the feasibility and pilot phases
were (1) an increased emphasis on the mental health-care co-ordination component of EPC and (2) a shift
from a ‘nurse-delivered’ to a ‘participant-led’ programme of self-help BA embedded within cardiac
rehabilitation, reflecting the need to reduce the impact of EPC on nurse time. The EPC training programme
and supporting materials, including the participant handbook (version 5, 4 June 2015) and nurse handbook
(version 5, 29 May 2015; available from the NIHR project website), were amended based on feasibility findings
(see Chapter 4, The transition between feasibility study and pilot study). Nurses were trained to implement
mental health-care co-ordination,33,34 including an embedded participant-led BA programme42,44–46,71,72 using
the restructured materials and training package. New materials were also provided to support nurses in
delivering EPC, including a structured form to insert in the participant’s clinical record for nurses to capture
core data on what aspects of EPC were offered at each session (see the EPC session planner in Appendix 2).
Patient-led, nurse-supported behavioural activation therapy
As in the feasibility study, the main psychological intervention consisted of six to eight sessions of BA flexibly
delivered face to face or via telephone (the latter was used for the follow-up session only). Sessions focused
on the three key components of BA: activity monitoring (recording what people were doing), functional
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analysis (developing a shared understanding of how activity relates to mood) and activity scheduling
(increasing pleasurable, routine and necessary activities that are less likely to maintain depression). Sessions
focused on encouraging the participant to follow the participant handbook and review progress, and
decreased the emphasis on the nurse leading the intervention. As a result, sessions were shorter, lasting
10–20 minutes, thereby reducing the burden on the nurse’s time.
The participant handbook (version 5, 4 June 2015) consisted of a structured programme aimed at enabling
participants to identify and re-engage with sources of positive reinforcement from their environment and
develop future strategies for managing their depressive symptoms. The handbook described the nature of
the BA intervention and the structure of the treatment patients would receive, and arrangements were
made to meet again to discuss the workbook and start the therapy. A functional analytical approach was
adopted as part of BA; participants were helped to develop an understanding of behaviours that might
interfere with meaningful, goal-oriented behaviours (e.g. negative avoidant behaviours). The handbook
also explained how to self-monitor mood, and then how to identify behaviour patterns associated with low
mood. Participants were encouraged to develop alternative behaviours that were goal-orientated, targeting
routine, pleasurable and necessary activities, and to undertake activity scheduling of these identified
behaviours. Although our pilot intervention involved a participant-led self-help BA manual, the cardiac
rehabilitation nurses were trained to support participants actively.
As in the feasibility study, each session began by assessing the patient’s symptoms (using the PHQ-9 and
the GAD-7) and assessing any identified risks of self-harm, suicide or risks to others. In session 1, the treatment
options were briefly discussed (BA with a cardiac nurse, referral to a GP or local IAPT services, or, if appropriate,
referral to psychological service provision associated with cardiac service, if available). Participants choosing
BA with the rehabilitation nurse were provided with a participant handbook (version 5, 4 June 2015). The
content of subsequent sessions remained flexible to accommodate different rates of progress, but also to
accommodate issues with physical health that frequently came up and needed to be dealt with immediately.
As serious physical problems could arise unpredictably and derail the discussions about BA, to operationalise
the treatment and allow calculation of the dose of BA (the number of sessions in which BA was delivered), it
was deemed to have occurred only if all of the following had occurred: an assessment of mood and risk, a
discussion of progress since last time and an agreement on a plan of activity for the next week.
Early sessions (2 and 3) still focused on encouraging patients to complete a diary of their activity throughout
their week, alongside a record of their mood rated on a 10-point scale (0 = lowest, 10= normal). Mid-range
sessions (3–5) focused on encouraging patients to identify the link between mood and activity (functional
analysis), although the tools to achieve this were simplified. Patients were encouraged to schedule in
achievable tasks (pleasurable, necessary and routine). Late sessions (6–8) continued the monitoring of mood
and activity and scheduling of further activities, but with an emphasis on identifying and reinforcing the
benefits of scheduled activities on mood, and considering the next steps (onwards referral if necessary, and
relapse prevention).
Mental health-care co-ordination
During the feasibility study, care co-ordination was conceived as occurring after BA to ensure that care was
handed on to another appropriate clinician when the cardiac rehabilitation nurses ceased to be involved.
What became apparent in the feasibility study was that considerably greater flexibility in mental health-care
co-ordination was required to accommodate patients with differing needs, that is, when patients refused
or discontinued BA or when the nurse did not have the capacity to support BA. Furthermore, in some
circumstances, a physical deterioration meant that nurses lost contact with patients (e.g. during readmission),
so psychological care could be delayed. Nurses were given the flexibility to co-ordinate care with another
clinician at any point during the patient’s journey, as they considered appropriate, and after discussion with
their supervisor.
To deliver mental health-care co-ordination, nurses were trained to apply clinical decision-making rules
based on current best practice,33,34 matching the intensity of treatment with participant preferences for
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mental health care. All patients referred to a cardiac rehabilitation team who agreed to undertake an initial
assessment (stages 2 and 3) were routinely screened for depressive symptoms using the PHQ-9, with
individuals who scored ≥ 10 being deemed eligible for inclusion. On identifying an eligible individual, the
nurse explained what evidence-based treatment options were available. This could include BA self-help
materials supported by the nurse, GP referral, referral to local IAPT services and/or referral to specific
cardiac patient psychological support services where available. Nurses co-ordinated care by monitoring
symptoms of depression and anxiety, assessing risk to self or others and agreeing a plan of care with
participants that may include BA and/or referral to a GP, IAPT services or other therapeutic agencies, as
described previously. As part of this care co-ordination protocol, all participants were offered patient-led,
nurse-supported self-help BA, as outlined in Enhanced psychological care.
Nurses’ training in enhanced psychological care
Two cohorts of nurses underwent training. Nurses’ training comprised either 1 or 2 days of face-to-face
classroom-based training, supplemented as appropriate by self-directed online teaching materials (including
videos of the previous training session), which could be worked through in preparation for taught sessions.
The course was delivered by experienced mental health practitioners (a liaison psychiatrist and a mental
health nurse with BA accreditation) who provided training on the key techniques of mental health-care
co-ordination, managing safety and risks and BA. This training allowed nurses to actively support
participants during care co-ordination, and to assist participants as they worked through the BA manual
alongside their cardiac rehabilitation programme. Nurses were provided with a session-by-session guide,
detailing the types of care co-ordination tasks that might be relevant for participants as they moved
through their 6- to 8-week comprehensive rehabilitation programme (see Appendix 3). This guide was
flexible to accommodate participant preferences for care. Nurses delivering EPC to study participants also
received clinical supervision by a mental health practitioner (an accredited BA therapist). Clinical supervision
was obligatory for nurses who delivered EPC to participants while they had one or more EPC participants
on their caseload. The sessions were usually delivered fortnightly by telephone, at a time that was
convenient to the teams and which met with their clinical demands; they could be arranged either one
to one or as a team. Each session lasted no more than 30 minutes.
On completion of cardiac rehabilitation (stage 5), the nurse sent structured details of a participant’s care to
their GP. All participants, including those receiving BA and whose depressive symptoms did not respond (based
on their PHQ-9 score), were given an opportunity to review their management options with the nurse. Here,
treatment response was defined as achieving a minimum clinically important difference (MCID) for the PHQ-9
that was equivalent to a 5-point reduction in score.73 It is important to note, however, that some people
achieving this MCID may remain above the PHQ-9 diagnostic threshold (i.e. a score of ≥ 10). As part of their
care co-ordination, these individuals will be referred for continuing mental health management.
Settings and study population
Cardiac rehabilitation programmes
We aimed to recruit and randomise eight locality-based comprehensive cardiac rehabilitation teams from
south-west England (the geographical regions of Bristol, Cornwall, Devon, Dorset and Somerset). After
excluding the four sites that took part in the feasibility study, a total of 20 teams (sites) were approached
to take part between December 2014 and February 2015. In each site, the lead cardiac rehabilitation
nurses from each team were invited to take part and provided detailed information about the study. In
each geographical region, the recruitment letter was co-signed by the trial chief investigator and, where
appropriate, the local co-applicant. In addition, the study recruitment letter was accompanied by a letter of
support from a local NHS cardiac rehabilitation lead for each region.
Teams that indicated an interest were visited by the research team, whereby the trial design and methods
were explained and staff were given the opportunity to ask questions. To support randomisation, teams
were asked to provide some descriptive information on their staffing model and service, as well as
reporting some audit data on patient throughput in the previous 2 months. In order for the team to take
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part, the team leader was required to provide written consent on behalf of the service. In addition, given
that nurses would be required to actively contribute to the research, we also requested written consent
from individual team members who would be directly involved in participant recruitment and, where
appropriate, implementation of EPC. After the last team was recruited (May 2015), the trial statistician
(FCW) randomised the teams into the respective allocation groups and teams were informed of
their allocation.
Managing a post-randomisation withdrawal
Immediately post randomisation, one team allocated to the EPC arm withdrew from the study. In the
period between providing consent to take part (April 2015) and randomisation taking place (May 2015),
the team had been informed that their service was to undergo a staff consultation, with a view to a
major reconfiguration of cardiac services being implemented within the next calendar year. Given this
uncertainty, the team no longer felt able to commit to the study. We therefore sought to replace this team
immediately. To maintain the balance between treatment arms, the site that withdrew post randomisation
was replaced with a new team recruited to have a similar patient throughput (high) and population
(a mixed community and hospital team delivering care to an inner-city/urban population). Although we
already had two teams on a reserve list, as both were of low throughput and catering for urban/rural
communities, neither were suitable replacements. Given the time constraints (i.e. the need to recruit a
replacement team before the EPC training days took place in June 2015), we therefore purposively
approached and recruited a cardiac rehabilitation team through our links with the BACPR (by necessity,
this team was recruited within the East Midlands). Although we were unable to select a replacement site
at random, the allocation was concealed from cardiac rehabilitation staff until the team had consented to
take part, at which point they were informed of their allocation by the trial researcher.
Training in research procedures
All cardiac rehabilitation nurses from teams allocated to UC received training (lasting approximately
2 hours) delivered by the trial researcher on the application of study recruitment procedures. Training
included the completion of study screening logs (see Appendix 4) and methods for approaching potential
participants (see Appendix 5). As part of the recruitment process, teams using the HADS were required to
replace this with new tools for anxiety (the GAD-7) and depression (the PHQ-9). Teams were trained in
how to apply and score these new measures, and also advised on how to manage any risk or safety issues
that might arise through their application.
In addition to the training in study procedures received by UC teams, teams allocated to the EPC
intervention arm were asked to nominate up to three nurses per team to be trained to deliver EPC. The
nurses were then invited to undergo training lasting 2 days (as described in Enhanced psychological care),
before starting participant recruitment. While managing CADENCE participants, EPC-trained nurses were
regularly supervised by an experienced BA practitioner recruited to support intervention delivery throughout
the pilot trial.
Participant eligibility criteria
The participant inclusion and exclusion criteria applied in the pilot trial were essentially the same as those
described for the observational study within the feasibility phase (see Participant inclusion and exclusion
criteria). The only difference related to the underlying cardiac condition of potential participants. Over
the last 3 years, UK cardiac rehabilitation services have been offering care to increasingly diverse cardiac
populations.26 Although the vast majority of patients were expected to be referred for rehabilitation as a
result of an ACS, any patient referred for rehabilitation was potentially eligible, and the sample for the
pilot study could now include, for example, patients with heart failure.
Participant recruitment and consent procedures
The process for identifying and recruiting trial participants followed the same procedure as outlined for the
observational study conducted within the feasibility phase (see Participant recruitment procedure). Potential
participants from teams allocated to UC or to the intervention group were recruited following the same
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procedures, with the only difference being that participant information sheets were tailored to reflect the
care provided by their rehabilitation team. At the time of recruitment, all patients recruited to the trial
were also asked if they would consider being approached for an interview as part of the study.
Data collection procedures
To facilitate data collection in two of our sites, which were remote from the main trial centre, and to
respond to the emerging geography of the trial, it was essential that remote data collection procedures
were established. We negotiated with a local clinical research network and university-based research team,
both of which provided local, trained research staff to collect participant and note review data in its area.
Remote staff were carefully briefed in respect of the design of the study and in data-capture procedures
and processes.
Participants in both trial arms completed baseline measures before they were scheduled to commence the
comprehensive cardiac rehabilitation programme. Participants were then invited to take part in two
face-to-face follow-up interviews at 5 months and 8 months post baseline.
The blinding of participants, cardiac nurses or researchers extracting data on study outcomes was not
possible as a result of the cluster design. However, the final analysis was carried out by the trial statistician,
who was blind to treatment allocation.
Process measures
Process measures relating to the recruitment and uptake of cardiac rehabilitation nurses/teams, and
participants and intervention fidelity, were collected using the methods described in the feasibility study
(see Process measures).
Outcome measures
Measures were selected on the basis of evidence of their validity in this population group, and to ensure
coverage of key areas of interest from a clinical and patient perspective. There was some variation in the
outcome measures assessed at each time point (Table 1).
TABLE 1 Pilot study: outcome measures collected at each assessment
Measure
Time point
Baseline 5 months 8 months
CIS-R ✓ – –
BDI-II ✓ ✓ ✓
BAI ✓ ✓ ✓
EQ-5D ✓ ✓ ✓
HeartQoL ✓ ✓ ✓
CSQ-8 – ✓ –
FFT – ✓ –
SRUQ – ✓ ✓
Cardiac nurse case notes review – – ✓
GP case notes review – – ✓
BAI, Beck Anxiety Inventory; BDI-II, Beck Depression Inventory, version 2; CIS-R, Clinical Interview Schedule – Revised;
CSQ-8, Client Satisfaction Questionnaire – 8; EQ-5D, EuroQol-5 Dimensions; FFT, Friends and Family Test; HeartQoL,
Heart Quality Of Life scale; SRUQ, Service and Resource Use Questionnaire.
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Baseline assessment only
Participants completed a paper-based questionnaire (see Appendix 6), followed by a laptop-based
administration of the Clinical Interview Schedule – Revised (CIS-R).74,75 When possible, participants were
encouraged to self-complete questionnaires, although the researcher was available to support questionnaire
completion. The baseline assessment included some participant measures that were not repeated at
subsequent follow-ups. The CIS-R was administered to ascertain a clinical diagnosis of depression and the
severity of depression, and/or the presence of other common mental health disorders such as anxiety,
according to the International Statistical Classification of Diseases and Related Health Problems, Tenth
Revision (ICD-10) criteria.76 The CIS-R score did not determine study eligibility, but allowed its comparison to
the other patient-reported measures of depression symptom severity, ascertained using the Beck Depression
Inventory, version 2 (BDI-II) (described in Participant questionnaires). Some short questions were included to
ascertain participant sociodemographic characteristics and to document patient treatment preferences for
mental health care. Participants were also asked to provide the contact details of their GP. Socioeconomic
status was measured using an area-based approach, the Index of Multiple Deprivation (IMD), based on the
patient’s residential postcode and divided into deciles (1 being the least deprived and 10 being the most
deprived). The IMD is a composite index of neighbourhood-level socioeconomic hardship, which takes into
consideration indicators in the domains of income, employment, health, education, housing and access to
services (higher scores indicate more deprived neighbourhoods).77
Baseline and follow-up assessments
We requested that NHS providers inform us immediately if a participant had died or had been admitted to
hospital between baseline and the 8-month follow-up, as this constituted a serious adverse event and would
need to be reported to the trial sponsor and ethics committee. A full description of the procedures for
reporting/handling potential adverse events within the context of the trial is provided in Appendix 7. Cardiac
rehabilitation teams were also asked to inform the study team immediately if the participant had experienced
a cardiac clinical event [i.e. death and/or hospital admissions for ACS or revascularisation procedures (CABG
or PCI)] or a mental health-care event (i.e. self-harm, suicidality) arising since study enrolment.
Case note review of cardiac nurse records Using a structured checklist, we extracted data on process
measures and intervention fidelity as described previously (see Data collection and analysis procedures),
and on clinical and mental health events, cardiac risk factors (biochemical or physiological measures) and
evidence of mental health-care co-ordination activities.
Case note review of general practitioner records We also contacted the participant’s GP to request
that the researcher undertook a case notes review of primary care records. During this notes review, we
collected information regarding the occurrence of any new cardiac or mental health events arising since
study enrolment, and of any treatments initiated with regard to the participant’s mental health needs.
Data were also captured on cardiac risk factors (biochemical or physiological) and service use data for the
purposes of economic evaluation (see Economic evaluation).
Participant questionnaires Participant baseline and follow-up interviews included self-reports of any
cardiac- and non-cardiac-related morbidity (e.g. infarction, vascularisation) and smoking status, participants’
use of antidepressant medication78 and resource use using a structured checklist.
Depressive symptoms were measured using the BDI-II,79,80 a 21-item self-report instrument developed to
measure symptom severity over the past 2 weeks, with an emphasis on affective and cognitive symptoms.
Higher scores represent greater depression severity (range 0–63), and minimal (0–13), mild (14–19),
moderate (20–28) and severe (29–63) symptom severity ranges were applied. There were five ways in
which treatment effects were measured using the BDI-II in our trial:
1. Mean (SD) and between-group mean difference.
2. Proportion of participants demonstrating a reduction in score from baseline by > 50% (deemed
a clinically important ‘response’ to treatment).81
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3. Proportion of participants demonstrating remission (going from scores of ≥ 14 to < 14).
4. Proportion of participants demonstrating a MCID in depression scores. Button et al.82 reviewed findings
from three trials that had used the BDI-II and which had also included a global measure of change;
the authors found that a 17.5% reduction in BDI-II score provided the best measure of a MCID; for the
purposes of this trial, we assumed that people had experienced a MCID if their depression score on
the BDI-II had dropped by 17.5%.
5. A clinically significant and reliable change (CSRC), defined as whether or not a participant meets
two criteria:
i. passing from above the specified threshold to below the threshold [the BDI-II remission threshold
described above in (3)]
ii. establishing that the magnitude of the participants’ change in score is statistically reliable.
To evaluate the last way, the difference between the participants’ scores at baseline and follow-up is
calibrated by the standard error of the difference between two scores.83
The Beck Anxiety Inventory (BAI)84,85 was administered, as anxiety is commonly comorbid with depression.
This 21-item self-report measure asks participants to report anxiety symptoms over the last week on the
following scale: 0 (none: it did not bother me at all), 1 (mildly: it did not bother me much), 2 (moderately:
it was very unpleasant, but I could stand it) and 3 (severely: I could barely stand it). Item scores are
summated with scores of 8–15, 16–25 and 26–63 being taken as the scoring ranges for mild, moderate or
severe anxiety respectively.
Health-related quality of life was assessed using both generic and disease-specific measures. The EuroQol-5
Dimensions (EQ-5D)86 is a standardised generic measure of HRQoL that is suitable for use in people with a
wide range of health conditions, and is considered to be a robust measure of health in patients with
cardiovascular disease.87 The EQ-5D is also recommended by NICE for economic evaluations in clinical
trials. The index score was valued by applying the approach outlined by Devlin et al.88 for responses to the
EQ-5D, five-level version (EQ-5D-5L). This value set is based on a large and representative study sample of
the general population in England, so it yields values appropriate for policy-making in the English NHS.
This EQ-5D also includes a visual analogue scale (VAS), which is scored from 0 (worst imaginable health
state) to 100 (best imaginable health state). The disease-specific Heart Quality Of Life (HeartQoL) scale was
also administered.89,90 The HeartQoL questionnaire comprises 14 items, with a 10-item physical subscale
and 4-item emotional subscale, which are scored from 0 (poor HRQoL) to 3 (better HRQoL). Participants
rate their HRQoL over the last 4 weeks. To assess when and how patients become activated over the
course of their cardiac rehabilitation programme or BA treatment, the nine-item Behavioural Activation for
Depression Scale – Short Form (BADS-SF) was also administered.91 BADS-SF scores range from 0 to 54,
with high scores representing higher activation.
Patient experiences of care were assessed only at 5 months (see Appendix 8), using the eight-item
self-reported Client Satisfaction Questionnaire – 8 (CSQ-8)92 and an adapted version of the NHS Friends
and Family Test (FFT). The CSQ-8 items are completed using four-point Likert scales (1–4), with scores
ranging from a possible 8 to 32, and higher values indicating higher satisfaction. The FFT consists of a
single item with a five-point rating scale (‘Extremely likely’ to ‘Extremely unlikely’) and two free-text items
(‘What was good about your experience?’ and ‘What would have made your experience better?’). The
free-text items were analysed using a basic content analysis.
Sample size considerations
Using the 2010–11 UK NACR audit data, 55,452 patients (for MI, PCI and CABG) attended a comprehensive
cardiac rehabilitation programme offered by 1 of 280 teams, which is equivalent to an average of 200 patients
per team per year. Assuming 17% of patients have depressive symptoms,28 this equates to 35 eligible patients
per team each year. A central aim of the pilot study was to estimate the participant eligibility and consent
rates, as no relevant UK data that are directly applicable to cluster trials are available. Two US RCTs (individual
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randomisation), exploring psychological/drug therapy in cardiac rehabilitation settings, observed highly variable
consent rates of 85% [150/177 – the Comparison Of Depression Interventions After Acute Coronary
Syndrome (CODIACS) vanguard study]93 and 37% [2481/6854 – the Enhancing Recovery in Coronary Heart
Disease (ENRICHD) study].94
Prior to undertaking feasibility work to inform our estimates of key parameters, we assumed a conservative
patient participation rate of 50%, estimating that it would take 6 months to recruit 64 patients through the
eight teams. This sample size is sufficient to estimate a follow-up percentage as low as 50% with a margin
of error of ± 13%, based on the width of the 95% CI, and as high as 90% with a margin of error of
± 10%, based on the lower bound of the 95% CI. We elected to recruit eight cardiac rehabilitation teams
(clusters), as this would allow us to (1) recruit sufficient patients within a set time frame deemed to be
acceptable to the funder, (2) ensure that sufficient numbers of teams gained exposure to EPC delivery in
diverse settings to comment on intervention delivery and (3) manage the maximum number of recruitment
sites in a single-centre RCT and given the geographically dispersed nature of the data collection. Process
data from the feasibility study subsequently identified that these assumptions were too optimistic (see
Appendix 9).
We did not plan to use estimates from the pilot of the intracluster (i.e. the intracardiac rehabilitation team)
correlation coefficients (ICCs) for key outcomes to plan the sample size for the definitive trial, as the available
pilot sample was small and estimates would have been imprecise. Using 2010–11 data supplied specifically
for this study by the NACR audit team (6272 patients; 119 cardiac rehabilitation teams), we estimated the
ICC for depression to be 0.047 (95% CI 0.034 to 0.062). We proposed that, notwithstanding the emergence
of new evidence in the interim, this estimate of the ICC would be used to inform the sample size calculation
for the definitive trial.
Statistical analysis plan
Trial data estimated cardiac rehabilitation team recruitment and patient participant study completion rates.
As this was a pilot study, we did not make definitive estimates of clinical effectiveness and costs; our primary
aim was to document the adequacy of trial procedures, intervention acceptability and outcome measures.
All pilot study data were collected and reported [in accordance with the Consolidated Standards of Reporting
Trials (CONSORT) statement]95 using good practice guidelines for cluster trials. A detailed statistical analysis plan,
including health economics, was developed prior to undertaking the analysis of trial data (see Appendix 10).
In summary, the recruitment rate, uptake in the intervention and control arms, outcome completion rates
and attrition rates were reported (with 95% CIs). It is a known feature of cluster randomised trials that when
participants are recruited after clusters have been randomised this can lead to selection bias.96 The recruitment
rate and participant characteristics at baseline were compared between the trial arms to assess whether or
not there was evidence of selection bias. Participant outcome data (including resource use) were analysed
descriptively (e.g. means, SDs) for each arm at each follow-up. As per the commissioning brief, we reported
the outcome effect sizes (i.e. between-group mean differences and 95% CIs) based on an intention-to-treat
analysis. We did not use analytical methods that allow for clustering because the number of clusters and
participants per cluster were too small. For this reason, and the fact that this is a pilot study, the CIs should
be interpreted cautiously and no p-value is presented. We carried out a complete-case analysis, including
only those participants who provided outcome data. No data were imputed as this is not a definitive trial
of intervention effectiveness. Patient treatment preferences for mental health care were documented
at baseline.
Economic evaluation
Adopting a societal costing perspective, we piloted the methods required to collect resource and service use
data in order to estimate costs to the NHS, costs to social care and personal social services and relevant costs
to participants and their carers/families (including NHS and privately funded mental health care). If feasible,
we planned to distinguish the use of services for (1) depression or anxiety, (2) other mental health problems
and (3) other health reasons or social needs. In addition, we also undertook a preliminary assessment of
the cost of providing EPC within cardiac rehabilitation teams. Service use data were collected from both
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(1) routine/administrative sources (e.g. hospital records, GP records, community mental health team records
and, where appropriate, social care records) and (2) via participant self-report using a Service and Resource
Use Questionnaire (SRUQ). The SRUQ was adapted from the Client Services Receipt Inventory (CSRI),97 with
input from the patient and public involvement (PPI) group, and some testing during the feasibility phase.
A detailed plan describing the analysis of health economics data is presented in Appendix 10. In summary,
we assessed the completeness, validity and reliability of patient-reported data versus routine administrative
data on the types and amounts of health care/service use by participants, and over the follow-up periods
planned for a definitive trial. This approach enabled better judgements to be made regarding which types of
health service, care professional or other resource use were most likely to be affected by the expected trial
outcomes, and to allow us to determine the optimal source of obtaining such data.
Nested qualitative study
Data collection
Data were collected during observations of staff training and during interviews with nurses and patients.
The qualitative researcher observed staff training to identify what issues nurses appeared to struggle with
and what practical concerns they had about EPC. Observations were recorded through extensive field notes.
All of the nurses who delivered EPC to one or more patients were invited to take part in an interview, in
order to explore their experiences of recruiting patients, EPC training and delivery (including managing
patients at risk of self-harm or suicide, and using the nurse and patient materials). A topic guide was used
to ensure consistency across the interviews and was structured around these main areas (see Appendix 11).
The researchers had planned to interview nurses once they had stopped delivering EPC, but this was not
feasible, as a result of delays in patient recruitment; hence, a pragmatic decision was made to interview
nurses at least 3 months after the delivery of their first EPC session, and once they had discharged at least
one participant (i.e. at a time when they had had some experience of delivering EPC).
Patient participants in both arms were approached for interview shortly after completing their 5-month
assessment in the trial. Prior to conducting the feasibility study, we anticipated conducting approximately
30 interviews, sampling participants who had taken part and who had either completed (n = 12) or not
completed (n = 8) EPC, or who had received UC (n = 10). We had also planned to sample participants
to achieve maximum variation in relation to trial arm, age, recruiting team, gender, depression score at
baseline and adherence to the intervention. However, as recruitment of patients was slow within the
pilot trial, our target sample was changed to include all intervention group participants (n = 15) and six
UC patients, purposefully sampled where possible, on the basis of team and gender. The purpose of the
interview was to discuss participants’ experiences of the psychological care received and, for those receiving
EPC, the acceptability of the study intervention. The topic guides had the same core questions for both UC
and intervention participants, with one section of the guide (which was specifically about EPC) being used
only for the latter, and the UC participants being asked more about the usual psychological care they had
received (see Appendix 1).
In addition to conducting interviews with patients recruited to the pilot trial, interviews were also held
with 10 patients who were offered trial entry, but who declined to take part. Their purpose was to explore
patients’ reasons for declining main trial participation. ‘Decliners’ were asked by the nurse trying to recruit
them to the trial if they would be happy for their contact details to be given to the research team so that they
could contact them and establish whether or not they would be willing to participate in a short telephone
interview. Once the referral was received, the researcher contacted the individual to discuss the interview and
arrange an interview appointment. A participant information sheet was sent to the person before they took
part in the interview, and the researcher gave the person an opportunity to ask any questions before
consenting and commencing the interview. A short decliners topic guide was written to guide the interview.
Written consent was gained from nurses and patients participating in the pilot trial immediately prior
to being interviewed. For decliners, verbal consent was audio-recorded at the time of the interview.
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All interviews were conducted by an experienced qualitative interviewer. Interviews were audio-recorded,
transcribed verbatim and anonymised prior to analysis.
Qualitative analysis plan
Notes taken during the nurse training were read and re-read, and key points concerning the design and
delivery of the training and intervention fed back to the research team.
Analysis of the nurse and patient interview data was thematic. A sample of transcripts was read and
independently coded by two qualitative researchers, who then discussed their coding and interpretation of
the data. This discussion led to two coding frames being agreed: one for the nurse interviews and one for
the trial participant interviews. Where possible, similar codes were used within each coding frame, as this
would assist later when findings between the data sets were triangulated. Transcripts were manually
coded, and data pertaining to each code were summarised in tables, using an approach based on a
framework analysis.68 Once this had been done, comparisons were made within and across the data sets
to identify key themes and deviant cases, and to highlight similarities and differences between them.
As only a few decliners were interviewed, and interviews were relatively short, transcripts were read and
re-read, and the main reasons for declining were summarised in a report.
Ethics and governance considerations
The Royal Devon and Exeter NHS Foundation Trust acted as the trial sponsor. The CADENCE study protocol
was reviewed, and a favourable ethics opinion obtained from the National Research Ethics Service (NRES)
Committee South West – Exeter (reference number 14/SW/0139). The relevant NHS research governance
approvals were obtained prior to commencing fieldwork for sites participating in the feasibility and pilot
phases of work. All protocol amendments were notified through existing pathways in the UK NRES and
NHS research governance systems, and the trial team ensured that all participating cardiac rehabilitation
teams, staff, patients and trial registries were informed of any changes to the protocol (see Appendix 12).
The CADENCE study was registered with a trials registry [as International Standard Randomised Controlled
Trial Number (ISRCTN) 34701576] and has been adopted by the UK NHS Clinical Research Network
(UKCRN ID: 17105). All researchers and nurses involved in participant recruitment underwent good clinical
practice training.
Data management
All personal information obtained about participants or staff for the purposes of recruitment or data
collection (e.g. names, addresses, contact details, personal information) was kept confidential and held in
accordance with the requirements of the Data Protection Act 1998.98 Each participant recruited to the study
was assigned a research number, and all outcome data entered were encrypted and stored without the
subject’s name or address. Electronic study records were held on a Structured Query Language (SQL) server
database managed by the Peninsula Clinical Trial Unit (PenCTU), which was stored on a restricted-access
secure server maintained by the University of Plymouth. Data were entered into the database via a bespoke
web-based data entry system, encrypted using Secure Sockets Layer (SSL). Access to electronic data was
permission based, with access to identifiable information limited to those processing questionnaires and
directly involved in data collection from participants. Data entered onto the database were backed up
according to the PenCTU standard operating procedures. Copies of the study data, retained at study sites,
were securely stored for the duration of the study prior to archiving at the University of Exeter. Electronic
copies of correspondence sent to study participants were stored securely on a password-protected computer
at the University of Exeter, and paper-based information held in a locked filing cabinet in the research team
office at the University of Exeter Medical School. Names and participant details were not passed onto any
third parties, and no named individuals were to be included in the write-up of the results. The only occasion
in which personal information would be passed onto a third party would be if we considered there to be a
risk of serious harm to a research participant, and normally this would occur only after discussion with the
person concerned and with their GP (where appropriate).
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All study data will be kept for 10 years under secure conditions on the University of Plymouth and the
University of Exeter secure servers. We sought consent from participants for core outcome data from the
pilot study to be released in an anonymised form to an independent data repository, following publication
of the key planned outcome papers. We anticipate that for the data set containing the main study outcome
variables, the approximate date of release to the archive would be 1 year following completion of the
grant (to allow time for the publication of key outputs). Although anonymised, as a result of the sensitive
nature of the data collected, the data will be shared under special licence for educational and research
purposes only. The data would be released only to users, approved by the programme management group,
following completion of user identification and intended use documentation administered through the data
repository. Data would also be subject to standard secure storage and usage policies of the data repository.
Safety of participants and researchers
Suicide protocols to protect staff, researchers and participants
Although we believe that the study has minimal implications for health-care staff, patient participants had
depressive symptoms, and a policy was put in place regarding the management of potentially serious
adverse events (e.g. self-injury or suicidality). All nurses participating in the study received training around
implementing the safety protocol (see Appendix 13).
The participant information sheet informs participants that if we were very concerned about their safety or
someone else’s safety, we may need to break confidentiality and inform their GP. This approach has worked
effectively in our other studies on depression,99,100 and we thus adapted the tried and tested protocols.
Safety of participants and study personnel during the research interviews
Participants were asked to reflect on their health issues during study participation, and there was a risk that,
in some cases, this may have caused distress. If any such difficulties occurred during a research interview,
the researcher offered support to the person involved. In the unlikely event that the individual appeared
significantly upset and at risk as a result of the interview, the researcher was trained to seek the participant’s
permission to advise the person’s GP of this distress and to encourage them to seek further help from the
support network available to them. Should there be any concern that a person was likely to cause harm
either to themselves or to another person, the person’s GP would be notified immediately by a senior
clinician from the study team.
As researchers were to be conducting interviews alone with participants, potentially in patients’ own
homes, safeguards were put in place to protect both the participant and the researcher. Data-barring
service checks were performed on any researcher taking part to ensure that they were an appropriate
person to be working with vulnerable adults. To ensure the safety of the researcher, a lone-worker policy
and ‘buddy system’, designed by the primary care research group, was used by the study’s researchers.
This approach provides a mechanism for ensuring that the exact whereabouts of the researcher is known
at any time point during fieldwork by a supervisor or a buddy.
Patient and public involvement
Patient and public involvement was sought during the protocol development. The NIHR Collaborations for
Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula (PenCLAHRC)
hosts the Peninsula PPI group. This group has published a framework regarding PPI in research,101 and
provides research training and support to facilitate the public becoming actively involved in all aspects of
the research process. A co-applicant (AG, the PPI facilitator) recruited four lay advisors with relevant lived
experience, each of whom was sent an overview of the emerging research protocol. Our advisors endorsed
the acceptability of the intervention and the importance of embedding psychological care within cardiac
care (rather than onward referral), the study design, project management arrangements and dissemination
plans. Advisors fed back on participant burden (e.g. questionnaires, timing of assessments) and on
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whether or not patient outcomes captured areas of importance. Our advisors agreed that, whenever
possible, our intervention should give patients choices over their treatment. The following practical
suggestions were made: (1) patients should always be made aware of alternative treatments for depression
while they are waiting for cardiac rehabilitation (with BA) to commence; (2) patients who are eligible for
the study should be given the option of having their carer involved in treatment discussions and (3) as it
was important, patient preferences should be recorded from the outset of rehabilitation.
Patient and public involvement continued throughout this project, with the precise roles of advisors
negotiated at each stage. During the preliminary stage of the feasibility study, our PPI advisors reviewed
outcome measures and informed the design of all study-related materials (e.g. participant information
sheets). Members of our PPI group were also involved in the development of the intervention manual,
helping to ensure its accessibility and acceptability to patients and carers. Another key area of involvement
was in dissemination plans. Our lay advisors reflected on the findings emerging from both the feasibility
and the pilot phases of the work, and provided important insights into recommendations arising from
these findings.
Across the duration of the study, lay advisors were routinely involved in project oversight and management
(see Project oversight), attending the regular project management group meetings. The lay advisors made
valuable contributions to these discussions, such as advising on what would be acceptable from a patient
perspective when we modified our intervention to make it more patient directed. Two (different) lay
advisors also sat on the Trial Steering Committee (TSC), and on this committee, advisors had equal voting
rights to academic/clinical members. Advisors were paid travel costs and for the time spent at meetings.
Project oversight
Day-to-day management
The chief investigator (JLC) and the scientific lead (SHR) supervised and monitored the strategic development
and progress of the project, liaising with the wider team and methodological leads on a routine basis. The
research staff members directly involved in data collection were based in Exeter. Two research fellows were
appointed to manage the quantitative (observational study, RCT) and qualitative components of the study.
Both research staff were responsible for managing the day-to-day aspects of the research relevant to their
own role, supported by an administrator at peak periods of fieldwork activity. Katrina Turner provided
qualitative expertise/supervision, Rob Anderson was the health economics lead, Obioha Ukoumunne was
the statistical lead and Andy Gibson led PPI engagement.
Monthly project management meetings were organised to ensure that co-applicants and lay advisors
(2–4 advisors) were informed of progress and contributed to the ongoing steering of the research. Face-to-face
meetings were held every 3 months, with the remainder being held via teleconference. Co-applicants were
expected to attend a minimum of one meeting every 3 months. Lay advisors were asked to attend meetings
every 3 months, with their interim specific input sought as required via the PPI lead.
Trial Steering Committee
A TSC with an independent chairperson (Professor Glyn Lewis, triallist and psychiatrist) was appointed in
accordance with MRC’s guidelines. Other TSC members were recruited with an appropriate range of
perspectives and expertise. Members included two lay advisors (Rev. Paul Lanham and Mr Ron Grant), a
cardiac rehabilitation expert (Professor Gill Furze), a qualitative methodology expert (Professor Anne Rogers)
and a statistical expert (Dr Sally Kerry). Three TSC meetings were held at critical points in the project timeline
(start-up, transition between feasibility and pilot study and study end). The TSC monitored the scientific
quality, ethics and general progress of the project, receiving regular reports from the study team. This
committee also monitored the serious adverse event and adverse event data emerging from the study. As no
definitive data on clinical effectiveness/safety were collected, the TSC agreed that it would absorb the role of
a Data Monitoring and Ethics Committee for the duration of the study.
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Chapter 4 Feasibility study results
The feasibility study consisted of two main elements: a before-and-after observational study and anested qualitative study, the results of which are presented below.
Observational study
Recruitment
Cardiac rehabilitation teams
Three cardiac rehabilitation teams (one hospital and two community) took part, recruiting study participants
for a 6-month period (Table 2). A fourth team (community) was recruited at the halfway point to bolster
participant recruitment, effectively screening for eligible participants for a 3-month period. In total,
five nurses screened patients for study eligibility.
A cardiac rehabilitation ‘team’ consisted of one or more nurses, with access to volunteers (who helped
with fitness sessions), a trainer or a physical therapist (to support patients during fitness sessions). One of
the community teams also gained access to an administrator part-way through the feasibility stage of the
study. A clinical psychologist was also available to the teams for referrals of patients with complex mental
health issues.
Each community team was led by a single nurse. The hospital team comprised a number of nurses, two of
whom were participating in the study. Two of the community team nurses visited five venues in different
locations (‘sites’) within their area where elements of the cardiac rehabilitation programmes were carried
out (i.e. monitoring, fitness groups, gym support, education, assessments and follow-up, administration
and telephone calls). For example, one community nurse conducted fitness classes across three different
sites and ran clinic appointments from two other sites. There was some overlap, in that some of the fitness
classes were run together by a nurse from each community team.
Participant recruitment and retention
Participant recruitment for the feasibility study took place between September 2014 and March 2015.
Participant flow from eligibility screening through to study recruitment and completion of the 5-month
assessment is outlined in Figure 2.
The nurses screened 203 patients for study eligibility during their initial cardiac rehabilitation assessment,
of whom 14 (7%) did not complete a PHQ-9. A total of 39 out of 203 patients (19%) were found to have
depressive symptoms (i.e. score of ≥ 10 on the PHQ-9) during their initial assessment. Eight participants
TABLE 2 Feasibility study: characteristics of participating teams
Team
Number of
Location Recruitment dateNurses Sites
I 2 2 Hospital August 2014
II 1 5 Community September 2014
III 2a 6 Community September 2014 and January 2015
a One nurse was new to this team at the time of the nurse training and thus, although they attended the training, they
were only recruited in January 2015.
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were already receiving active treatment for pre-existing depression and one was deemed ineligible for
cardiac rehabilitation at the point of assessment, leaving 30 out of 203 participants (15%) meeting the
CADENCE study definition of new-onset depression, who were therefore eligible for the trial. Of the
30 eligible patients, nine (30%) were recruited to the trial; this represents 4% of the 203 patients
initially screened.
Five of the 30 participants (17%) eligible for the feasibility study were not offered study entry, the reasons
for which are presented in Figure 2. Nine of those offered study entry (36%) agreed to take part and
provided baseline data. All patients who were due to be followed up for the observational study completed
their 5-month assessment. Based on these data, it took approximately 7.1 weeks per team to recruit
each participant.
Attend assessment with
CR nurse
(n = 203)
Age: mean 65.2 years (range 25 – 87 years)
Gender: male, n = 157 (77%); female, n = 46 (23%)
Ethnicity: white, n = 198  (97.5%);
Chinese/other, n = 4 (2%); Asian/Asian British, n = 1 (0.5%)
PHQ-9 score of ≥ 10 at initial
CR assessment
(n = 39; 19%)
Score of < 10 on the PHQ-9, n = 150 (74%)
PHQ-9 not completed, n = 14 (7%)
Eligible for study inclusion
(i.e. patient meets all criteria)
(n = 30; 15%)
  Ineligible for study
   (n = 9)
Pre-existing treatment for depression, n = 8
Not eligible for CR at present, n = 1
Offered study information
(approached by nurse)
(n = 25)
       Not offered study information
                                        (n = 5)
Nurse at BA capacity, n = 2
Insufficient time in first session/DNA next, n = 1
Patient denies low mood, n = 1
Referring to hospital team for assessment, n = 1
Agreed to baseline visit
(n = 9)
Declined study entry
(n = 0)
Consented and completed
baseline assessment
(n = 9)
Age: mean 60.4 years (range 26 – 85 years)
Gender: male, n = 7 (78%); female, n = 2 (22%)
Ethnicity: white, n = 9 (100%)
Completed
5-month follow-up
(n = 9)
Declined/lost to follow-up
(n = 0)
Contact details released to
study researcher
(agreed to telephone contact)
(n = 9)
           Declined researcher contact
                                         (n = 16)
Reasons given (where recorded):
Wished to read study leaflet first, n = 5
Family circumstances, n = 1
Patient would prefer to try the gym, n = 1
FIGURE 2 Feasibility study: participant flow diagram. CR, cardiac rehabilitation; DNA, did not attend.
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The majority of the 203 patients screened attended a community-based cardiac rehabilitation clinic
(164 out of 203; 81%), with many fewer invited to attend a hospital-based service (39 out of 203; 19%).
The mean age of patients attending an initial nurse screening clinic was 65.2 years (range 25–87 years),
157 out of 203 (77%) were male and the vast majority (198 out of 203; 97.5%) reported their ethnicity as
‘white’ (see Figure 2).
The sociodemographic characteristics of study participants (n= 9) recorded at baseline are presented in Table 3.
The mean age of the sample recruited was 60.4 years, and most were male (7/9). All participants reported their
ethnicity as ‘white’, and their preferred language was English. One-third of participants were working full time,
with just under half currently in retirement. The majority of the sample were homeowners, and just under half
were either married or living with a partner. The nature of the cardiac event that initiated referral to cardiac
rehabilitation was recorded for eight participants. Three participants had a MI with PCI (insertion of stent,
coronary angiography and left heart catheterisation), one had a MI, one had a MI with atrial flutter, two had a
CABG, and one had a PCI (heart catheterisation) and left ventricular dysfunction.
Sample characteristics
Intervention fidelity
From data extracted from the notes recorded by cardiac rehabilitation nurses (Table 4), the number of
cardiac rehabilitation sessions attended ranged from 1 to 18 (mean 10.1, SD 5.0 sessions attended) for the
nine participants. There was evidence that the cardiac nurse discussed a mental health referral in just
under half (four out of nine) of the participants. Of these four participants, only one received a GP referral
for onward psychological care following completion of EPC.
TABLE 3 Feasibility study: participant sociodemographic characteristics at baseline
Characteristics Baseline values (N= 9)
Gender (male), n (%) 7 (78)
Mean age (years) (SD; min., max.) 60.4 (18.2; 26, 85)
Ethnicity (white), n (%) 9 (100)
Preferred language (English), n (%) 9 (100)
Marital status, n (%)
Married/living as married 4 (44)
Single 2 (22)
Divorced 1 (11)
Widowed 2 (22)
Employment status, n (%)
Working full time 3 (33)
Retired 4 (44)
Unemployed jobseeker 1 (11)
Unemployed as a result of ill health 1 (11)
Housing status, n (%)
Homeowner 7 (78)
Tenant 2 (22)
max., maximum; min., minimum.
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Participant-reported outcome measures
At baseline, the CIS-R was used to determine a primary and secondary psychological diagnosis. Only two
patients did not receive a diagnosis, with the other participants ranging in their diagnoses from mild
depressive episodes to severe depressive episodes, and one participant having agoraphobia (Table 5).
Most participants (eight out of nine) reported that they felt that they had low mood, and when asked
what professional help they would consider, around half indicated that a non-pharmacological approach
was preferable (four out of eight), although two participants ultimately preferred not to receive any
professional help.
TABLE 4 Feasibility study: process data regarding delivery of intervention at follow-up
Outcome Follow-up values (N= 8)
Cardiac rehabilitation sessions attended, n (%)
1 1 (13)
7 1 (13)
8 1 (13)
11 2 (25)
12 1 (13)
13 1 (13)
18 1 (13)
Mean (SD) 10.1 (5.0)
Time (days) elapsed from the point of consent to the start of EPC, mean (SD),
n; median (min., max.)
9 (4), 6; 8 (4, 14)
Time (days) elapsed from the point of consent to nurse discharge from cardiac rehabilitation,
mean (SD), n; median (min., max.)
82 (66), 6; 69 (8, 197)
Time (days) elapsed from nurse discharge from cardiac rehabilitation to date of the GP
discharge letter; mean (SD), n; median (min., max.)
68 (63), 5; 103 (0, 125)
Psychological care co-ordination activities provided on exit from cardiac rehabilitation (N= 6), n (%)
GP referral for mental health 1 (17)
No evidence of care co-ordination 5 (83)
Discussion with participant regarding referral to GP/IAPT services/other psychological care services, n (%)
Yes 4 (50)
No 4 (50)
Referral made to GP/IAPT services/other psychological care services, n (%)
Yes 1 (13)
No 7 (88)
Care accessed for depression privately (N= 5),a n (%)
No 5 (100)
Care accessed for depression via established NHS mental health pathways, n (%)
Yes 1 (13)
No 7 (88)
max., maximum; min., minimum.
a Data from participant self-reported data – all other data were obtained from clinical records.
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The mean BDI-II score at baseline was 21.8 (SD 9.8) and the BAI score was 18.2 (SD 12.4). By the 5-month
follow-up, participants reported lower mean levels of depression (BDI-II score of 18.0, SD 13.7) and anxiety
(BAI score of 16.1, SD 14.3; Table 6). Four out of nine participants had a 50% reduction in scores from
baseline at 5 months, and three out of eight were in remission (BDI-II score of < 14) at 5 months. Although
all participants had reported not taking antidepressants at baseline, one participant reported taking
antidepressant medication at follow-up for their low mood.
Most participants (eight out of nine) reported being ex-smokers at baseline, and at the 5-month follow-up,
one participant had recommenced smoking (see Table 7). Participant-reported health outcomes, including
self-reported cardiac diagnoses and other long-term health conditions, at baseline and the 5-month follow-up,
are presented in Table 7. The EQ-5D-5L had a mean of 0.707 (SD 0.255) at baseline and 0.631 (SD 0.351)
at 5 months; equivalent data for the mean VAS score were 55.7 (15.9) and 67.7 (21.2), respectively. The
HeartQoL score had increased from a mean of 16.0 (SD 8.4) at baseline to 25.1 (SD 12.7) at 5 months.
Participants reported a positive experience of their cardiac rehabilitation programme, based on both the CSQ
and FFT (Table 8), although one participant reported being mildly dissatisfied and ‘extremely unlikely’ to
recommend the service to friends and family. Most participants reported that the quality of the service they
received was excellent (six out of nine) and they were very satisfied with the amount of help they received
(six out of nine). The majority of the participants reported being very satisfied overall (seven out of nine) and
TABLE 5 Feasibility study: patient psychological characteristics at baseline
Outcome measurement Baseline values (N= 9)
CIS-R score, mean (SD) 17.7 (9.9)
CIS-R primary diagnosis category, n (%)
No diagnosis identified 2 (22)
Agoraphobia 1 (11)
Mild depressive episode 2 (22)
Moderate depressive episode 2 (22)
Severe depressive episode 2 (22)
Secondary diagnosis category, n (%)
No diagnosis identified 4 (44)
Mild anxiety and depressive disorder 4 (44)
Specific (isolated) phobia 1 (11)
Do you believe you have low mood?, n (%)
Yes 8 (89)
No 1 (11)
Do you want any professional help for your low mood? (N = 8), n (%)
Strongly prefer help 2 (25)
Prefer help 4 (50)
Prefer not to receive help 2 (25)
What type of professional help would you prefer? (N= 8), n (%)
Strongly prefer non-drug help 4 (50)
Prefer non-drug help 3 (38)
Do not mind 1 (13)
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that they were willing to return to the programme in the future (eight out of nine). Six participants were
extremely likely to recommend the service to friends and family (six out of seven).
Acceptability of study procedures
At follow-up, eight out of nine participants had completed participant-reported outcome data for all
measures. In terms of the acceptability of study procedures, most participants reported that the baseline
and follow-up assessments were of ‘the right length’ and had ‘the right number of questions’, although
two participants felt that there were slightly more questions in the baseline assessment than they would
have liked (Table 9). Most participants did not report noticing any repetition of questions at the baseline
(four out of seven) and follow-up assessments (five out of seven).
TABLE 6 Feasibility study: psychological outcomes at baseline and 5 months
Outcome measurement
Time point (N= 9)
Baseline 5 months
BDI-II score, mean (SD); min., max. 21.8 (9.8); 2, 36 18.0 (13.7); 0, 34
50% reduction in BDI-II score from baseline, n (%)
Yes NA 4 (44)
No 5 (56)
Remission (i.e. a BDI-II score of < 14), n (%)a
Yes NA 3 (38)
No 5 (63)
17.5% reduction in BDI-II score from baseline (MCID), n (%)
Yes NA 4 (44)
No NA 5 (56)
CSRC index, n (%)a
Yes NA 2 (25)
BAI score, mean (SD); min., max. 18.2 (12.4); 1, 44 16.1 (14.3); 0, 44
Are you currently taking any antidepressant medication (medicine to help low mood)?, n (%)
Yes 0 (100) 1 (11)
Is your medicine for low mood prescribed by a qualified doctor?, n (%)
Yes NA 1 (100)
For how long have you been taking your medicine for low mood?, n (%)
< 6 weeks NA 1 (100)
Within the past 6 months, have you received any help for your low mood from the following people, n (%)
GP 0 (0) 1 (11)
Therapist (e.g. psychotherapist, nurse) 0 (0) 0 (0)
Another health/social care professional 2 (22)b 4 (44)c
max., maximum; min., minimum; NA, not applicable.
a The denominator of this proportion is the number of individuals whose baseline BDI-II scores were ≥ 14 (N= 8).
b Two participants received help (EPC) from a cardiac rehabilitation nurse.
c Three participants received help from a cardiac rehabilitation nurse (i.e. EPC), and a fourth participant received help from
another psychological therapist arising from their study participation.
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TABLE 7 Feasibility study: smoking characteristics and health outcomes at baseline and 5 months
Characteristics and outcomes
Time point (N= 9)
Baseline 5 months
Smoking status, n (%)
Never smoked 1 (11) 1 (11)
Ex-smoker 8 (89) 7 (78)
Current smoker 0 (0) 1 (11)
Time (years) since quitting smoking (ex-smokers only)
Median (IQR), n 14.8 (0.3–30.4), 8
Smoking behaviour (current smokers only), median (IQR)
Cigarettes per day Not recorded 0a
Cigars per day Not recorded 10–12a
Pipe (g/day) Not recorded 0a
HRQoL, mean score (SD)
EQ-5D-5L 0.707 (0.255) 0.631 (0.351)
EQ-5D VAS 55.7 (15.9) 67.7 (21.2)
HeartQoL 16.0 (8.4) 25.1 (12.7)
Participant-reported heart problems, n (%)
MI
Yes 7 (78) 7 (78)
Angina
Yes 5 (56) 6 (67)
Hospital admission – non-cardiac chest pain (N= 8)
Yes 1 (13) 2 (22)
Unsure 0 (0) 1 (11)
Heart failure
Yes 0 (0) 1 (11)
Arrhythmia
Yes 2 (22) 5 (56)
Not sure 1 (11) 0 (0)
PCI procedure
Yes 7 (78) 5 (56)
Not sure 1 (11) 0 (0)
CABG procedure
Yes 5 (56) 5 (56)
Any other heart problem/procedure
Yes 2 (22) 1 (11)
continued
DOI: 10.3310/hta22300 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 30
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Richards et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
37
TABLE 7 Feasibility study: smoking characteristics and health outcomes at baseline and 5 months (continued )
Characteristics and outcomes
Time point (N= 9)
Baseline 5 months
Participant-reported health problems, n (%)
Asthma
Yes 1 (11) 1 (11)
Lung disease (N = 8)
Yes 0 (0) 0 (0)
Diabetes mellitus (N= 8)
Yes 2 (22) 2 (25)
Ulcer/stomach disease
Yes 0 (0) 1 (11)
Bowel disease (N = 8)
Yes 1 (11) 0 (0)
Kidney disease (N= 8)
Yes 1 (11) 0 (0)
Liver disease (N= 8)
Yes 0 (0) 0 (0)
Anaemia/blood disease
Yes 2 (22) 1 (11)
Cancer (N = 8)
Yes 1 (11) 1 (13)
Nervous system disease
Yes 0 (0) 0 (0)
Arthritis (N = 8)
Yes 3 (33) 4 (50)
Back pain
Yes 3 (33) 3 (33)
Mental health problems (N = 8)
Yes 0 (0) 1 (13)
Skin disease
Yes 2 (22) 1 (13)
Hearing/visual impairment (N= 8)
Yes 3 (33) 4 (50)
IQR, interquartile range.
a Data from one current smoker.
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Qualitative study findings
Early feedback from nurses and the patient and public involvement group
The PPI group and two cardiac rehabilitation nurses attended a preliminary meeting to discuss the intervention
design facilitated by the researchers (DAR and SHR). Lay advisors included two people who had used BA
and two who had received cardiac rehabilitation. The PPI group offered insights into experiencing cardiac
rehabilitation and/or BA. PPI advisors and nurses also discussed the potential, and challenges, of implementing
BA and mental health-care co-ordination within cardiac rehabilitation services.
TABLE 8 Feasibility study: CSQ-8 and FFT at follow-up
Patient experience item Follow-up values (N= 9), n (%)
Quality of service
Good 3 (33)
Excellent 6 (67)
Kind of service you wanted?
Yes, generally 4 (44)
Yes, definitely 5 (56)
Needs met?
Most of my needs have been met 5 (56)
Almost all of my needs have been met 4 (44)
Recommend programme?
Yes, I think so 1 (11)
Yes, definitely 8 (89)
Satisfied with amount of help
Mostly satisfied 3 (33)
Very satisfied 6 (67)
Services helped to deal with problems?
Yes, they helped somewhat 4 (44)
Yes, they helped a great deal 5 (56)
Overall satisfaction
Indifferent or mildly dissatisfied 1 (11)
Mostly satisfied 1 (11)
Very satisfied 7 (78)
Come back to programme?
Yes, I think so 1 (11)
Yes, definitely? 8 (89)
How likely are you to recommend this help or support to friends and family if they needed similar care or treatment? (N= 7)a
Extremely unlikely 1 (14)
Extremely likely 6 (86)
a Two participants reported that they had not received any support for their mood as part of cardiac rehabilitation.
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The relevant points arising from this meeting were supplemented with feedback from early meetings with
individual cardiac rehabilitation nurse teams. Key areas were the realisation that community teams would
be conducting nearly all the initial patient assessments, which is the point at which participants enter the
study, and hence the community teams would have a much bigger role in recruiting participants than the
hospital team; nurses being concerned about changing to the PHQ-9 and the GAD-7 from their current
mood measurement tool (the HADS) and cardiac rehabilitation services differing in how they operated, and
the need to accommodate these differences during implementation of the EPC intervention.
Observations of usual care in participating sites
The qualitative researcher conducted seven observational sessions relating to three teams during the early
phase of the feasibility study (Table 10). Nurses working in different regions allowed patients a choice of
venue for their rehabilitation, which also enabled nurses to steer patients towards the venue that they
thought would be most suitable for the individual. In each region, nurses conducted their rehabilitation
programmes in different ways; for example, one community nurse tended to run group fitness class
sessions, and had less private space, whereas another community nurse had more clinic time and was able
to offer more one-to-one clinic appointments. Box 2 details the insights gained from these observations.
Observations of nurse intervention training
The CADENCE training programme was delivered to four nurses from the three teams. Key points from
the field notes taken during observations of nurse training were organised into three main categories:
(1) general reflections on training (2) practical issues about the training materials and (3) intervention
delivery issues. Nurses welcomed new knowledge that would help in managing patients’ mental health
needs. Nurses gained new knowledge about the existence of, and how to refer patients to, existing
community mental health services (e.g. IAPT) and on how to manage mental health risk issues when they
arose. While undergoing the training nurses highlighted practical issues, such as the layout of the patient
TABLE 9 Feasibility study: feedback on study assessments at baseline and follow-up
Interview and participant assessment Values (N= 8), n (%)
Baseline (N = 7)
Length of assessment
About the right length 7 (100)
Number of assessments
About the right number of questions 5 (71)
Slightly more questions than I would have liked 2 (29)
Repetitive?
Not at all – I did not notice any overlap or repetition 4 (57)
A little bit – I noticed some overlap or repetition 3 (43)
Follow-up (N = 7)
Length of assessment
About the right length 7 (100)
Number of assessments
About the right number of questions 7 (100)
Repetitive?
Not at all – I did not notice any overlap or repetition 5 (71)
A little bit – I noticed some overlap or repetition 2 (29)
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and nurse handbooks and how to make them more user-friendly. In terms of intervention delivery, nurses
expressed concerns over how long BA would take to deliver in a typical cardiac rehabilitation session and
the extra paperwork involved. Many of the points were resolved interactively during the training, whereas
others (e.g. time concerns around implementation) would require monitoring and feedback once nurses
implemented EPC.
Observation of clinical supervision sessions with nurses
Two telephone clinical supervision sessions with one nurse and two supervisors were observed, and six sets
of supervision records were reviewed. These observations identified two key practical challenges. First, that
the paperwork supporting nurse recording of EPC within the clinical notes required improvement to more
accurately document the care received by the patient. For example, it was difficult to identify the number
and length of BA sessions offered as part of the cardiac rehabilitation programme, and it was unclear what
TABLE 10 Feasibility study: characteristics of qualitative site observations
Observation type (by team)a Site Setting
Number of
patients
presentb
Observation
length
(minutes)
Staff present at
session
Team I: hospital
First hospital assessment Hospital Clinic room 1 40 One nurse
Fitness class Hospital Physiotherapy
gym
13 20 Two nurses and
one volunteer
Post-exercise cool-down period Hospital Physiotherapy
room
12 20 Three nurses and
one volunteer
Health education presentation Hospital Physiotherapy
room
1 30 Three nurses and
one volunteer
First hospital assessment Hospital Clinic room 1 40 One nurse
Team II: community
Individual fitness checks/training Leisure centre Gym 5 75 One nurse, one
volunteer and
one exercise
trainer
Post-exercise cool-down period Leisure centre Changing
room
5 20 One nurse, one
volunteer and
one exercise
trainer
Pre-exercise check Health centre A Cafe 7c 20 One nurse
Individual fitness checks/training Health centre A Gym 6 60 One nurse and
one exercise
trainer
Initial community assessment Community hospital Clinic room 1 50 One nurse
Review clinic appointment Community hospital Clinic room 1 40 One nurse
Team III: community
Initial community assessment Health centre B Clinic room 1 60 One nurse
Initial community assessment Health centre B Clinic room 1 (with wife) 60 One nurse
Initial community assessment Health centre B Clinic room 1 60 One nurse
a Four out of five nurses were observed. There were seven sites where no observations took place.
b Patients arrived and left fitness classes at different intervals, so the exact number of attendees was not always
ascertainable.
c One man was deemed not well enough to stay for the exercise class, and left.
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activities (e.g. symptom monitoring, diary review) constituted an adequate session of BA. Second, there
was a need to develop procedures to ensure that nurses informed the clinical supervisors and research
team when a participant was discharged from EPC. Embedded within this was ensuring that the nurse
had a clear definition of when EPC ceased, as this might be different from when an individual stopped
engaging with the wider cardiac rehabilitation programme.
BOX 2 Feasibility study: qualitative study site observation findings
Key points
Resources (space, time, privacy)
Cardiac rehabilitation is delivered in a variety of settings. In some locations, there is restricted or no space in
which EPC could be delivered in privacy.
In some settings, the nurse works solo, whereas others work as a team. A solo nurse would be unable to conduct
BA in privacy and without disruption, as they are responsible for the larger group of non-depressed patients.
Whether solo or working as part of a team, there is very little spare time in which EPC could be embedded.
Location of care
Although patients often have a choice of community sites, they are encouraged/referred for hospital-based
rehabilitation if they have more severe health conditions (e.g. previous heart attacks) or multimorbidity.
Variation in patterns of working
Some nurses have the opportunity to provide more one-to-one appointments; others spend more time on
fitness and education classes, and may see patients briefly after the class. Some patients choose not to come to
the fitness classes, but could be invited to a clinic appointment if necessary.
Variation in waiting list times between sites
Once patients are referred to the hospital team following their initial community assessment, they may wait for
any length of time between 3 and 8 weeks (on top of medical recovery time) between the initial community
assessment and the first hospital assessment, compared with little or no additional wait for community
cardiac rehabilitation.
Concurrent psychological treatment
A clinical psychologist presents a talk to all patients in hospital rehabilitation, and takes referrals from hospital
and community-based nurses.
Administrative duties
A substantial part of the nurses’ time is taken up with administration.
Patients who decline cardiac rehabilitation
Nurses tend not to see any patients who decline rehabilitation. Such patients either cancel their initial
assessment appointment or do not contact the nurse to make an appointment (depending on how nurses
manage appointments).
FEASIBILITY STUDY RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
42
Nurse interviews post training
All four nurses who attended the EPC training were interviewed within 4 weeks of completing their
training. The interviews lasted between 25 and 36 minutes. Owing to the small number of nurses
interviewed, to protect anonymity, quotations reproduced in this report from these interviews have not
been tagged to indicate which interviewee is being quoted.
Nurses commented that the training was well organised, relevant and stimulating. The small group size
(5–10 nurses was seen as optimal) provided a supportive and confidence-building environment. Nevertheless,
the training was viewed as intense and thought-provoking (‘a good brain-ache’), with particular challenges
being the initial understanding of the BA concept and how to explain BA to patients, and, later, how to
explain and implement specific components of BA with patients. Role play was used throughout and,
although daunting, the nurses commented on the benefits of this technique from observing and learning
from each other.
Nurses were generally happy with the contents and completeness of the supporting materials provided.
However, they found it difficult to differentiate between the participant handbook and nurse handbook, and
requested that these were made distinctive in terms of colour/design. Nurses suggested having a few
sentences and possibly some pictures in the nurse handbook that they could use with patients to help them
describe/introduce BA to participants. They also requested access to electronic copies of the various materials,
so that they could print copies off or e-mail them to participants. There was also some concern that the
added BA materials might overload some participants, and nurses would need to make decisions about what
to give out.
With regard to implementing EPC, prior to the training, nurses said that they had felt that they could
provide only superficial support to patients experiencing low mood because they did not have the tools
or resources to deal with it. After training, they were positive about the expected benefits of using BA with
their patients:
I do a bit [working with patients with mental health issues] already but it tends not to, currently not to
get to the nitty gritty of it but you just touch the surface with it and offer them some support.
Nurses expressed an eagerness to start using their new skills, but also concerns about how they would fit
the BA sessions around their current workload. A few of the nurses had made plans about how they
should implement the CADENCE programme within their rehabilitation sessions:
. . . we thought we’ll probably do the exercise sessions and then have the time with the client afterwards
[yeah] when everybody else has gone [. . .] Rather than at the beginning where you might think, ‘oh god
I’ve only got 20 minutes I’ve got to stop, no, you can’t talk anymore’, and that’s negative isn’t it?
Before participants were officially recruited to CADENCE, some of the nurses began using the PHQ-9 and
the GAD-7 instead of the HADS. Unlike the HADS, the PHQ-9 included a question about suicide risk. The
nurses commented that they preferred these measures and felt that the EPC training had given them the
confidence to discuss mental health risk issues and a clear pathway to follow to manage these situations:
I wouldn’t have known what to do or what to say or [yeah] what actually was available for people so,
and actually we never asked that question [no], we’ve never asked that question since I’ve been doing
rehab[ilitation] so it is something that we should be . . .
. . . having a proper structured risk assessment and a plan of ‘what if’ just means that I wouldn’t have
any worries talking about it.
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Some nurses had not practised mental health-care co-ordination before, and several had not been aware
that they were able to access IAPT services. Information on mental health-care co-ordination had provided
nurses with options over referral, and it was evident that they now felt more able to direct patients:
I didn’t know anything about mental health-care co-ordination at all [no] before, not at all. I wouldn’t
have known where to go and I wouldn’t have known what to do so it opened up a lot of avenues for
us definitely.
. . . so I think in the programme, the training we had has already had an impact on enhancing the
psychological services people will get through cardiac rehab[ilitation], which can only be a good thing.
Despite having been trained and being made aware that ongoing clinical supervision would be available,
when imagining EPC working in practice, nurses remained concerned that they would not have enough
time to deliver the intervention effectively:
. . . we’ve been given this great training and all of us we felt were very positive and we can imagine
this really working, really, really well. But I think it would be really awful if we find then, well we can
do this, but we can’t do it properly because we don’t have enough time.
Qualitative interviews after experiencing implementation of the intervention
Nurses and participants both commented that they felt that the EPC intervention was timely and
appropriate within the context of cardiac rehabilitation. Participants explained how their cardiac event had
left them feeling vulnerable and low in mood, and that they were glad to have the opportunity to discuss
these feelings. Nurses remarked on how providing the intervention had provided them with new ways of
supporting their patients, and the training had given them a pathway to deal more fully with individual’s
mental health issues.
Nurse interviews
Nurses remained positive about moving from using the HADS to using the PHQ-9 and the GAD-7 to screen
and monitor mood, describing how the training had given them the confidence to discuss arising risk issues.
Their self-assurance in discussing risk also resulted from the fact that the research team had provided them
with a distinct pathway to follow if a patient was identified as being at risk:
The HAD score was not that helpful and didn’t give an indication of risk . . . using GAD-7 and PHQ-9
instead of HAD, means that the screening is more efficient, I think we are much more aware of risk
management and risk and what to do.
It was clear from observing supervision sessions, from the supervisor’s report and from nurse interviews,
that various factors (e.g. cardiac complications, family issues) had prevented participants from regularly
attending EPC sessions within their cardiac rehabilitation. Nurses found this disjointed flow a challenge
for EPC delivery:
It’s been challenging, extremely challenging, I would say, because nothing is ever straightforward with
patients that we’re dealing with. So you think you’re on track with dealing with maybe their mood
and then suddenly they’ll have a cardiac event or something else in their life, some other illness and
then of course their mood then, isn’t the priority, it’s their physical health, cos obviously with hearts,
that’s going to always take priority.
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Cancelled or incomplete EPC sessions (i.e. unattended or as a result of the focus of the appointment
moving to mainly physical health issues) regularly needed to be rearranged. Nurses felt that delivering
EPC had led to some patients being seen more often than in usual cardiac care:
Because of the BA, I was making sure I was speaking to them next week and then they’d want to
come into clinic and it would create more [clinic contact], whereas before we might well have said,
‘Well, you’ve got physical symptoms, you’re seeing your GP’, or, ‘You’re seeing the cardiologist in
3 weeks’ time, give me a ring once you’ve seen them, let me know how you got on and then we’ll
make a plan from there’. [. . .] whereas with BA of course, in that 3 weeks you could have seen them
three times in clinic. [. . .] Taking up three half-hour slots, so I think that’s probably the reason why it
took up more [time].
Nurses struggled to persuade participants to read the CADENCE participant handbook, although most
participants did engage with the BA ‘homework’ (e.g. completing a daily mood and activity diary,
identifying activities that promote mood). However, nurses felt less confident in knowing when to use a
worksheet intended to aid functional analysis (‘triggers, response, avoidance pattern’/’triggers, response,
alternative coping’).
Nurses reverted to delivering EPC by telephone, rather than face to face, when there was a lack of privacy
or time. Even finding privacy to make the telephone call could be challenging:
I had to sneak up and hide in a room that luckily wasn’t booked, try and find reception to be able to
make the call [for an EPC session], because I couldn’t make the call in the gym off the telephone as
there was people throwing weights around.
However, nurses sensed that reviewing homework was simpler and participants engaged more fully when
meeting in person rather than over the telephone.
Although EPC was seen as potentially worthwhile, nurses could not envisage incorporating the treatment
into their rehabilitation sessions, in the longer term, in its present form. They found that providing the
intervention was an extra burden and a source of anxiety:
Sometimes we felt slightly relieved when the PHQ come back, it’s still low, you’d [sigh], [. . .] it was
relief when they scored low.
Two of the nurses had only delivered the intervention to one patient each; however, they imagined finding
it too challenging to have more participants receiving the intervention on their caseloads at the same time,
because of the impact on their time, clinic space and workloads. Another nurse, who had delivered EPC to
four patients, three of whom had received EPC sessions concurrently, commented that the squeeze on
time was the biggest challenge:
I think the [extra] time [required] effectively, and it has been really difficult, really difficult to do, and I
mean I don’t feel like I’ve had a huge number of patients on it, [. . .] over the past few months, it
shouldn’t have been, but it did have, bearing in mind I’m only a part-time worker, we’re lone workers,
that does have an impact on it, [. . .] it’s definitely just the time.
Nurses made comments on the CADENCE materials during their training, which were revised before being
implemented. In later interviews, two nurses said that they had used their nurse handbooks frequently
to guide them through the EPC sessions. Nurses also made suggestions for more structured sheets for
recording EPC sessions within the clinical record, as each were recording details in different ways, which
meant that records were unsystematic and varied from nurse to nurse.
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Participant interviews
Nine participants who took part in the observational study also agreed to be interviewed. Consistent with
the nurse comments, participants admitted to not reading their CADENCE participant handbook for a
range of reasons. For example, some participants said that they were dyslexic, too busy or just felt that
they were provided with all they needed to know about EPC from the nurse. One participant felt that the
handbook needed to be much more concise. When interviewed, participants remembered little about
the contents of the handbook, except for the descriptions of patient case summaries, with which some
individuals identified well. Nevertheless, most did complete the weekly mood diaries, although some said
that they completed them retrospectively or changed entries they had put down earlier in the week.
By completing the mood diary regularly and discussing it with the nurse, most participants who engaged
with BA commented that they had gained an awareness of how their behaviour affected their mood
and vice versa. Participants had benefited from this by actively changing their behaviour in response to
recognising that they felt low:
When I’m noticing that I’m on a downward spiral, I need to pick up the phone and I need to say,
‘Can we go out, can we go and have a cup of coffee somewhere, can we go and do something?’
Because actually, it breaks the mood. And I think I’ve done that relatively successfully.
Participant 4
Other benefits of BA brought up by participants were having the opportunity to talk about how they were
feeling and gaining understanding into triggers for their low or improving mood. Some mentioned being
more proactive in helping themselves or in finding professional help (e.g. from therapists or their GP) to
avoid their mood dropping too far, and in identifying issues in their lives that they needed to address:
I think it [BA] accelerated it [mood improvement] because I had a lot on my mind and [the nurse]
knew that and we were able to talk about a number of things. I was very straight with [the nurse]
and very frank with [the nurse] and I found it very good, but [the nurse] didn’t offer advice. It was
like a good ear, and maybe I needed that. I probably did. [. . .] yes for me it was very beneficial.
Participant 9
Several participants commented that specifically the BA component of the intervention had helped to
improve their mood:
So what was great about the CADENCE pilot that I’ve done is it’s shown me that my life–work balance
isn’t very good. I probably was aware of it anyway, but it certainly flagged it up. I’ve been trying to
walk more and get more exercise generally, and I think by actually noting my mood during the day and
during every 2 hours and jotting it down I learnt quite a bit about myself, which I wasn’t expecting.
Participant 9
She told me to keep a diary of what I did throughout the day and that’s, and like what my mood was
like, and always just and stuff, basically to work out what was making me put in a bad mood and
whatever. And that kind of helped.
Participant 5
As participants were often making major lifestyle changes and decisions in response to their cardiac
experience (e.g. stopping smoking, moving home), it was not possible to identify if cardiac rehabilitation
alone would have had the same effect.
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Two participants, however, felt that receiving EPC had not helped them. One 85-year-old man, with
multiple health concerns, opted to withdraw from the BA component of the intervention after a few
sessions. He was having difficulty completing the paperwork and was put off by the need to constantly
monitor his mood:
That’s what was required on a daily and then virtually an hourly [basis]. The bit that thoroughly put me
off was the fact that I was expected to concentrate on that and know when I was having a low mood.
Well, I find these moods suddenly come on you and you don’t think about them, you just try and think
about something else. And you have to concentrate on noting when this mood changes. While I’m
doing that, I’m not relaxing, I’m thinking about this thing that I’m supposed to be doing and it didn’t
make me feel at all comfortable, I mean, it was a question of, ‘Oh, did I just have a mood change?’
Participant 2
The other participant felt that physical and mental aspects of care should be kept apart, and he would
have preferred to see a male practitioner devoted to providing mental health support.
Participants recognised that the space available for EPC delivery was not always ideal. One man said that he
had had EPC sessions in the changing room after the fitness session and in a café bar attached to the gym
and, although he had no concerns with this, he felt that other people might feel uncomfortable explaining
emotional matters in these environments. Although occasional EPC sessions provided by telephone were
seen as acceptable to participants, most much preferred face-to-face contact for their sessions.
The transition between feasibility study and pilot study
Table 11 summarises the main findings from all strands of the qualitative work undertaken during the
feasibility study, merged into key areas of learning. These areas were reviewed by the research team and,
as a consequence, aspects of the EPC intervention and study procedures were refined prior to piloting.
Refinements to the enhanced psychological care intervention prior to the pilot study
Several key refinements were made to the EPC intervention during the transition period. The most significant
change was the fundamental redesign of the intervention from a nurse-led intervention, with significant
emphasis on delivering the BA component within cardiac rehabilitation, to a patient-led, nurse-supported
programme. The pilot intervention placed greater emphasis on the mental health-care co-ordination as the
core component, rather than BA, and provided nurses with clear guidance on how to structure care. Details
of the practical changes to procedures are described in Table 11. The EPC intervention tested within the pilot
study is also described in detail in Enhanced psychological care.
Refining pilot study methods
Data from the qualitative study (see Table 11) were also used to refine study procedures prior to piloting.
For example, to support the extraction of data relevant to the assessment of intervention fidelity, a structured
form was developed (see Appendix 2) to assist nurses in recording key elements of the EPC intervention
delivered to participants within each cardiac rehabilitation session. A team profile questionnaire was also
developed, in order to capture information on the variability of service provision (e.g. team size, settings)
across teams that elected to participate in the pilot trial. It was also apparent that even after a substantive
redesign of the EPC intervention designed to reduce nurse workload, implementation issues would need to
be revisited in qualitative interviews conducted with nurses and patient participants.
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TABLE 11 Transition from feasibility study to pilot study: key learning identified from the qualitative research
Key learning Changes implemented for the pilot study
Variation between nursing teams in ways of working and patient pathways
l Number of sessions offered (6–12)
l Length of time over which the sessions are offered
(6–8 weeks)
l Types of sessions (e.g. fitness classes, one-to-one
clinic sessions)
l Facilities vary between locations (e.g. public gym,
hospital gym)
Methods: questionnaire devised to send out to potential
teams to assess patterns of working
Practical challenges and concerns over delivering effective intervention
Concerns over extra time required to deliver EPC within
existing services (including consultation time and extra
paperwork), lack of private space to deliver EPC
confidentially and without distraction and nurse
availability to deliver EPC while retaining clinical oversight
over patients from the wider cardiac rehabilitation groups
EPC: intervention fundamentally redesigned from a nurse-led
intervention to a patient-led, nurse-supported intervention.
Greater emphasis placed on mental health-care co-ordination
as the core component rather than BA. BA offered as a
patient ‘self-help’ intervention, that is, participants encouraged
to read the BA handbook and to complete the recommended
homework (e.g. activity/mood diaries, activity scheduling).
Nurses were trained to support participant engagement by
introducing BA, and to encourage individuals experiencing
difficulties in engaging with the self-help materials
Methods: implementation to be monitored in qualitative
interviews
Concerns over working with, and communication to,
other psychological services, and the wider primary and
secondary clinical care teams
EPC:
1. structured template developed to standardise the recording
of psychological treatments in nurse notes
2. template mental health referral letters provided to
standardise information given to other clinicians
Definitions of what constitutes an EPC session (e.g.
length, content) were unclear, and there was ambiguity
in how it should be recorded in the cardiac rehabilitation
notes
Methods: structured template developed to standardise the
recording of psychological treatments in nurse notes will also
facilitate data extraction to support measuring intervention
fidelity
Difficulties in engaging with clinical supervision as a
result of a lack of structured clinical note-keeping
(e.g. around risk issues), and nurses unsure about how to
engage effectively with clinical supervision
EPC:
1. structured template to record EPC in nurse notes
2. intervention training to include session on how to engage
effectively with mental health clinical supervision
Participants may have interrupted cardiac rehabilitation
(breaks over several months) because of physical health
problems, and nurses were unsure how to manage the
individual’s mental health needs within this extended/
interrupted timeline
EPC: intervention training and supporting materials altered to
emphasise that the participant’s mental care follow best
practice, that is, that mental health-care co-ordination should
not be delayed because of physical health problems
Nurses made practical suggestions to improve the
training materials, and requested scripts to introduce EPC
and concepts around BA and mood
EPC: the nurse handbook and participant handbook were
revised to improve user-friendliness (e.g. colour coded, scripts
provided to introduce concepts)
The ‘TRAP/TRAC’ functional analysis tools used in the
delivery of BA were not well used or understood by
nurses and participants
EPC: TRAP/TRAC tools omitted from the intervention
TRAP/TRAC, triggers, response, avoidance pattern/triggers, response, alternative coping.
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Data from the observational study also informed pilot study procedures in five main ways:
1. The eligibility criteria for participants recruited into the trial were broadened to reflect changing
practice, whereby increasingly diverse patients were being referred for cardiac rehabilitation (i.e.
patients with heart failure, not just patients with ACS).
2. The content of the case note review paperwork was revised to decrease the time burden on researchers
collating detailed information around consultations with health professionals.
3. The information sought regarding participant employment and antidepressant use (via the SRUQ) was
amended and simplified.
4. The assumptions underpinning the accrual of participants into the pilot RCT were deemed unrealistic
based on new, previously unknown process data obtained on participant recruitment and retention
(see Participant recruitment and retention). As a result, a working paper was drafted, outlining the
implications regarding the design of the pilot study (see Appendix 9). In summary, we recommended
that the 6-month recruitment period was not long enough to recruit sufficient participants to estimate
the pilot study primary outcome (follow-up rate) with the required precision. After reviewing the sample
size calculations and exploring different scenarios for our assumptions, we therefore recommended that
the recruitment period be extended by 3 months (i.e. a total recruitment period of 9 months). Even with
this extension, if the conditions of the feasibility study were replicated in the pilot trial, the likely accrual
of participants into the pilot study might still result in the recruitment of only 43 participants (compared
with the original target of 64). Despite our estimates based on feasibility data, the request to extend
participant recruitment in the pilot study was rejected. As a consequence, a priori, we predicted the
pilot study would fail to achieve its recruitment targets, anticipating recruitment within the region of
43 participants (half of whom would receive EPC).
5. The lower than expected participant accrual rate also had serious implications for the nested qualitative
study. We had originally intended to undertake maximum variation sampling from a pool of EPC
participants (see Data collection), to obtain diversity in terms of their sociodemographic characteristics,
as well as their engagement (or otherwise) with EPC. In reality, the lower accrual rate meant that we
had to invite most of the trial participants to take part in a qualitative interview.
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Chapter 5 Pilot study results
The pilot study consisted of three main elements (i.e. a pilot RCT, an economic evaluation and a nestedqualitative study), the results of which are presented below.
Pilot randomised controlled trial
Recruitment
Cardiac rehabilitation teams
The period of recruitment of the cardiac nursing teams ran from December 2014 to February 2015, with a
total of 8 out of the 20 approached agreeing to participate (40%) in the pilot trial. Nine teams declined
participation, two teams did not respond and one team ceased to exist as a result of service reconfiguration.
Teams (clusters) were then randomised to one of the two trial arms (five to EPC and three to UC), with one
team withdrawing from the EPC arm immediately post randomisation (May 2015). The mixed community
and hospital-based team was replaced with another team that was similar with respect to patient throughput
and population mix.
The timeline for obtaining local approvals is summarised in Table 12; in two areas, approvals took < 2 months
from the initial contact, in five areas it took between 2.5 and 3.5 months and, in the final area, it took
> 5 months. This posed a serious problem for participant recruitment, with delays experienced by teams in
most areas. Of particular concern were the two areas where nearly a 2-month delay was encountered
between the teams receiving all the necessary research/intervention training and then being able to
implement the study protocol (i.e. effectively shortening their participant recruitment period from 6 months
to 4 months).
Table 13 describes the geographic location, setting, team composition, type of programme offered to
the patient (including ‘usual psychological care’) and the average number of patients assessed for each
of the cardiac rehabilitation nursing teams. There were two hospital-based teams and three teams based
in the community, and the remaining three teams were based both in the community and at the hospital.
The teams had a varying number of cardiac nurses working either part time or full time, with one team only
having one part-time cardiac nurse undertaking an average of 32 assessments per month. Most of the teams
offered centre-based programmes either in the community and/or at the hospital, clinic-based individual
appointments and home-based programmes, with one team offering only centre-based programmes.
The majority of hospital and community-based teams covered a rural setting, and two teams covered an
inner-city patient population. The three UC teams had no access to psychological support integrated within
their cardiac rehabilitation programme, although one team had limited access to a clinical psychologist.
Three of the EPC teams had little or no access to psychological support; the other two EPC teams,
located in inner-city areas, had established close links to the clinical psychology/IAPT services for mental
health support.
Participant recruitment
Owing to limited numbers of patients within the individual cardiac rehabilitation teams, contrary to the
statistical analysis plan (see Appendix 10), we did not attempt to report participant recruitment rates for each
team on a weekly basis. We report aggregate data across teams within each trial arm for the number of
participants who were eligible for, and subsequently recruited to, the trial. The flow of cardiac nursing teams
and patients through the pilot stage of the CADENCE study is summarised in Figure 3. Cardiac nursing
teams started patient recruitment on different dates depending on approvals (see Table 12), with individual
teams recruiting for between 3 and 6 months during the period of June 2015 to 31 December 2015.
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TABLE 12 Pilot study: timeline outlining the length of time from the first approach to the securing of regulatory approvals
Team First approach to team Initial EOI from team
Trial allocation
confirmed
EPC training
delivered
First NHS R&D
contact
NHS R&D approval
letter issued
Participant
recruitment started
A 4 December 2014 19 December 2014 1 May 2015 UC 9 April 2015 28 May 2015 w/c 22 June 2015
B 4 December 2014 19 December 2014 1 May 2015 UC 9 April 2015 1 June 2015 w/c 22 June 2015
C 4 December 2014 5 January 2015 1 May 2015 UC 9 April 2015 20 July 2015 w/c 10 August 2015
D 4 December 2014 8 January 2015 1 May 2015 2 June 2015 and
3 June 2015
9 April 2015 7 July 2015 and
13 July 2015 (two trusts)
w/c 3 August 2015
E 26 January 2015 3 February 2015 1 May 2015 2 June 2015 and
3 June 2015
9 April 2015 16 July 2015 18 August 2015
F 26 January 2015 29 January 2015 1 May 2015 13 July 2015 9 April 2015 13 July 2015 w/c 20 July 2015
G 4 December 2014 10 April 2015 1 May 2015 13 July 2015 10 April 2015 10 September 2015 10 September 2015
H 27 May 2015 8 June 2015 9 June 2015 13 July 2015 15 June 2015 2 September 2015 2 September 2015
EOI, expression of interest; R&D, research and development; w/c, week commencing.
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TABLE 13 Pilot study: cardiac rehabilitation nursing team characteristics and the availability of usual psychological care
Team Team location Setting Cardiac team composition
Type of cardiac rehabilitation programme offered
(including usual psychological care)a
Average number of patients
assessed per monthb
A Hospital Rural Seven nurses (two full time; five part time)
One team manager (part time)
Centre-based groups (community/hospital)
Clinic-based individual appointments
Home-based programmes
40
B Community Rural Seven nurses (one full time; six part time)
Two administrators (part time)
Centre-based groups (community/hospital) – some areas/
teams had support from a clinical psychologist
Clinic-based individual appointments
Home-based programmes
60 (for the whole service)
15–20 per area
C Community Rural Three nurses (part time)
One team manager (part time)
Centre-based groups (community/hospital) 12–16
D Community Rural/urban Two nurses (one full time; one part time) Centre-based groups (community/hospital)
Clinic-based individual appointments
Home-based programmes
26
E Hospital Rural/urban Two nurses (part time)
One team manager (part time)
One administrator (part time)
Centre-based groups (community/hospital)
Clinic-based individual appointments
Home-based programmes
70
F Mixed hospital and
community
Urban One nurse (part time)
One administrator (part time)
Centre-based groups (community/hospital)
Clinic-based individual appointments
Home-based programmes
32
G Mixed hospital and
community
Inner city Four nurses (part time)
One administrator (part time)
Centre-based groups – limited psychological input via
referral to local IAPT programmes
Clinic-based individual appointments
Home-based programmes
33
H Mixed hospital and
community
Inner city Six nurses split across hospital and community
settings rotating between both settings
Centre-based groups (community)
Clinic-based individual appointments – part-time clinical
psychologist linked to the team
Home-based programmes
50–60
a Unless stated otherwise, there is no dedicated psychological support available (either within the team or through an established referral pathway).
b Data derived from the team profile questionnaire completed prior to randomisation.
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Cardiac nursing teams approached
(n = 20)
Cardiac teams agreed to be randomised
(n = 8)
Cardiac teams agreed to be randomised
(n = 8)
Patients not attending stages 2 and  3 of 
the CR pathway
 [n = 614 (EPC = 422; UC = 192)]
Cardiac teams randomised to EPC
(n = 5)
Patients referred to stages 2 and  3 of 
the CR pathway
(n = 811)
Patients attended stages 2 and  3 of 
the CR pathway
(n = 389)
Patients invited to take part
(n = 26)
Patients agreeing to participate
(n = 16)
Patients providing baseline data
(n = 15)
Patients providing 5-month data
(n = 13)
Patients providing 8-month data
(n = 9)
Patients with depression based on 
the PHQ-9 score, n = 54
Patients with new-onset depression, n = 41
Overall eligible patients, n = 30
Cardiac teams randomised to UC
(n = 3)
Teams declined, n = 9
Team no longer existed, n = 1
Teams unresponsive, n = 2
One team dropped out immediately 
post randomisation and was replaced 
with a new team
Patients referred to stages 2 and  3 of 
the CR pathway
(n = 417)
Patients attended stages 2 and  3 of 
the CR pathway
(n = 225)
Patients invited to take part
(n = 25)
Patients agreeing to participate
(n = 14)
Patients providing baseline data
(n = 14)
Patients providing 5-month data
(n = 14)
Patients with depression based on the 
PHQ-9 score, n = 35
Patients with new-onset depression, n = 27
Overall eligible patients, n = 25
Patients not invited to take part
 [n = 4 (EPC = 4; UC = 0)]
Patients declined trial participation
[n = 21 (EPC = 10; UC = 11)]
Patients not providing baseline data
[n = 1 (EPC = 1; UC = 0)]
Patients lost to 5-month follow-up
[n = 2 (EPC = 2; UC = 0)]
Patients not depressed based on the 
PHQ-9 score
 [n = 525 (EPC = 335; UC = 190)]
Patients lost to 8-month follow-up
[n = 4 (EPC = 3; UC = 1)]
Patients ineligible for 8-month follow-up
[n = 8 (EPC = 3; UC = 5)]
Patients providing 8-month data
(n = 8)
FIGURE 3 Pilot study: CONSORT flow diagram (with cluster extension). CR, cardiac rehabilitation.
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A total of 614 patients (389 in the EPC arm and 225 in the UC arm) were screened for eligibility at
hospital and community-based cardiac rehabilitation clinics. The mean age of patients attending an initial
nurse screening clinic was 66.2 years (range 32–95 years), with the majority being male (481 out of 614;
70.2%) and reporting their ethnicity as white (579 out of 614; 94.3%).
A total of 29 participants were randomised via their clusters (cardiac rehabilitation teams): 15 patients
were randomised to the EPC arm and 14 to UC. The flow of participants at different stages of the trial is
shown in Figure 3. Patients were screened at cardiac rehabilitation appointments, with 89 out of 614
(14.5%) scoring ≥ 10 on the PHQ-9 questionnaire, indicating depression. Of these 89 patients, 55 out of
614 were found to be eligible to participate in the trial (9%, 95% CI 7% to 12%); 33 were not eligible,
as they were either actively being treated for depression (n = 21; 3%, 95 CI 2% to 5%) or were individuals
with depression who were excluded for other reasons (e.g. alcohol and/or drug dependency problems,
were currently ineligible for cardiac rehabilitation based on their cardiac condition or had language and
communication problems).
Fifty-one of the 55 patients deemed to be eligible by a nurse were invited to participate. Of the four patients
not invited, one patient declined any further input from the cardiac rehabilitation service, two patients were
not offered EPC as the nurse was at capacity and could not take on more patients and the final patient
reported a marked improvement in mood and did not feel that they required EPC. Of the 51 patients offered
study entry, 21 (41%) declined participation for a variety of reasons including a preference to see their GP
(n = 6); feeling better and would prefer to see how mood goes while taking part in cardiac rehabilitation
(n = 3); that their mood was a long-standing problem unrelated to this current hospital stay (n = 2); or they
did not want the EPC intervention (n = 2) (nine patients did not give reason). Of the 55 eligible patients,
30 out of 55 (54%, 95% CI 41% to 68%) were initially recruited (one of whom withdrew prior to providing
baseline data). Four eligible patients, all in the EPC arm, were not invited to participate in the trial.
Of the denominator of 614 patients who attended an initial nurse assessment, the percentage recruited
was 5% (95% CI 3% to 7%). Of the 29 participants who were recruited to the trial, 27 provided data at
the 5-month follow-up (93%, 95% CI 77% to 99%). At 8 months, data were not able to be collected for
8 out of 29 participants because of late recruitment to the trial. Of the 21 participants for whom 8-month
data could have been obtained, data were collected for 17 (81%, 95% CI 58% to 95%).
Sample characteristics
Sociodemographic characteristics, smoking status and baseline psychological descriptors of participants
entered into the study are reported in Table 14. Both trial arms had approximately equal proportions of
males and females; all participants were white and all apart from one participant reported that English
was their preferred language. The mean age of the sample recruited was 62.7 years in the EPC arm and
68.1 years in the UC arm. There was, however, some imbalance between the arms, with the EPC arm having
a higher proportion of participants in the three most deprived deciles (6 out of 15; 40%) than UC (2 out of
14; 14%).
In terms of depressive symptoms, the EPC group reported higher levels of depression at baseline than the
UC group, as recorded by both the PHQ-9 (14.2 vs. 11.9) and the BDI-II (18.4 vs. 12.5) scores. At baseline,
10 out of 15 (67%) participants in the EPC arm had a BDI-II score of ≥ 14 compared with 7 out of 14
(50%) in the UC arm. The highest BDI-II score in the UC group at baseline was 20, whereas there were
seven participants in the EPC group who had a score of ≥ 20 at baseline. Of note, participants from the
more deprived backgrounds also had higher baseline BDI-II scores (see Table 14).
The majority of participants were former smokers (four in the EPC arm and five in the UC arm); none was
current smokers. There was a wide range of time since quitting smoking, with some participants having
quit several years ago and six participants having quit < 6 months prior to entering into the study.
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TABLE 14 Pilot study: participant characteristics at baseline
Characteristic
Treatment arm
UC (N= 14) EPC (N= 15)
Gender, n (%)
Male 7 (50) 8 (53)
Age (years), mean (SD); min., max. 68.1 (8.6); 53, 79 62.7 (8.9); 47, 75
Ethnicity, n (%)
White 14 (100) 15 (100)
Preferred language, n (%)
English 13 (93) 15 (100)
Other 1 (7) 0 (0)
Smoking status, n (%)
Never smoked 5 (36) 4 (27)
Ex-smoker 9 (64) 11 (73)
Time since quitting smoking (ex-smokers only), n (%)
< 6 months 3 (33) 3 (27)
6–12 months 0 (0) 0 (0)
1–5 years 0 (0) 2 (18)
5–10 years 1 (11) 0 (0)
> 10 years 5 (56) 6 (55)
IMD, median decile (IQR)a 6 (4–8) 5 (1–7)
Indicating cardiac event and/or proceduresb
MI (includes STEMI, NSTEMI or unclassified MI), n (%) 1 (7) 2 (13)
MI and PCI (angioplasty, angiogram or stent), n (%) 5 (36) 4 (27)
Angina, n (%) 1 (7) 0 (0)
Other heart condition,c n (%) 3 (21) 1 (7)
PCI (angioplasty, angiogram or stent), n (%) 4 (29) 2 (13)
CABG, n (%) 0 (0) 3 (20)
Other cardiac procedure (pacemaker, valve surgery), n (%) 0 (0) 3 (20)
CIS-R (N = 13) (N = 14)
Primary diagnosis category, n (%)
No psychiatric diagnosis identified 9 (69) 6 (43)
Mixed anxiety and depressive disorder – mild 1 (8) 1 (7)
Mild depressive episode 3 (23) 4 (29)
Moderate depressive episode 0 (0) 3 (21)
Secondary diagnosis category, n (%)
No psychiatric diagnosis identified 12 (92) 9 (64)
Mixed anxiety and depressive disorder – mild 1 (8) 1 (7)
Generalised anxiety disorder – mild 0 (0) 1 (7)
Mixed anxiety and depressive disorder 0 (0) 2 (14)
Specific (isolated) phobia 0 (0) 1 (7)
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A post hoc comparison was conducted on the sociodemographic characteristics (age, gender and ethnicity)
and PHQ-9 scores of patients who were invited to participate but who declined (where sufficient data
were recorded on the screening logs). Of the 51 eligible participants who were offered study entry, 15 out
of 29 (52%) male patients and 15 out of 22 (68%) female patients accepted. Of 49 eligible white patients
invited to participate, 19 (39%) declined, as did both of the two Asian/Asian-British patients. The mean age
among 30 eligible patients who accepted participation was 63.8 years (SD 9.5 years), range 47–78 years;
among 21 patients who declined, mean age was 61.1 years (SD 12.3 years; range 36–83 years). For the
acceptors, mean PHQ-9 score was 13.4 (SD 4.1; range 10–25); for the decliners, mean PHQ-9 score was
14.4 (SD 4.6; range 10–24).
The indicating cardiac events, as recorded in GP or cardiac nurse records, and participant self-reported
cardiac conditions at baseline are recorded in Table 15. Trial participants had experienced a wide range of
cardiac events that precipitated their referral to cardiac rehabilitation according to their clinical records, the
most frequent of which were MI (STEMI or NSTEMI) and PCI.
TABLE 14 Pilot study: participant characteristics at baseline (continued )
Characteristic
Treatment arm
UC (N= 14) EPC (N= 15)
Emotional health
PHQ-9, mean score (SD); min., max. 11.9 (1.8); 10, 16 14.2 (4.7); 10, 25
BDI-II, mean score (SD); min., max. 12.5 (4.9); 4, 20 18.4 (7.4); 7, 31
BAI, mean score (SD) 12.5 (4.4) 19.3 (10.7)
Do you believe you have low mood?, n (%)
Yes 11 (79) 11 (73)
No 3 (21) 4 (27)
Do you want any professional help for your low mood? (N = 11), n (%)
Strongly prefer help 1 (9) 5 (45)
Prefer help 4 (36) 2 (18)
Prefer not to receive help 3 (27) 3 (27)
Strongly prefer not to receive help 3 (27) 1 (9)
What type of professional help would you prefer? (N= 11), n (%)
Strongly prefer non-drug help 6 (55) 9 (82)
Prefer non-drug help 3 (27) 0 (0)
Prefer drug-based help 1 (9) 0 (0)
Strongly prefer drug-based help 0 (0) 0 (0)
Do not mind 1 (9) 2 (18)
HRQoL
EQ-5D-5L score, mean score (SD) 0.801 (0.097) 0.644 (0.226)
EQ-5D VAS score, mean score (SD); min., max. 63.0 (23.5); 4, 95 48.7 (19.3); 10,
100
IQR, interquartile range; max., maximum; min., minimum.
a Lower deciles are more deprived.
b Indicating cardiac condition as recorded from either GP and/or cardiac nurse records. Clear diagnostic information was
not always present; some individuals only had evidence of a procedure recorded within their clinical notes.
c Other heart conditions include atrial fibrillation, chest pain, heart failure or ischaemic heart disease.
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TABLE 15 Pilot study: participant-reported smoking status, heart problems and procedures, and other health
problems at baseline, 5 months and 8 months
Outcome
Time point, n (%)
Baseline 5 months 8 months
UC (N= 14) EPC (N= 15) UC (N= 14) EPC (N= 13) UC (N= 8) EPC (N= 9)
Smoking status
Smoking status N= 14 N= 15 N= 14 N= 13 N= 8 N= 9
Never smoked 5 (36) 4 (27) 5 (36) 4 (31) 3 (38) 3 (33)
Ex-smoker 9 (64) 11 (73) 8 (57) 9 (69) 5 (63) 5 (56)
Current smoker 0 (0) 0 (0) 1 (7) 0 (0) 0 (0) 1 (11)
Participant-reported heart problems and procedures: have you ever had this heart problem or procedure?
MI N= 14 N= 15 N= 14 N= 13 N= 8 N= 9
Yes 8 (57) 12 (80) 8 (57) 11 (85) 4 (50) 8 (89)
Not sure 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Angina N= 13 N= 14 N= 14 N= 13 N= 8 N= 9
Yes 6 (46) 6 (43) 4 (43) 4 (31) 3 (38) 3 (33)
Not sure 1 (8) 0 (0) 1 (7) 0 (0) 1 (13) 0 (0)
Hospital admission –
non-cardiac chest pain
N= 12 N= 14 N= 14 N= 13 N= 8 N= 9
Yes 0 (0) 4 (29) 0 (0) 4 (31) 0 (0) 2 (22)
Not sure 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Heart failure N= 13 N= 14 N= 14 N= 13 N= 8 N= 9
Yes 1 (8) 3 (21) 2 (14) 2 (15) 0 (0) 2 (22)
Not sure 0 (0) 2 (14) 0 (0) 2 (15) 0 (0) 1 (11)
Arrhythmia N= 13 N= 14 N= 14 N= 13 N= 8 N= 9
Yes 2 (15) 6 (43) 4 (29) 6 (46) 1 (13) 2 (22)
Not sure 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
PCI procedure N= 14 N= 15 N= 14 N= 13 N= 8 N= 9
Yes 8 (57) 7 (47) 9 (64) 7 (54) 5 (63) 6 (67)
Not sure 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
CABG procedure N= 13 N= 14 N= 14 N= 13 N= 8 N= 9
Yes 3 (23) 3 (21) 3 (21) 2 (15) 1 (13) 1 (11)
Not sure 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Valve surgery N= 13 N= 14 N= 13 N= 13 N= 8 N= 9
Yes 1 (8) 3 (21) 1 (8) 3 (23) 0 (0) 1 (11)
Not sure 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
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TABLE 15 Pilot study: participant-reported smoking status, heart problems and procedures, and other health
problems at baseline, 5 months and 8 months (continued )
Outcome
Time point, n (%)
Baseline 5 months 8 months
UC (N= 14) EPC (N= 15) UC (N= 14) EPC (N= 13) UC (N= 8) EPC (N= 9)
Other current health problems
Asthma N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 1 (8) 5 (33) 1 (7) 4 (31) 3 (38) 3 (33)
Lung disease N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 2 (15) 3 (20) 3 (21) 2 (15) 2 (25) 1 (11)
High blood pressure N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 11 (85) 4 (27) 8 (57) 6 (46) 5 (63) 7 (78)
Diabetes mellitus N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 3 (23) 1 (7) 3 (21) 1 (8) 1 (13) 2 (22)
Ulcer/stomach disease N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 6 (46) 2 (13) 2 (14) 1 (8) 0 (0) 1 (11)
Bowel disease N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Kidney disease N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 1 (8) 1 (7) 1 (7) 1 (8) 0 (0) 1 (11)
Liver disease N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 1 (8) 1 (7) 1 (7) 1 (8) 0 (0) 1 (11)
Anaemia/blood disease N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 5 (38) 0 (0) 4 (29) 3 (23) 2 (25) 1 (11)
Cancer N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 1 (8) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Nervous system disease N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 1 (8) 1 (7) 1 (7) 1 (8) 1 (13) 1 (11)
Arthritis N = 14 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 11 (79) 8 (53) 11 (79) 8 (62) 7 (88) 5 (56)
Back pain N = 14 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 10 (71) 7 (47) 10 (71) 8 (62) 8 (100) 6 (67)
Mental health problems N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 0 (0) 0 (0) 1 (7) 2 (15) 0 (0) 1 (11)
Skin disease N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 4 (31) 1 (7) 4 (29) 1 (8) 1 (13) 0 (0)
Hearing/visual
impairment
N = 13 N= 15 N = 14 N= 13 N = 8 N= 9
Yes 1 (8) 4 (27) 2 (14) 3 (23) 1 (13) 2 (22)
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Enhanced psychological care intervention delivery
Seven nurses from four teams provided EPC to one or more participants (one team recruited no participants
to the study). Three teams had two nurses providing EPC and one team had a single practitioner. Most nurses
had their own participants allocated to them, with some shared cases when the index nurse was unavailable.
Thirty supervision calls were made to the teams over a 7-month period (August 2015 to February 2016).
Some teams opted for joint supervision (i.e. both nurses listening in to all cases), whereas others had
individual calls related to their own cases, and then handed the telephone to the other team nurse.
Intervention fidelity
From data extracted from the notes recorded by cardiac rehabilitation nurses (Table 16), the number of
cardiac rehabilitation sessions attended ranged from 0 to 22 (mean 8.3 sessions, SD 8.1 sessions) for the
TABLE 16 Pilot study: process data for delivery of EPC at the 8-month follow-up
Outcome
Trial arm
UC (N= 14) EPC (N= 15)
Number of cardiac rehabilitation sessions, mean (SD), n; median (min., max.)
Offered 8.8 (3.2), 14; 8 (2, 14) 9.4 (8.1), 15; 7 (0, 24)
Attended 7.4 (2.7), 14; 7.5 (1, 12) 8.3 (8.1), 15; 7 (0, 22)
Number of EPC sessions attended, n (%)
8 NA 8 (53)
7 1a (7)
6 1b (7)
1 1c (7)
0 4 (27)
Time (days) elapsed from consent date to starting cardiac
rehabilitation, mean (SD), n; median (min., max.)
14 (2), 14; 3 [–15, 27] 3 (12), 15; 5 (–35, 22)
Participants who started cardiac rehabilitation prior to trial
recruitment, n/N (%)
6 (43) 2 (13)
Time (days) elapsed from trial entry to start of EPC, mean (SD), n;
median (min., max.)
NA 6 (5), 11; 5 (0, 19)
Time (days) elapsed from trial entry to nurse discharge from cardiac
rehabilitation, mean (SD), n; median (min., max.)
64 (28), 14; 69 (13, 112) 96 (37), 12; 89 (48, 185)
Time (days) elapsed from discharge to sending GP discharge letter,
mean (SD), n; median (min., max.)
5 (7), 11; 1 (0, 23) 1 (3), 7; 0 (0, 8)
Psychological care co-ordination activities provided (evidence of
care co-ordination during at least one attended EPC session), n (%)
NA 5 (33)
Nurse referral to GP/IAPT services/other psychological care services,d
n (%)
0 (0) 7 (47)
Care accessed for depression privately (participant self-report), n (%) 0 (0) 0 (0)
Care accessed for depression via established NHS mental health
pathways, n (%)
0 (0) 0 (0)
max., maximum; min., minimum; NA, not applicable.
a Participant had only seven sessions scheduled.
b Participant had eight sessions scheduled, but did not attend two sessions.
c Participant had only one session scheduled.
d Seven participants (three in the UC arm and four in the EPC arm) had no evidence of the nurse generating a discharge
letter to the GP. There was also inconsistency in the notes relating to care co-ordination activities (i.e. referrals made by
letter, but not explicitly indicated as a separate entry in the clinical record).
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15 EPC participants, and from 1 to 12 sessions (mean 7.4 sessions, SD 2.7 sessions) in the UC arm. The
mean time between the date of consent to the start of cardiac rehabilitation was 3 days (SD 12 days) in
the EPC group and 14 days (SD 2 days) in the UC group.
Consistent with the training provided, in the EPC arm there was documentary evidence that a maximum of
eight sessions of EPC were offered. Just over half of the participants in the EPC arm received the maximum
number of sessions (8 out of 15; 53%), whereas 4 out of 15 participants (27%) had no EPC sessions
recorded. Despite the intervention being designed to place much greater emphasis on mental health-care
co-ordination, documentary evidence of co-ordination activities was observed in around half of the EPC
patients (7 out of 15; 47%); these individuals were referred to another NHS service (e.g. GP, IAPT, another
psychological care service). This compared with 0 out of 14 UC participants (0%). No participants in either
the EPC arm or the UC arm had evidence recorded in the nurse’s notes that they were accessing private
mental health care.
There were no deaths recorded in either arm of the trial between baseline and the final follow-up.
Using data extracted from either the GP or cardiac nurse records, there was evidence of a small number of
new cardiac events/diagnoses between baseline and the 5-month follow-up (EPC = five events; UC = four
events) and a further four events (EPC = three events; UC = one event) between 5 months and 8 months.
The description of cardiac events is presented in Table 17.
Using data from the GP case notes review (Table 18), only two participants (one EPC participant and one
UC participant) had evidence of a mental health event related to a newly diagnosed condition recorded
within the practice records, and only one EPC participant had evidence of prescribing for antidepressant
medication recorded within their GP records. Three participants had evidence of amitriptyline prescribing
(one EPC participant and two UC participants) during the follow-up period. Two amitriptyline prescriptions
were for 10 mg for ‘sleep problems’ and the third was for 25 mg with no recorded indication; given the
low doses, these prescriptions were unlikely to be intended as antidepressant medications.
To test the feasibility of collecting physiological and biochemical measurements from routine records, we
noted the availability of data from either GP or cardiac nurse records. As can be seen in Table 19, the
routine recording of such measurements was highly variable; blood pressure measurements were the most
frequently reported, whereas other measurements, such as glycated haemoglobin (HbA1c) and triglycerides
levels, were frequently omitted from the record.
TABLE 17 Pilot study: cardiac events (diagnoses and procedures) derived from GP or cardiac nurse records at follow-up
Cardiac eventa
Follow-up time period in each trial arm, n (%)
Baseline to 5 months 5–8 months
UC (N= 14) EPC (N= 13) UC (N= 8) EPC (N= 9)
MI (STEMI or NSTEMI) 0 (0) 1 (8) 0 (0) 0 (0)
ACS (not specified) 2 (14) 0 (0) 0 (0) 0 (0)
Angina 0 (0) 1 (8) 0 (0) 1 (11)
Other diagnosisb 2 (14) 1 (8) 1 (13) 2 (22)
PCI procedure 0 (0) 1 (8) 0 (0) 0 (0)
a Multiple outcomes can occur in an individual participant.
b Other diagnoses recorded include atrial fibrillation, heart failure, ischaemic coronary disease and left ventricular dysfunction.
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Mental health risk and adverse event reporting
During the course of the pilot trial, the protocol relating to managing self-harm/suicide risk was triggered
for four events in relation to three participants. Three risks were recorded by the nurse during an EPC
intervention session and one managed by a study researcher during a research interview. For the three
participants triggering the risk protocol, all were initially identified at ‘Level B1’ risk; that is, they reported
plans/preparations to self-harm, but with protective factors identified, and the participant was advised to
seek help from their GP. One individual was subsequently escalated to ‘Level B2’ risk; they had taken no
action to talk to their GP regarding their mood, and their GP was contacted (with the participant’s
permission) to alert them to the risk.
Although no adverse events were identified, 11 serious adverse events (regarding six participants) were
recorded by the research team. All serious adverse events came to light through researcher follow-up
assessments or through case note reviews of clinical records; none was reported ‘in real time’ from clinical
teams. Four events occurred during the course of the treatment period, whereas seven occurred after
TABLE 18 Pilot study: mental health events and use of antidepressant medication at follow-up according to the
GP records
Mental health event and use
of antidepressant medication
Follow-up time period in each trial arm, n (%)
Baseline to 5 months 5–8 months
UC (N= 14) EPC (N= 13) UC (N= 8) EPC (N= 9)
Mental health event(s) during follow-up
0 13 (93) 12 (92) 0 (0) 0 (0)
1 1 (7)a 1 (8)b 0 (0) 0 (0)
2 or more 0 (0) 0 (0) 0 (0) 0 (0)
Using antidepressant medication
at follow-up
1 (7)c 1 (8)d 0 (0) 0 (0)
a One participant was diagnosed with depression.
b One participant was diagnosed with anxiety and depression.
c One participant was prescribed citalopram.
d One participant was prescribed citalopram and sertraline.
TABLE 19 Pilot study: availability of biochemical and physiological outcome data
Outcome measure
availabilitya
Follow-up time point in each trial arm, n (%)
Baselineb 5 monthsc 8 monthsd
UC (N= 14) EPC (N= 15) UC (N= 14) EPC (N= 15) UC (N= 8) EPC (N= 9)
BMI (kg/m2) 9 (64) 6 (40) 9 (64) 5 (33) 1 (13) 4 (44)
Blood pressure (mmHg) 13 (93) 13 (87) 13 (93) 15 (100) 4 (50) 7 (78)
HbA1c (%) 1 (7) 2 (13) 4 (29) 1 (7) 0 (0) 1 (11)
Total cholesterol 7 (50) 8 (53) 9 (64) 6 (40) 2 (14) 0 (0)
Triglycerides 2 (14) 2 (13) 5 (36) 1 (7) 1 (13) 1 (11)
a Data available in GP notes and/or cardiac rehabilitation team notes (data source not reported).
b Most recent measurement between indicating cardiac event and baseline.
c Most recent measurement between baseline and 5 months.
d Most recent measurement between 5 months and 8 months.
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treatment and within the trial follow-up period; all patients recovered fully. The serious adverse events all
related to participant admission to hospital on account of infective conditions, asthma or cardiac complications
(e.g. chest pain, additional stent, postural hypotension). None of the serious adverse events was judged by the
TSC to be related to the trial intervention or research procedures.
Participant-reported outcome measures
Psychological outcomes
The participant-reported outcomes relating to their mood at each follow-up point are reported in Tables 20
(5 months) and 21 (8 months), and Figure 4. In terms of depressive symptoms, at the 5-month follow-up,
the mean BDI-II score was reduced from baseline in both groups. Three participants in the EPC arm did not
report a BDI-II score at the 5-month follow-up (baseline BDI-II scores were 14, 25 and 31). For 26 participants,
the mean difference in BDI-II scores at the 5-month follow-up (with adjustment for baseline score), comparing
EPC with UC was 1.7 (95% CI –3.8 to 7.3). For the 17 participants available for analysis, by 8 months the
mean difference in BDI-II scores (EPC vs. UC) was 4.4 (95% CI –1.4 to 10.2).
Around half the participants with data available at both baseline and 5 months (n = 26) had a 50%
reduction in BDI-II scores at 5 months: 5 out of 12 (42%) in the EPC arm and 7 out of 14 (50%) in the UC
arm, yielding an odds ratio of 0.71 (95% CI 0.16 to 3.25). A 17% reduction from baseline symptoms
(the MCID) was observed for 10 out of 12 participants in the EPC arm (83%) and 11 out of 14 participants
in the UC arm (79%); by 8 months, this was 6 out of 9 (67%) and 5 out of 8 (63%), respectively.
In the EPC arm, seven participants with a BDI-II score of ≥ 14 at baseline also had follow-up data at 5 months,
of whom three (43%) were in remission (i.e. with a BDI-II score of < 14). Only seven participants in UC had a
baseline BDI-II score of ≥ 14 and follow-up data at 5 months, of whom 6 (86%) were in remission at 5 months.
Among these participants, in the EPC arm 2 out of 7 (29%) had a CSRC, compared with 3 out of 7 (43%)
in UC.
The maximum BDI-II score at the 5-month follow-up was 14 in the UC arm. In the EPC arm, there were
two participants who scored 15 and one participant who scored 33 (this participant scored 25 at baseline).
Therefore, overall, in both groups, with the exception of one participant in the EPC arm, all 5-month BDI-II
scores were in the moderate depression range or below.
At 8 months, the highest BDI-II score in the UC arm was 12, whereas in the EPC arm there were five
participants with a score of ≥ 14. The highest score in this group was 22; this participant scored 31 at
baseline and did not provide sufficient BDI-II data at 5 months. The participant who scored 33 at 5 months
scored 18 at 8 months.
In terms of anxiety, the mean BAI score was also reduced at 5 months in both groups, with a between-arm
mean difference between EPC and UC of 4.6 (95% CI –0.8 to 10.0). By 8 months, the between-group
difference was 5.0 (95% CI –1.2 to 11.1).
Roughly equal numbers of participants in each arm believed that they had low mood, and there was a
general preference in both groups to receive non-drug support for their low mood.
Other outcomes
Participant-reported HRQoL outcomes at each follow-up point are summarised in Tables 20 (5 months) and
21 (8 months). EQ-5D-5L scores within the EPC or UC groups appeared to be unchanged across time, and
the between-group mean difference in EQ-5D-5L and VAS scores (adjusted for baseline score) between the
EPC and UC groups at the 5-month follow-up were 0.045 (95% CI –0.023 to 0.113) and –0.014 (95% CI
–0.145 to 0.064) respectively. The mean HeartQoL score had increased from baseline to 5 months in both
the EPC and UC arms. The mean difference in HeartQoL score (adjusted for baseline score) between EPC
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TABLE 20 Pilot study: participant-reported mental and physical health outcomes at baseline and 5 months
Outcome variable
Follow-up time point in each trial arm
Mean difference or
ORa (95% CI)
Baseline 5 months
UC (N= 14) EPC (N= 15) UC (N= 14) EPC (N= 13)
BDI-II
Mean score (SD), n; min., max. 12.5 (4.9), 14; 4, 20 18.4 (7.4), 15; 7, 31 7.4 (3.7), 14; 2, 14 10.2 (8.4), 12; 2, 33 1.7 (–3.8 to 7.3)
50% reduction in score from baseline, n/N (%) – – 7/14 (50) 5/12 (42) 0.71 (0.16 to 3.25)
Remission (score of < 14) from baseline,b n/N (%) – – 6/7 (86) 3/7 (43) 0.13 (0 to 1.37)
MCID in score (17.5% reduction from baseline), n/N (%) – – 11/14 (79) 10/12 (83) 1.36 (0.22 to 8.31)
CSRC in score from baseline,c n/N (%) – – 3/7 (43) 2/7 (29) 0.53 (0.07 to 4.33)
BAI
Mean score (SD), n; min., max. 12.5 (4.4), 14; 4, 21 19.3 (10.7), 15; 4, 36 9.2 (4.0), 14; 4, 15 14.7 (8.3), 13; 3, 27 4.6 (–0.8 to 10.0)
EQ-5D-5L
Mean score (SD), n; median (IQR) 0.869 (0.085), 14;
0.893 (0.866–0.924)
0.751 (0.182), 15;
0.751 (0.652–0.886)
0.875 (0.115), 13;
0.901 (0.843–0.951)
0.885 (0.065), 13;
0.866 (0.828–0.924)
0.045 (–0.023 to 0.113)
EQ-5D VAS
Mean score (SD), n; min., max. 63 (24), 14; 4, 95 49 (19), 15; 10, 100 72 (21), 14; 30, 100 72 (21), 12; 30, 100 5 (–13 to 22)
HeartQoL
Mean score (SD), n; min., max. 21.3 (9.1), 14; 5, 37 15.2 (9.9), 15; 1, 35 31.5 (4.9), 14; 23, 38 22.9 (10.3), 13; 4, 41 –8.2 (–14.9 to –1.4)
IQR, interquartile range; max., maximum; min., minimum; OR, odds ratio.
a Between-group comparison. The mean difference is adjusted for baseline score.
b At baseline, 7 out of 14 UC participants and 10 out of 15 EPC participants had a BDI-II score of ≥ 14; participants with scores of ≤ 13 at baseline were excluded.
c CSRC can be calculated only for participants with a baseline BDI-II score of ≥ 14.
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TABLE 21 Pilot study: participant-reported mental and physical health outcomes at baseline and 8 months
Outcome variable
Follow-up time point in each trial arm
Mean difference or ORa
(95% CI)
Baseline 8 months
UC (N= 14) EPC (N= 15) UC (N= 8) EPC (N= 9)
BDI-II
Mean score (SD), n; min., max. 12.5 (4.9), 14; 4, 20 18.4 (7.4), 15; 7, 31 7.0 (3.5), 8; 1, 12 12.6 (6.6), 9; 1, 22 4.4 (–1.4 to 10.2)
50% reduction in score from baseline, n/N (%) – – 4/8 (50) 2/9 (22) 0.29 (0.04 to 2.09)
Remission (score of < 14) from baseline,b n/N (%) – – 4/4 (100) 2/5 (40) 0 (0 to 1.10)
MCID in score (17.5% reduction from baseline), n/N (%) – – 5/8 (63) 6/9 (67) 1.20 (0.18 to 7.99)
CSRC in score from baseline,c n/N (%) – – 2/4 (50) 1/5 (20) 0.25 (0 to 3.56)
BAI
Mean score (SD), n; min., max. 12.5 (4.4), 14; 4, 21 19.3 (10.7), 15; 4, 36 6.4 (4.6), 8; 0,12 12.7 (7.1), 9; 4, 24 5.0 (–1.2 to 11.1)
EQ-5D-5L
Mean score (SD), n; median (IQR) 0.869 (0.085), 14;
0.893 (0.866–0.924)
0.751 (0.182), 15;
0.751 (0.652–0.886)
0.876 (0.092), 8;
0.868 (0.830–0.951)
0.827 (0.116), 9;
0.874 (0.697–0.951)
–0.041 (–0.145 to 0.064)
EQ-5D VAS
Mean score (SD), n; min., max. 63 (24), 14; 4, 95 49 (19), 15; 10, 100 64 (18), 7; 40, 90 64 (12), 8; 50, 80 1 (–17 to 19)
HeartQoL
Mean score (SD), n; min., max. 21.3 (9.1), 14; 5, 37 15.2 (9.9), 15; 1, 35 28.3 (6.7), 8; 17, 36 28.6 (7.6), 9; 16, 36 0.1 (–7.9 to 8.0)
IQR, interquartile range; max., maximum; min., minimum; OR, odds ratio.
a Between-group comparison. The mean difference is adjusted for baseline score.
b At baseline, 7 out of 14 UC participants and 10 out of 15 EPC participants had a BDI-II score of ≥ 14; participants with a score of ≤ 13 at baseline were excluded.
c CSRC can be calculated only for participants with a baseline BDI-II score of ≥ 14.
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and UC at the 5-month follow-up was –8.2 (95% CI –14.88 to –1.43). At the 8-month follow-up, the
between-group mean difference was negligible (0.1, 95% CI –7.9 to 8.0).
One participant in the UC arm, an ex-smoker at baseline, had recommenced smoking 20 cigarettes per
day by the 5-month follow-up (see Table 15). Furthermore, one participant in the EPC arm, also an
ex-smoker at baseline, had recommenced smoking by 8 months.
Participant experiences of care
Participants in both arms reported a positive experience of their cardiac rehabilitation programme, based
on both the CSQ-8 and the FFT reported at the 5-month follow-up, although there may be some
indication of a more positive experience in EPC (Table 22).
Most participants across both treatment arms reported that the quality of the service they received was
excellent (EPC = 9 out of 11 participants; UC = 9 out of 13 participants). All of the participants in the EPC
arm were extremely satisfied with the amount of help they received (11 out of 11), and most of the
participants in the UC arm were extremely satisfied (8 out of 13). Although most of the participants in the
UC arm reported being very satisfied overall (9 out of 13), more of the EPC participants were satisfied
(10 out of 11) and willing to return to the programme in the future (EPC = 10 out of 11 participants;
UC = 7 out of 13 participants). The majority of participants in both arms were extremely likely to recommend
the service to friends and family (EPC = 11 out of 13 participants; UC = 10 out of 14 participants).
Analysis of the FFT free-text items identified aspects of the cardiac rehabilitation experience that were
good, and those that could be improved. Of the 27 participants followed up at 5 months, 19 provided
comments about their experience. Some participants (6 out of 19) mentioned that the group element of
the rehabilitation was beneficial to their recovery, providing participants with additional support. Just over
half the participants (10 out of 19) reported that the nurses were very supportive and that it was helpful
having a named person to contact. Participants also reported the mental and physical health benefits of
cardiac rehabilitation (4 out of 19 and 3 out of 19 respectively), as it improved their mood, increased
their confidence and improved their physical strength. Finally, 8 out of 19 participants reported that the
rehabilitation groups were informative, providing additional, reassuring information about recovery from
different health professionals. As to what would make their experience better, only six participants
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FIGURE 4 Pilot study: BDI-II scores for participants with baseline and at least one follow-up observation. (a) UC; and
(b) EPC.
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TABLE 22 Pilot study: patient experience ratings from the CSQ-8 and FFT at 5 months
Patient-reported outcome
Trial arm, n (%)
UC (N= 14) EPC (N= 13)
CSQ-8
How would you rate the quality of service you have received? N= 13 N = 11
Excellent 9 (69) 9 (82)
Good 3 (23) 2 (18)
Fair 1 (8) 0 (0)
Poor 0 (0) 0 (0)
Did you get the kind of service you wanted? N= 13 N = 11
Yes, definitely 8 (62) 10 (91)
Yes, generally 5 (38) 1 (9)
No, not really 0 (0) 0 (0)
No, definitely 0 (0) 0 (0)
To what extent has our programme met your needs? N= 13 N = 11
Almost all of my needs have been met 9 (69) 9 (82)
Most of my needs have been met 3 (23) 2 (18)
Only a few of my needs have been met 1 (8) 0 (0)
None of my needs have been met 0 (0) 0 (0)
If a friend were in need of similar help, would you recommend our programme to him or
her?
N= 14 N = 11
Yes, definitely 9 (64) 11 (100)
Yes, I think so 5 (36) 0 (0)
No, I do not think so 0 (0) 0 (0)
No, definitely not 0 (0) 0 (0)
How satisfied are you with the amount of help you have received? N= 13 N = 11
Very satisfied 8 (62) 11 (100)
Mostly satisfied 5 (38) 0 (0)
Indifferent or mildly dissatisfied 0 (0) 0 (0)
Quite dissatisfied 0 (0) 0 (0)
Have the services you received helped you to deal more effectively with your problems? N= 13 N = 11
Yes, they helped a great deal 8 (62) 9 (82)
Yes, they helped somewhat 5 (38) 2 (18)
No, they really did not help 0 (0) 0 (0)
No, they seemed to make things worse 0 (0) 0 (0)
In an overall, general sense, how satisfied are you with the services you have received? N= 13 N = 11
Very satisfied 9 (69) 10 (91)
Mostly satisfied 4 (31) 1 (9)
Indifferent or mildly dissatisfied 0 (0) 0 (0)
Quite dissatisfied 0 (0) 0 (0)
continued
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responded, with three participants referring to the accessibility of the service provided (i.e. timings were not
suitable for working people, challenges for those who are hearing impaired or the content was more
relevant to patients with severe heart conditions). The remaining comments referred to the need for a
balanced mix of genders in the group, as it was more heavily weighted towards male patients, the notion
that cardiac rehabilitation was physically demanding for their age and the lack of information about
the pain experienced in the year after the heart attack.
Methods to support economic evaluation
Cost of delivering the intervention
The estimated cost per participant receiving the EPC intervention, and the main elements of this cost,
are presented in Table 23.
The calculation presented in Table 23 makes no adjustment for the small scale of the pilot trial, and so
it is inevitably an overestimate of what the actual cost would be if the intervention were to be delivered
routinely to larger numbers of patients. For example, in this calculation, the initial training of nurses
accounts for a significant proportion of the overall cost of providing EPC, but this would, in reality, be
shared across a larger number of patients receiving EPC over a longer period.
The estimated time nurses take to deliver EPC elements within rehabilitation accounts for a relatively
small amount of the overall cost (£63 of the estimated £959 per participant). This was estimated by trial
researchers from the information that has been collected to describe the delivery of the intervention (see
Appendix 3). However, the qualitative interviews with nurses, conducted as part of this study’s process
evaluation, showed clearly that the nurses found it extremely difficult to distinguish clearly their EPC-delivering
time from other aspects of the care they usually provide. Nevertheless, we believe that the cost breakdown
shown may help those developing and evaluating similar nurse-delivered interventions in hospital and
TABLE 22 Pilot study: patient experience ratings from the CSQ-8 and FFT at 5 months (continued )
Patient-reported outcome
Trial arm, n (%)
UC (N= 14) EPC (N= 13)
If you were to seek help again, would you come back to our programme? N= 13 N = 11
Yes, definitely 7 (54) 10 (91)
Yes, I think so 4 (31) 1 (9)
No, I do not think so 2 (15) 0 (0)
No, definitely not 0 (0) 0 (0)
FFT
How likely are you to recommend this help or support to friends and family if they needed
similar care or treatment?
N= 14 N = 13
Extremely likely 10 (71) 11 (85)
Likely 4 (29) 0 (0)
Neither likely nor unlikely 0 (0) 0 (0)
Unlikely 0 (0) 0 (0)
Extremely unlikely 0 (0) 0 (0)
Do not know 0 (0) 0 (0)
I did not receive any help or support 0 (0) 2 (15)
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community settings to estimate the cost of their intervention. The estimated cost of designing and developing
the intervention, including intervention manual development and the creation of related learning materials,
has been separately estimated and is available from the authors.
Cost of health service use
Table 24 shows the cost of health service use by participants in the trial, based on self-reported service
use in the two time periods (baseline to 5 months, and 5 months to 8 months). This analysis provides an
overall indication of the types of health service use that accounted for the majority of health service costs
incurred in this group. All participants reported using GP services in both periods, and the majority also
had hospital outpatient appointments. Although a minority had hospital inpatient stays, these account for
a large proportion of the total costs of health-care use.
Owing to the small sample size, any differences in costs between the trial arms should be ignored, as they
could easily be chance findings. For example, the > £700 difference in mean hospital inpatient costs
between the EPC group and the UC-only group (baseline to 5 months) is almost wholly attributable to one
participant in the EPC group who reported having two 10-day hospital admissions as a result of asthma
attacks during that period (total estimated cost: £10,518). This is not likely to be due to the EPC intervention.
However, these costs could provide useful point estimates and SDs for planning future definitive randomised
trials of similar interventions in similar patient groups.
Health-related quality-of-life and utility scores
The EQ-5D-5L index scores at baseline, 5 months and 8 months, calculated using the most recent and
reliable UK population-derived preference weights for health states,88 are presented in Tables 20 and 21.
TABLE 23 Pilot study: per patient cost of delivering EPC
Costs Unitsa Unit costs (£) Total cost (£)
Initial costs
For nurse training (trainers’ and facilitators’ time, delivery and
preparation)
45+ 41 hoursb Various 7157
Nurse training (cardiac rehabilitation nurses’ time) 56 + 21 hoursc 35d 2695
Leader manuals (printing) 8 4 32
Ongoing costs
Telephone clinical supervision of BA delivery 35 hours 50 1750
Nurses’ time for having supervision (estimated 50 hours overall) 50 hours 35b 1750
Total overhead cost of providing EPC 13,384
Number of participants in the EPC trial arm 15
Mean allocated overhead cost of EPC per patient
(in the feasibility trial)
892
Per-participant nurse time for delivering EPC within cardiac
rehabilitation sessions
1.8 hoursc 35b 63
Patient booklet print costs 1 4 4
Estimated cost per EPC recipient 959
a Data sources: trial records (e.g. invoices) or interviews with relevant study personnel, unless otherwise stated.
b Two different time estimates presented as EPC training were delivered to two different nurse cohorts.
c Mean of the 7.8 rehabilitation sessions attended. First, mid-point and final session were 20 minutes each; other 4.8
sessions were 10 minutes each =mean of 1 hour and 48 minutes per participant in total.
d Cost per working hour for a band 5 hospital-based nurse (excluding qualification costs).102
DOI: 10.3310/hta22300 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 30
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Richards et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
69
Apart from the previously noted difference at baseline between the two trial groups, there were no
notable differences or changes over time. If a definitive trial were to be conducted, these quality-of-life
estimates could be used to determine a trial sample size based on the expected cost-effectiveness of
the intervention.
Comparing self-report service use data with data from clinical and service records
As well as participant-reported health service use data, the study also gathered selected health service use
data from clinical records held by the participant’s general practice, and those held by the participant’s
cardiac rehabilitation nurse. Owing to the curtailed follow-up of some participants at 8 months, combined
with study attrition, the self-reported service use data are available for small samples. Although service use
data from GP records were available from all but two trial participants, complete self-reported service
use data (for both baseline to 5 months and 5 months to 8 months) were available for only 17 of the
29 study participants.
For the 17 participants with data from both sources, Table 25 summarises the level of agreement in the
number of services used between participant-reported data and GP records. There was poorest agreement
between self-reported service use data and GP records for the number of visits to GPs or practice nurses,
with no participants recalling the same number of GP visits as their GP records showed, and only 3 out of
17 participants (18%) recalling the same number of practice nurse visits. This might be expected for these
frequent types of health service use. Further inaccuracy is added when asking about the type of health
professional seen (whether practice nurse or GP).
TABLE 24 Pilot study: participant-reported health service use
Time period and service use
Trial arm
UC (N= 14) EPC (N= 13)
Participants with
≥ 1 contact, n (%)
Mean cost,
£ (SD)
Participants with
≥ 1 contact, n (%)
Mean cost,
£ (SD)
From baseline to 5 months
GP visits (including practice nurses) 14 (100) 335 (276) 13 (100) 445 (307)
Seeing other care professionals 5 (38) 31 (62) 8 (57) 550 (1542)
Hospital inpatients 4 (29) 456 (784) 4 (31) 1246 (1879)
Hospital outpatients 10 (71) 170 (213) 11 (85) 194 (161)
Emergency care (e.g. ED, 999) 3 (21) 28 (54) 8 (62) 82 (110)
Mean total cost (£) of health service use 1020 (955) 2516 (3044)
UC (N= 8) EPC (N= 9)
From 5 months to 8 months
GP visits (including practice nurses) 8 (100) 211 (123) 9 (100) 170 (105)
Seeing other care professionals 1 (13) 6 (16) 3 (33) 56 (95)
Hospital inpatients 1 (13) 221 (585) 0 0
Hospital outpatients 4 (50) 157 (207) 5 (56) 130 (175)
Emergency care (e.g. ED, 999) 2 (25) 70 (124) 1 (11) 12 (35)
Mean total cost (£) of health service use 664 (822) 368 (265)
ED, emergency department.
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For the less frequent, and more significant and costly, occurrences of accident and emergency (A&E)
attendances and hospital inpatient stays, the level of crude agreement between the two data sources was
much higher, with 11 out of 17 participants (65%) recalling the same number of A&E attendances as their GP
records show, and 14 out of 17 participants (82%) recalling the same number of hospital inpatient stays.
For all four types of health service use/episode, there seems to be no systematic tendency to either overestimate
or underestimate the number of episodes of service use (with similar numbers and proportions over- and
under-estimating). This partly explains the broadly similar mean number of episodes of each type. For example,
although none of the participants recalled the same number of GP visits as their GP records showed, the mean
number of GP visits was the same whether calculated from self-reported data or GP-recorded data. For the
potential purposes of costing within an economic evaluation, this provides some evidence to support the use of
self-report service use data in this patient group (and over these recall periods), so long as loss to follow-up and
questionnaire non-completion could be minimised.
The cardiac rehabilitation nurse notes only consistently recorded the use of other hospital services and,
thus the level of agreement could be estimated only for the number of hospital admissions (inpatient stays)
reported by participants and nurse records. Overall, there was a high level of crude agreement, with 15 out
of 17 (88%) agreement between participant reports and nurse records of inpatient stays for the 8-month
follow-up period. The mean number of self-reported hospital admissions was 0.5 (SD 0.9), compared with
0.3 (SD 0.6) admissions, as recorded in the nurse notes. The intraclass correlation coefficient, reflecting the
strength of association, was 0.55. No participants underestimated the number of hospital stays, although
two participants (12%) overestimated the number of hospital admissions.
Nested qualitative interview study
The qualitative interview study results are presented for patient participants, followed by nurses
(see Nurse interviews).
Patient interviews
The purpose of these interviews was to gather qualitative evidence on the content of usual psychological
care and to assess the acceptability of EPC and study materials to patients. Interviews were conducted
once participants had completed their 5-month assessment for the trial, and most had completed their
fitness programme (including EPC where relevant).
TABLE 25 Pilot study: comparison of data completeness between self-reported data and routine GP records:
number of episodes/visits to different health services
Professional seen or
service visited
Mean (SD) number of visits
ICCa
Crude
agreement,
n (%)
Participant estimate,b n (%)
Self-reported GP records Underestimate Overestimate
GP (surgery visits) 6.1 (5.7) 6.1 (3.8) 0.34 0 (0) 9 (53) 8 (47)
Practice nurse visits 4.7 (5.4) 3.9 (5.1) 0.62 3 (18) 7 (41) 7 (41)
A&E visits 0.6 (1.1) 0.7 (1.5) 0.70 11 (65) 4 (24) 2 (12)
Hospital admissions 0.5 (0.9) 0.4 (1.0) 0.85 14 (82) 1 (6) 2 (12)
A&E, accident and emergency.
a ICC = intraclass correlation coefficient.
b Participant under- or over-estimating number of events when compared with GP records.
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Participant sample
Eighteen trial participants (12 in the EPC arm and six in the UC arm) were interviewed between January
and June 2016. Just under half of the 18 interviewees were male (8 out of 18; 45%), and all reported their
ethnicity as white British. The mean age of interviewees receiving EPC was slightly younger (64.3 years; range
52–76 years) than that of UC interviewees (72.5 years; range 65–79 years). Similarly, the mean PHQ-9 score
for the EPC group was higher at baseline than that of the UC group (15.0 vs. 11.7, respectively). All but two
interviews were held by telephone. The interviews with EPC participants lasted longer on average than those
held with UC participants (52 minutes vs. 32 minutes).
In addition to interviewing trial participants, interviews were also held with three individuals (all male) who
had declined to take part in the pilot trial (October–December 2015) to explore the reasons behind their
decision (see Individuals who declined trial participation). Decliners were aged 35–60 years. The interviews
were conducted by telephone and lasted for an average of 24 minutes.
Cardiac events reported by the 21 participants included heart attacks, angina, cardiomyopathy, heart failure
and valve disorder treated with CABGs, stent insertion, valve replacement, medication or a combination
of these. Of the 21 individuals interviewed, all said that they had attended at least an initial appointment
with the rehabilitation nurse, and 18 had attended some cardiac rehabilitation that had included a fitness
programme. Two participants commented that they dropped out of the fitness programme at an early
stage because of a combination of health problems and logistics issues. Instead, two participants reported
receiving a series of one-to-one appointments with the nurse, one overlapping with his fitness programme
and the other receiving these instead of a fitness programme.
Main themes
We detail findings from the trial participant interviews before describing those from the decliner interviews.
Quotations have been tagged with an individual identifier, and details of whether the individual was in the
EPC arm or the UC arm or if they had declined trial participation.
There were a number of main themes identified within the patient participant interviews, including the
context of cardiac care; experiences of cardiac rehabilitation; UC participants’ experiences of support for
mental well-being; EPC participant’s experiences of support for mental wellbeing; integrating EPC into
cardiac rehabilitation; mental and physical outcomes after receiving cardiac rehabilitation; taking part in a
research study and intervention feedback.
Context of cardiac care
Enhanced psychological care and UC interviewees described the massive impact their cardiac event had had
on them physically and mentally, and also on their family. As one individual explained, he felt ‘mentally and
physically shell-shocked’ (EPC, participant 12) following his cardiac event. Most participants had viewed
themselves as fit, strong and sociable, and having not previously experienced low mood. Many participants
described still experiencing pain (chest, limbs, post operative) following hospital discharge, loss of appetite,
sleeplessness, lacking energy and motivation. There was some suggestion that how they felt related not only
to their body recovering from the cardiac event, but also to the new medication they now needed to take:
I felt terrible, emotionally I have never felt so low in all my life. It was a horrible, horrible experience,
I just felt my life was ebbing away, and I’ve never felt that low before, and I just put it down to the
medication because, and I couldn’t eat, I couldn’t sleep, I was still getting pains but nothing like
I’d had, but I just felt terrible, it was just awful, I had no go in me, no energy, no focus, horrible,
horrible sensation.
UC, participant 2
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Most trial participants were very surprised at the overwhelming and quite sudden impact that their cardiac
experience had had on their mental state:
I mean I’ve always been a busy businessman, self-employed for 30 odd years, being heavily involved in
business to ending up in a situation where I couldn’t make a decision as to what day it was.
EPC, participant 12
Descriptions included a general but quite dramatic loss of self-confidence, feelings of apprehensiveness
and failure, being detached or experiencing panic attacks and a loss of control over their life. Some
participants (male and female) explained how they had felt suicidal at the time:
It just all came out and I was surprised at myself, to be honest, I had no idea that I was, my
overwhelming feeling was disappointment that I’d actually survived and that frightened me because
I’ve never felt that before [suicidal] . . . And I think that had a really big impact. And I think that,
it threw up so much other stuff that it was quite frightening, to be honest. I always thought,
I considered myself a very happy-go-lucky type of person.
EPC, participant 14
I sat here alright and I just watch telly and something stupid comes on the telly and it all comes back
and you feel [pause] [Interviewer: Really emotional?] Yes and you don’t show it, I don’t show it but
you feel it here and you feel really drained and really start thinking the worst and what’s the easiest
way out which is, and then you think ‘which is the easiest way out tablets or’ [speech trailed off].
EPC, participant 9
At least four participants had given up their work following their cardiac event, and this had added to their
feelings of anxiety and depression:
I was angry, frightened, upset . . . I just got worse and worse. I got very depressed, I lost my job, I
loved my job. You’ve got to understand, I absolutely loved my job . . . suddenly everything had been
ripped out from under my feet and I got very depressed, very anxious and felt a failure, I felt failed,
that I’d let everybody down, so yes huge.
UC, participant 17
Family members were often reported to be shocked and frightened by the suddenness of the event, and it
appeared to affect how they dealt with the participant:
They treated me like I was a china doll when I first came out of hospital, even though I felt like I could
tackle a rugby player [laughs].
EPC, participant 14
Support from family was welcomed and described as reassuring. However, it could also be ‘stifling’ at this
early stage:
I think the hardest I found with all of it is my family, it knocked the stuffing out of them, and ‘oh no,
you can’t do this mum, no, you can’t do that mum’, but . . . they’re better now . . . they know that I’ll
only do what I can do and if I can’t do it, I won’t do it . . . but my youngest, it took her ages to accept,
‘no, you’re not allowed to do that’. She’d get very cross with me [laughs].
UC, participant 4
Despite being close to her family, one individual who had described feeling suicidal stated that she could not
share her feelings with her husband and family, and felt quite alone. In addition, she felt cut ‘adrift’ from
the professional help she needed initially and lacked any information about what she could or could not do.
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Several participants had very little or no family around and also felt alone and unable to cope after the
‘cosseted’ hospital environment. Thus, although some participants mentioned being contacted by a cardiac
rehabilitation nurse early after discharge, for most, the weeks between being discharged from hospital and
starting their rehabilitation sessions were long, and a time when they struggled emotionally and physically.
Experiences of cardiac rehabilitation
At the time of their interview, all of the EPC and UC participants interviewed had attended an initial
cardiac rehabilitation assessment with the nurse. Many had also completed a fitness programme. Some
had been offered attendance at further rehabilitation fitness sessions, which a few participants attended.
Most of the participants described an initial one-to-one assessment, then a structured programme of
exercises within a gym or leisure centre. Some commented that, after the exercises, there was usually an
opportunity for light refreshment and to attend a short group talk led by the nurse or other practitioner on
some aspect of rehabilitation (e.g. cholesterol, diet or medication). Occasionally, participants said that they
had seen the nurse for some one-to-one sessions instead of attending a fitness programme, and some
commented that a nurse had set-up exercises for them to continue at home.
Although some participants had been reluctant to attend the fitness programme, as they were
apprehensive about exercising, most felt that they ought to take up the opportunity in order to aid their
recovery. Many did not know what the first or subsequent appointments would entail, and some would
have liked more information prior to starting.
Participants attending the rehabilitation fitness programme commented that it had benefited them, both
mentally and physically. They had gained fitness, changed their diet, lost weight, talked through their
cardiac concerns with a nurse, met others and gained confidence:
I can’t honestly say I remember thinking, ‘oh, I feel better doing that’, but I did think I had more
confidence in myself to do it. Beforehand I was, ‘oh, I’d be frightened to do this in case, and I can’t do
that in case’ and I just thought, ‘no, get on with it’.
UC, participant 5
It was also apparent that some participants enjoyed the opportunity to talk about their cardiac experiences
with other participants who ‘were in the same boat’ (UC arm, participant 1). They realised that they were
‘not the only one’ (UC arm, participant 4), and listening to others’ accounts put their own in perspective.
In addition, comradery and mutual experiences helped in their recovery:
I suddenly realised that here we are, all having gone through the same thing experience and at
different levels and I was in the first week sort of gullible, people who were there and I’d been talking
to had been there nearly 6 weeks were much more confident and I realised then that this is what it
was all about, it was getting some reassurance that you weren’t on your own and it does take time
and you will get better.
EPC, participant 12
By going there it was helping me a lot, it really helped me, going to the rehabilitation, it got me away
from the house, and I started doing things and meeting people.
EPC, participant 18
Patients in both the EPC and UC arms built up good relationships with their nurse and perceived them as
being professional and approachable.
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Usual-care participants’ experiences of support for mental well-being
Usual-care participants did not feel that they had discussed their mental well-being with their nurse in any
depth or, in some cases, at all:
Interviewer: When you went to your cardiac rehab[ilitation] sessions, did the nurse talk to you at all
about your anxiety at the time or anything that she could help you with, did she give you a leaflet or
did she talk about it?
EPC, participant 18: No, no, because I don’t expect she knew about it. Unless she knew about it and
didn’t say nothing. As far as I can remember, it was never ever talked about.
It was evident that some participants wanted to discuss how they were feeling and viewed their nurse as
someone they could talk to, but felt that they had not been given the opportunity to do so by their nurse.
It was also apparent that nurses had not referred, or offered to refer, them to a psychological service.
One participant who had been offered a referral did not take it up, as she did not want to be labelled as
depressed, but did indicate that she had wanted to talk to somebody:
I don’t really want to go and see anybody, but at the same time, I wish I’d had the opportunity to talk
to somebody, but not about, I didn’t want to go down, ‘oh, she’s depressed’, I don’t want to go
down that route, because I wasn’t depressed ‘depressed’, I just felt so down and low in myself.
UC, participant 2
However, occasionally, UC participants mentioned that their nurse had put forward other suggestions to help
them deal with low mood. These included providing reassurance that it was normal to feel low after a cardiac
event and encouragement to participate in the fitness programme as a way to improve mental health. The
nurse had also given this participant the number of the department that she could ring if she felt low:
[The nurse] did say that, contrary to what I might think, but doing the gym might actually make me
feel a little bit better, because then I would say I could do this or I could do that and meet different
people, the same as what I was and stuff like this, and that might make me feel better. And he also
said if I really felt down or anything, I had their department’s phone number and I had to feel free to
use it.
UC, participant 5
Enhanced psychological care participants’ experiences of support for mental well-being
Relationship with the nurse and level of comfort discussing mood issues Most EPC participants
welcomed the opportunity to talk about their emotions with a nurse and felt comfortable doing so:
Oh I thought it was great I could tell her anything.
EPC, participant 10
I thought it [having the opportunity to talk about low mood] was an absolutely brilliant idea. I felt very
comfortable. It was almost like it’s a relief to talk to somebody as well because . . . when these sort of
things happen, you don’t know who to talk to. You can talk to family members but they are not
physicians or doctors or nurses, you know they don’t know about these events, they can only advise.
But when you are talking to a professional you are getting information back, it is fantastic.
EPC, participant 17
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Participants were pleasantly surprised that they could receive dedicated time with a nurse to discuss their
emotional concerns alongside their physical needs:
It was a good surprise in that I thought the cardiac rehab would just be ‘Hello! Do a few exercises’,
and that’s it. I thought it was really brilliant, that it was looked at holistically, brilliant. I came out
thinking, ‘oh this is a real breath of fresh air, that people should actually look at me as a total person
and not just as a patient with a dodgy heart’, sort of thing.
EPC, participant 13
Enhanced psychological care participants stated that they had a good relationship with their nurse, and were
very complimentary about their abilities. However, some commented that their nurse was very busy and
that they would have liked to have had even more time to discuss mental health issues. In addition, not all
participants felt that nurses were best placed to deal with their mental health needs. One lady commented
that she did not want to talk about mental health with a ‘physical’ health practitioner (EPC, participant 14:
‘I wouldn’t discuss my emotions with my dentist’), and had felt uncomfortable about doing so.
This lady was offered a referral to a psychological service as part of her EPC care co-ordination but
eventually took up some counselling offered through her GP. The counselling sessions identified issues
from her past that she had hidden or forgotten. This may have been one reason why she had felt
uncomfortable about the idea of talking to her nurse.
Materials: use, usability and relevance Most EPC participants had received a CADENCE participant
handbook and had read all or part of it. Participants described the section in the handbook that described
a series of case scenarios as the most memorable, with many feeling that they could relate to one or
another of the people, and had found this ‘absorbing’ and helpful:
Some of the people in there, they’d relate to me . . . how can I put it, they feel exactly the same as I
feel. They’re old, and they think, ‘well, what, there ain’t nothing worth, what am I doing on this
earth?’ And I read it a couple of times, actually, and it’s quite useful.
EPC, participant 8
No one suggested that the handbook had been too long or difficult to understand, although one
participant said that he and his partner felt that the scenario outcomes had been quite negative.
Participants used the mood/activity diary and said that it had been positive in several ways: it helped get
their feelings out onto paper, it highlighted patterns of behaviours that needed changing and it enabled
them to compare activity levels and mood scores from earlier weeks with later weeks to see any progress
they had made. As memory was described as difficult after a heart attack, being able to track progress was
described as reassuring. Participants also felt that they were helping the nurse by completing it (i.e. doing
what they were told to do).
Understanding of the intervention and experiences of engaging in behavioural activation Whether
or not participants had completed all the BA sessions, BA was not a term most participants described
themselves as being familiar with. It is not clear whether this was because participants did not recognise the
term (despite it being mentioned many times in the handbook) or because nurses had not used it. Either way,
not all participants were able to provide a clear description of how BA worked, with some participants feeling
that the one-to-one sessions were more about having the opportunity to talk through their emotional issues;
for example, when asked about the BA sessions, one participant, who was very positive about their interaction,
said:
We just talked, talked about like I’m talking to you now.
EPC, participant 8
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However, when prompted, participants who had completed their BA sessions were able to describe and give
examples from one or more of the steps involved in BA (such as measuring mood, keeping a mood/activity
diary, describing links between mood and activities or rescheduling activities and behaviour important to
them), and many described discussing their completed mood/activity diary with their nurse:
I had taken part in writing down each day the sort of things that I was feeling, the sort of things that I
was doing, what did, did I go for walks, if so, how far and how I generally felt in my mood and so on,
so I wrote this down on a daily basis and then took it in, twice a week and then the nurse would sit
down and go through it with me.
EPC, participant 12
Occasionally, a participant was able to expand and give examples of how they changed or increased
activities to help enhance their mood:
We done different things so if I felt, say for instance if I wanted to go out in the garden and I felt well
doing that, I tend to do it a bit more than what I did before. If I sat down and watched something and
I did, as I say the telly sometimes you think ‘that rubbish is on’, and [I’d] switch it off . . . I’ve found
that by going to this with [name of nurse] I found I was doing more and more and more so I still do it
now, I hoovered up this morning.
EPC, participant 9
Four female participants did not complete the diaries at all, and two were not keen to continue with BA in
general and were referred to other psychological services early on; one participant had concerns that the
diary would be read by a family member who might be alarmed by the strength of her feelings:
I didn’t really want them to know what was going on in my head.
EPC, participant 14
The other lady was very happy to talk through her activities, but said she found the paperwork too much.
However, the nurse had encouraged her to continue with EPC and the participant was happy to talk
through her activities and mood instead:
I didn’t want to be filling in a load of forms and things in and they said ‘You don’t have to’, but she
said ‘I’d still like to talk to you, if you didn’t mind’, and I said ‘No I don’t mind and ask your questions’,
and I’m not, I didn’t like all the paperwork, it was too much . . . If I didn’t want to do it, I didn’t have
to do it, they made that very clear.
EPC, participant 18
This participant was offered a referral for counselling. She did not take this up, perhaps because she felt
able to talk to the nurse (‘felt as though I could speak to [the nurse] like a friend’), and because she gained
a great deal out of sitting with the nurse and completing the activity diary together.
Provision of dedicated one-to-one time to discuss mental health Most EPC participants felt that
having dedicated one-to-one time with a nurse had been crucial to their mental recovery. Participants
commented that, without this support, their recovery would have taken longer or their mood would have
deteriorated more:
I honestly think had it not been for the rehab and her input, I don’t know, I mean I presumably would
have progressed but I think it [would have] taken a lot longer, I think that they helped in so many ways.
EPC, participant 12
I think I’d have got really down if I hadn’t been able to talk to her.
EPC, participant 18
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Male participants were particularly emphatic about the help they had received. They reported being glad
to have the opportunity to express how they felt and they commented on their surprise at opening up to
the nurse about their mental health, something that they would not have contemplated when they had
started cardiac rehabilitation:
When she [the nurse] first met me, she would probably say ‘well actually [name of participant] was
fairly very tight lipped and didn’t give anything away’, but by the end, yeah, I learned to sort of open
up and I learned to sort of tell her things that I never dreamt I would. You know so that was again
down to her, her being knowledgeable and applying her experience to get things out in the open,
which was important to do so.
EPC, participant 12
For two participants, both of whom had had suicidal thoughts, the input from the nurse had seemed to be
literally life-saving:
I think a lot of people when they commit suicide and things like that, a lot of it is to do with that
because they feel by themself, they feel, well they just feel useless to everybody and nobody and the
good thing with that [EPC] is they do help you. I’m not saying it’s going to help everybody it might
not, but it’s certainly helped me.
EPC, participant 9
Without people like you and [name of nurse] talking to me and me talking to you, I might not be
here now.
EPC, participant 8
Enhanced psychological care with dedicated nurse–patient time was perceived to help participants in a
variety of ways. The sessions helped participants gain confidence to talk about their feelings and talk to
others, increase their physical activity levels at home and increase their motivation to do more. They also
helped some patients who were frustrated by their physical inability to complete everything to focus on
several important activities and understand how their feelings and behaviours affected them:
It helped me in the sense that it was giving me answers as to why I was behaving the way I was
behaving, or not doing the things I should have been doing or not having any motivation.
EPC, participant 11
However, sometimes participants found it difficult to go to their rehabilitation if they felt down, as their
low mood meant that they were reluctant to go out. Although some participants had gained comfort from
the occasional check-up telephone call from the nurse (and one participant had had most of their EPC
sessions by telephone), participants mainly preferred the face-to-face contact, as it was more intimate and
they felt that it was easier to talk in person.
Mental health-care co-ordination
Several participants had problems with panic attacks or complex emotional difficulties, or just did not get
on with BA as a treatment. Four participants (including three who dropped out of BA sessions at an early
stage and one who had completed all eight BA sessions) were referred on to a counsellor as a result of the
nurse contacting their GP, psychological services or psychiatric services. Three participants felt that this had
been beneficial. The fourth had decided not to take up the counselling offer (within psychiatric services)
after the first visit, but she was now aware that she could self-refer to IAPT services, which she felt may be
more confidential. Two other participants who felt better after EPC said that they would contact the nurse
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if they experienced a recurrence of low mood, even though they had finished the cardiac rehabilitation
programme. Being referred to other services at an early stage during EPC had helped several participants
to receive the care they needed without too much delay:
She would send a recommendation to my doctor that maybe I need a therapist, and she [the nurse]
was amazing actually. She was brilliant and that kicked that off and now I am seeing a therapist once
a week.
EPC, participant 17
Sometimes nurses had advised participants to go back to see their GP. However, six of the EPC arm
participants were quite vociferous, commenting that they would not go to their GP to discuss mood issues,
feeling that they would only be given antidepressants, or that GPs did not have the time to discuss mood
in any depth:
I’d say, ‘what’s the point in me going to the doctors, he gives me these bloody tablets, I’m not going
to live on sodding tablets, what’s the point?’
EPC, participant 9
They haven’t really got the time and you don’t like to burden them, do you, I mean, GPs are different
aren’t they, well, they’ve not set something up for somebody who’s got low moods and depression in
their office, have they, they’ve just got to say, ‘oh, I think you’re going through a low mood at the
moment, because of what you had, oh, here’s a tablet, see you later’, type of thing, cos that’s what
they do, isn’t it?
EPC, participant 11
Some EPC participants said that attending other services, such as IAPT services or a counsellor, would be
preferable to seeing their GP. They were aware that they could self-refer or be referred by the nurse to IAPT
services, and those who had attended IAPT services had received treatment relatively quickly (i.e. within 2 weeks).
Integrating enhanced psychological care into cardiac rehabilitation
Several participants acknowledged that a private space was not available to talk about their mental
well-being, and they often received their EPC session in a corner of the gym or leisure centre. However,
nurses were practised at adapting a space for their needs, and there seemed to be an understanding with
other participants and helpers not to interrupt their sessions. Also, most participants seemed unbothered
by the lack of privacy, even though some needed to talk about very personal and private issues:
I don’t think anybody heard for one, I think people knew not to come to the table . . . cos they
obviously knew what was going on, it didn’t bother me, no, because I feel that I could have said to
[name of nurse], can we go outside? I mean, she asked me if that was okay.
EPC, participant 11
Privacy was not an issue for those participants who managed to see their nurse before or after most
people arrived for the fitness class.
The amount of time an EPC session took appeared to vary between participants, with one individual
mentioning that his session lasted around 1 hour, and another stating that theirs was around 15–20 minutes
long. Another participant would have liked more time, but recognised the need for brevity, considering the
number of participants that nurses had to deal with.
Travel and parking had been concerns for at least two participants, who had consequently dropped out of
the fitness and BA sessions at an early stage. One had arthritis affecting her mobility and the other had
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chronic obstructive pulmonary disease affecting her breathing; overall, their anxiety problems made them
very reluctant to travel:
I think suffering from anxiety, going from hospital and back again has been absolutely horrific
[laughs]. I don’t travel well in cars any more so I spend a lot of time with my eyes shut . . . It is pot luck
to whether you get a parking spot. Literally pot luck.
EPC, participant 17
I’m exhausted when I get there and can’t breathe properly for ten minutes. But I can get through that,
because that’s how my life is anyway . . . But it’s just the bicycles really, I’m terrorised that I’m going to
have another [cardiac] event on the way to do the rehab because of the bicycles . . . After the [second]
heart attack, I just said to them ‘don’t even put me down for it [cardiac rehabilitation]’ . . . each time
there was an appointment I was cancelling them, because I was just lying awake all night getting
absolutely massive panic attacks about the thought of going into town the next day. And it wasn’t
because of the exercise, which I do actually feel committed to, it was because of trying to get there
and get back to the bus stop again.
EPC, participant 16
Some participants recognised that nurses were ‘under tremendous pressure’ (EPC arm, participant 12),
yet they remained focused and made time for participants requiring EPC. Despite wanting more time with
the nurse, some participants commented that they tried hard to keep contact as brief as possible, feeling
uncomfortable that they were adding to the nurse’s daily burden:
Running another one [class] tandem, trying to eat their lunches as they’re on the job there and you
think, ‘gosh, yeah I can understand how overworked they are [. . .] I’m inclined not to do it’, rather
than thinking, ‘hey, I’ve got demands and I need them to be met’.
EPC, participant 13
Mental and physical outcome after receiving usual cardiac rehabilitation care and cardiac
rehabilitation with enhanced psychological care
Over time, several of the participants receiving UC felt that their mental well-being had gradually improved.
Some had developed strategies to help themselves, such as gardening or talking to the dog, and two
individuals were feeling mentally a lot better. For most of these participants, however, chronic health
problems were still affecting their physical ability and overall well-being.
Many intervention participants described how the EPC and cardiac rehabilitation together had helped their
physical and mental health, improved their resilience in existing activities and helped to encourage them to
find other activities they enjoyed. For example, one man had learned to be less compulsive about tidiness,
which could lead to a panic attack. Despite having to manage some major disabilities, he had started
walking his dog again, which made him feel ‘perky’ and also meant that he saw other people. No longer
feeling that life was not worth living, he felt a lot better and was grateful for the help he had received
during his rehabilitation:
I’ll be honest with you, if I hadn’t gone to rehab[ilitation] I don’t think I’d be here.
EPC, participant 9
Other intervention participants had made positive life and lifestyle changes (e.g. stopped smoking, reduced
alcohol intake, given up their business, talking to and supporting others) and now felt more able to manage
low mood if it occurred. In general, many felt that they could cope better with their circumstances:
If your one [EPC provision] or anybody else’s service to me [had been] rubbish, I wouldn’t be any further
than what I was when I had the heart attack . . . I’d come quite far in the 6, 7 months, whatever it is, I
feel that I have.
EPC, participant 11
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However, similar to those in the UC arm, some EPC arm participants continued to experience mental
health problems, struggling with chronic mental and/or physical health issues, which had often been
exacerbated by their heart condition:
I was on tablets yes for my hips and knees but I’ve never had the problems I’ve got now. Even my
confidence, my balance has got, all my confidence and everything I am doing has just shattered. I walk
with a stick now if I am outside. I can’t go on buses because they make me feel ill and dizzy. I’ve got a
disability badge, you know so it is dreadful.
EPC, participant 17
Intervention feedback
Most EPC participants had confidence in, and felt comfortable with, a nurse providing both physical and
mental support, as well as referring patients to other services. They felt that the nurse was competently
able to explore emotional issues that had surfaced as a result of their cardiac experience, or, indeed, those
already present, but which had not been addressed until their rehabilitation. However, both EPC and UC
arm participants recognised that there was a need for more care for patients with low mood following a
cardiac event, and saw the potential benefit that the CADENCE intervention could offer to patients if EPC
was rolled out more widely:
It’s vitally important that hopefully this particular pilot will progress because the people who have had a
heart attack need this support and if they don’t get it, I genuinely think there could be further down the
line, people having problems that wouldn’t have them, you know, had they been to rehab[ilitation], had
they had this particular involvement with the nurses, would have helped them progress much quicker.
EPC, participant 12
A few possible changes or improvements to the intervention were brought up by EPC participants. First,
the weeks between hospital discharge and starting rehabilitation felt like a long time to some participants,
and this was often when their mood was lowest and their anxiety levels were high. Several participants
commented on the timing of the EPC they received – many felt that it had come at the right time, helping
them to get through a very bleak period, whereas some felt that they needed the psychological care to
start a lot earlier, while still in hospital or just after discharge. Participants suggested including a visit from
a nurse while still in hospital to discuss options, a leaflet or a telephone call to support mental health
during the period between hospital discharge and starting the cardiac rehabilitation programme:
I think they should catch you earlier, when you’re in hospital, when you’re in that hospital in bed . . .
feeling down I think they should have a nurse like yourself or [name of nurse] to visit you, not every
day, every other day to try to boost your morale up and I think it do . . . They [hospital nurses] don’t
talk to you about the stuff like you talk.
EPC, participant 9
Ending cardiac rehabilitation and EPC was also viewed as a vulnerable time for some participants, and
several voiced their concern of being suddenly cut off by cardiac rehabilitation services:
I think additional help after this [end of EPC] is a definite must for some people, it was for me, though
it shouldn’t just be a cut-off thing, I don’t know how you would do that, like, ‘oh, 12 weeks and it’s
cut-off’, or something like that . . . if they [your nurse] feel that you need more help [at the end of
EPC], that should be offered definitely. Or if it’s a waste of time, cos you just literally will go back to
how you were before, I think.
EPC, participant 11
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Having to wait for their counselling to commence after ending rehabilitation was also seen by participants
as an opportunity for setback. In addition, one participant felt that it would be beneficial to have regular
contact with the cardiac unit to avoid consulting her GP:
If I was having say a phone call from the hospital, from the cardiac department or a cardiac unit there
once every 3 months, maybe it is something I would not have to keep bothering my local doctor with.
EPC, participant 17
This sense of vulnerability could explain why participants found it very reassuring when their nurse said
that they could contact them for further support if needed.
For most participants, rehabilitation of the body and the mind together was vital, and dedicated one-to-one
time with a practitioner provided the medium within which most felt comfortable discussing personal
emotional issues:
To have somebody that deals with the mental health side as well as the physical I think is incredibly
important. As somebody who has been through this myself, I think that mental health is definitely linked
to the physical part of rehabilitation and health. I think it is a serious, serious thing that it shouldn’t be
just about rehabilitating the body, it should be rehabilitating the mind as well.
EPC, participant 17
I really genuinely do hope that this [study] is extended and I think from my personal point of view a bit
more should be given, if it’s possible, I know that costs are involved, but you know definitely, I think
there’s a future for this type of thing, without a doubt.
EPC, participant 12
Although the importance of having one-to-one sessions with the nurse was emphasised by many
participants, some indicated that they could see the advantages of having some aspects of EPC in a group
setting, having found it reassuring to talk about their experiences and listen to others. However, others
viewed the idea of a group environment for EPC as inhibiting, feeling that they would struggle to talk
about their emotions in a group context.
Individuals who declined trial participation
Individuals interviewed who declined to take part in the trial commented that they did not feel very low in
mood when they started their cardiac rehabilitation programme. In addition, they thought that they could
manage their mood themselves by keeping busy, doing their hobbies, talking and walking with friends,
and using knowledge they had gained through their work:
Being a support worker I’ve learnt to develop you know, training, techniques and things like that
where I can sort of pull myself out.
Decliner, interviewee 19
Two of the three decliners interviewed were not keen to discuss their mood with strangers or health
professionals, including their GP. The third interviewee said that he would see his GP if his mood had not
improved. One interviewee said that he did not like the idea of a talking therapy.
One interviewee had declined to take part because he had felt hassled by researchers when involved in
a previous research study. The two others were not averse to research participation in general if they
perceived that it could benefit them, but had not taken part because they felt that it was not relevant to
them in their circumstances. One participant also felt that it was inconvenient:
I just find it a bit inconvenient you know, like today, no disrespect right . . . I could be getting on with
a mega job I have got to do in the house because we have got a leak.
Decliner, interviewee 20
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One interviewee said that he had received too much information about making changes following his
cardiac event and information on study participation added to this burden:
I felt like a lot of people have [been] telling me what I’ve got to do, I’ve got to change this, got to
change that and I just, kind of too much information overload.
Decliner, interviewee 19
Interviewees were not able to accurately describe the study aims or what the study would involve for them:
I was of the understanding it was just more of doctors watching and, watching my moods basically.
Decliner, interviewee 19
One interviewee perceived the EPC intervention to be a bit like going to a ‘shrink’ (decliner, interviewee 20).
Taking part in a research study
Participants from both trial arms remembered the initial screening assessment by the nurse (which involved
completing the PHQ-9 and the GAD-7, going through a checklist of eligibility criteria and discussing the
CADENCE intervention). Most participants in both groups were comfortable with being assessed by a nurse,
although not all were used to or happy to score their mental health on a scale, and there were several
participants who said that they had not completed one or more of the scores on the mood measures or
activity diary to reflect how they really felt:
I know how it all works you see. You don’t put the lowest and you don’t put the highest, so even if I was
feeling great I wouldn’t have put it anyway, even if I was feeling low I think, ‘well just put one up to that’.
EPC, participant 7
Consequently, although this interviewee enjoyed attending the EPC sessions and completed all the paper
materials, he felt that most of the EPC sessions were irrelevant to him, as he felt that he had never been
low in mood:
It’s like I told her [the nurse], ‘you have picked the wrong person in me really because I am never
moody or a person who goes into moods’.
EPC, participant 7
Reasons put forward by participants for why they had decided to take part in the study were that it might do
some good for themselves or others, it provided an opportunity to talk about how they were feeling or it was
a way of helping out the nurse
She was looking for somebody to get it started.
EPC, participant 7
Usual-care and intervention participants’ accounts of taking part in the CADENCE study were positive;
participants had not minded the fairly long baseline assessment by the researcher, had found the researchers
approachable and professional and felt well informed about what was expected of them:
The way it’s been done has been extremely good and I am very impressed by it actually so yes . . .
I like the fact you get a couple of home interviews and then a telephone interview which makes it
easier for everybody. That’s a really good way of doing it.
EPC, participant 17
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Being part of the CADENCE study had provided the continuity of care missing for some participants between
the original cardiac event and the start of rehabilitation, as well as being a good opportunity to talk about
the aftermath of the cardiac event:
When I came out of hospital I felt like I’d been cut adrift, this [CADENCE study] went in some kind of
thread that leads back to the event.
EPC, participant 14
I’ve had the opportunity to speak to you [today at the interview] about things that I hadn’t after I had
the heart attack, so to me that’s been quite a nice thing.
UC, participant 4
All participants fed back very positively and felt that they had enjoyed their participation in the study.
Completing the paperwork at various stages of the study was not seen as too arduous, and participants
described the researcher who visited to do baseline and follow-up assessments as ‘charming’.
Nurse interviews
Participant sample
Seven nurses (all female) from four of the five intervention teams were interviewed. These nurses had been
involved in screening, recruiting, referring and delivering EPC to participants. No nurses from the fifth team
were interviewed, as this team did not recruit. Interviews took place between December 2015 and March 2016.
Three nurses were interviewed in person, and the remaining four nurses were interviewed by telephone.
Interviews were audio-recorded and ranged in length from 38 to 64 minutes (mean length 52 minutes).
At the time of interview, each nurse had delivered EPC to between one and four patients. Six nurses
reported sharing the delivery of EPC to one or more of their patients, whereas one nurse had sole
responsibility for each of her patients. Nurses reported that six patients had completed EPC, six patients
had withdrawn early from the BA element of EPC (five of whom received care co-ordination and one of
whom did not return at all), two patients were still waiting to start EPC and two patients were receiving
EPC at the time of their nurse’s interview.
Main themes
There were five main themes that were identified from the nurse interviews: (1) usual psychological care,
(2) nurse training and materials, (3) acceptability of EPC, (4) views and experiences of delivering EPC and
(5) integration of EPC into existing pathways.
Usual psychological care
Each nurse said that they were used to screening patients for mental health symptoms either prior to
hospital discharge or during the patient’s initial assessment. To screen, nurses had used either the HADS29
or, in the case of one team, two mental health screening questions and then the HADS for patients for
whom the two questions suggested low mood. Based on the accounts given, it was evident that the
nurses viewed the provision of psychological care as a significant part of their role:
It’s never been formally identified that actually that [psychological care] is a massive part of our role.
Nurse 3B
I’ve got to be honest, I mean, sometimes I’ve left a cardiac rehabilitation clinic and all that we have
addressed is the psychological side of things and particularly for people who have clearly been
affected by their cardiac event.
Nurse 4C
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Although nurses commented that they had no formal arrangements in place to support patients with low
mood, during the interviews it was apparent that, prior to their involvement in the CADENCE study, they
had provided a range of support. Some nurses commented that they offered short group sessions, talks
on stress and relaxation, or a telephone number to talk to the cardiac rehabilitation team. Nurses often
referred patients back to their GP or provided a leaflet on local community mental health services. Links
with local IAPT services were generally reported to be fairly good, although nurses were not clear on
whether or not patients who they had encouraged to self-refer went on to make a referral. Three of the
teams could also refer patients to a psychologist (who was either attached to the cardiac rehabilitation
services or to the psychology department within the hospital), but there were waiting lists (for 6–8 weeks)
for one-to-one services. Nurses from two of the teams also mentioned referring patients to psychiatric
services for more complex problems. However, nurses had received no specific training in psychological
care. In addition, some nurses commented that, having been involved in the CADENCE study, they now
realised that they had lacked the skills needed to effectively support patients with low mood.
Nurse training and materials
Nurses had received structured training, a nurse handbook, record sheets, tools and paperwork for their
patients and some template letters (e.g. for referral to the GP). They felt that the training they had received had
covered most areas that they needed to know about. Generally, the training covered assessing and discussing
and managing risk; it was clear, and the EPC risk protocol was helpful in terms of providing a pathway for
action. However, one nurse felt that they needed more time to practise their new skills during training.
Most nurses commented on the frustration of not being able to start using their new skills immediately,
because there was a delay (sometimes of several months) in them seeing EPC patients. This delay was
attributable to delays in securing research and development (R&D) approvals, identifying eligible patients
through the screening and/or patients not starting their rehabilitation immediately.
Nurses described the training manual as invaluable, and commented that they checked it regularly to
ensure that they were conducting EPC and risk procedures correctly. Overall, they felt that information in
the manual was well laid out and simple to find. Scripted words about how to talk about EPC to patients
had also been helpful. Suggested improvements in the accompanying paperwork included having a
separate template of a GP letter for patients who were screened and were then found to be ineligible for
the trial but who triggered the suicide protocol. In addition, it was suggested that it should be made
clearer as to when any communications with patients should be documented and that there should be a
list of which paperwork was needed for each situation (e.g. for screening, EPC or supervision).
Experiences of assessing mental health risk in the pilot trial
During the CADENCE study, nurses were asked to screen for low mood using the PHQ-9 and the GAD-7
instead of the HADS, and to continue to regularly monitor patients using the PHQ-9 over the course of their
EPC. Most of the nurses commented that they preferred these tools, and teams often said that they would
continue to use them once the study was complete. Reasons given were that the questions were more
direct, the layout was better and nurses were able to liaise more easily with primary care practitioners who
used the same measures. In addition, using the PHQ-9 (which, unlike the HADS, includes a question
specifically about thoughts or plans of suicide) along with the risk protocol provided by the research team
reassured nurses that they were identifying and managing risk more readily:
Now it’s a lot more formalised and I’m more aware of that patient, because before I wasn’t picking
them up, because I wasn’t doing the PHQ-9.
Nurse 1A
The PHQ-9 and the GAD-7 were administered either by the reception staff or by a nurse handing it out
prior to a clinic appointment, or by the nurse during the patient’s clinic appointment. Either way, the nurse
then discussed the patient’s score during their appointment. One team found that, occasionally, patients
did not want to complete the PHQ-9 in front of them, and so the team started to give these patients the
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form to complete after the appointment and to leave it at reception ready for discussion at their
next appointment.
Despite their preference for the PHQ-9, several nurses suggested that the PHQ-9 did not always reflect the
severity of the patient’s mood. Nurses mentioned a number of reasons as to why a patient might score
lower than expected: some patients did not want others to know how they felt; patients manipulated the
scores so that they were not stigmatised for having mental health issues and patients did not recognise
their symptoms as low mood:
They’ve been describing their symptoms and their experience in life, and yet they still come out with
these practically zero scores on their scoring tools, so yeah, I think I guess every tool has the ability to
be maybe underplayed or if patients maybe aren’t recognising in themselves the way that they’re
feeling or they don’t want you to intrude on what they perceive to be private.
Nurse 5C
On the other hand, completing the PHQ-9 and the GAD-7 could provide a welcome opportunity for
patients to discuss any mental health issues. For one patient, the nurse said that it had been like opening
’a can of worms’ (Nurse 5C), delaying her assessment of other patients. However, this person had been
her first (and only) participant receiving EPC, so this situation might have been worsened by her lack
of experience:
It was quite a long assessment [including EPC delivery] so it did delay the [cardiac rehabilitation]
assessments of all the other patients. So we were late running on the programme that morning
because of that.
Nurse 4C
Exploring and dealing with the risk of suicide was new to nearly all of the nurses. Using the PHQ-9 meant
that they now found it one of the biggest challenges to deal with. Some nurses were surprised at how
frequently they identified patients with thoughts of suicide or self-harm, and that patients were willing to
discuss these feelings, which would often ‘come a bit out of the blue’ (Nurse 4C). Most nurses commented
on how ‘nervous’ or fearful they had initially been of identifying and dealing with risk issues:
The only part of it that was a bit scary was the really low mood and was their life at risk, it’s
something that made you think, which we all know about but it was asking that question, and then
you think, ‘oh god’ [laughs], ‘what if they say “yes”, oh my god’.
Nurse 3B
I felt stressed every time I had to have the conversation, but I would say that the training did help
prepare us to ask the right questions. I still felt like I maybe needed a bit of a prompter with the
paperwork and yet when somebody’s telling you those sorts of things, it doesn’t necessarily always
feel right dragging out a piece of paper [to check what action was needed on the risk protocol].
Nurse 5C
One large team, in which only a subset of nurses received full CADENCE training, reported that the key
lessons from managing mental health risk training had been cascaded across the wider team and had
added value to their usual practice:
It’s been a really, really useful process for the whole team . . . in the past we’ve done what we’ve had
to do in terms of ringing the GP and getting them help, but having a more structured process like this
again has, so that’s really helped us.
Nurse 6D
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Overall, nurses had gained new clinical skills in terms of assessing patients using the PHQ-9 and the GAD-7
and following structured process when risk issues were identified. They all preferred these to their previous
tools and found it reassuring that the PHQ-9 was highlighting patients who were at risk of self-harm,
which previously they may not have become aware of.
Acceptability of enhanced psychological care
Acceptability of enhanced psychological care for patients It was clear that nurses felt that patients
varied in how acceptable they had found the intervention and whether or not they benefited. Nurses
related this variation to whether or not the patient felt that the BA treatment ‘was for them’ and the extent
to which they were motivated to engage with EPC. One nurse felt that the highly motivated patients were
the ones who benefited the most, and those who were less motivated were often those who scored highly
on the PHQ-9, suggesting that reduced motivation came along with increased depressive symptoms.
Patients who were viewed as engaging well with EPC were described as having grasped concepts of BA,
and as having become more physically or socially active. It was evident that patients could be viewed as
benefiting even when their PHQ-9 scores had not changed:
I definitely think it is a really good, really good thing, it’s definitely a benefit and certainly you know, of
the say four patients that we’ve done, . . . two of them have got a benefit [which was reflected in their
PHQ-9 score] and two of them got a benefit but it doesn’t necessarily show up in their PHQ, but
certainly they’ve got something out of it.
Nurse 2B
Although some patients completed the eight BA sessions that were recommended, other patients did not
fully engage in the BA element. Nurses said that some patients dropped out of BA early, as they were not
keen to complete the mood diaries, and during the nurse interviews, two patients were described as
thinking BA was not for them. Both patients were viewed as having complex psychological problems,
and were referred to psychological or psychiatric services.
Acceptability of enhanced psychological care to nurses Many nurses reported that they had enjoyed
being part of the pilot study and developing another clinical skill. Nurses felt that the EPC training they had
received had covered most areas they needed, and it was useful to have the training manuals so that they
could look back over the training.
Whatever the nurses’ experiences of individual patients, all nurses commented that there was a place for
EPC in their work and that BA was an extra tool that they could use. Nurses also commented that it was
good to have a designated time to talk to patients, as they felt that patients really valued this, and that it
was very helpful that the BA component had been integrated within cardiac rehabilitation rather than
through referral to another service, as many patients declined referrals elsewhere:
Giving them something else that they can do in the background that’s not obvious to everybody else
but it is actually showing how they are improving week by week by week is fantastic, so I think yes,
actually having something like behavioural activation is a really good thing . . . we’ve mentioned about
the psychology service at the hospital, we’ve mentioned about the anxiety and depression clinics,
we’ve mentioned about speaking to their GPs about anti-depressants, so we’d done all that before
and we’d all, most of the time, ninety percent of the time people would say ‘no I don’t want to do
that I’m just going to work through it, I’m going to see how I get on’. So actually being able to offer
an extra option that didn’t involve all of that, people were more receptive.
Nurse 2B
Those nurses who had delivered EPC to patients a few times seemed more accepting of the intervention
and recognised that it got easier to deliver as they became more familiar with it.
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Clinical supervision Clinical supervision was new to nurses, and sometimes it took them a little time
to understand its purpose. Supervision was held by telephone, sometimes on a one-to-one basis and
sometimes with other nurses. Nurses found clinical supervision helpful. One nurse mentioned that it had
helped her to think of ways to end a BA session and move on to the next stage. Another nurse felt that it
had helped to keep her on the right track and think about ways to deal with situations more creatively:
He gave me good, some pointers at times, which I made note off and I tried to act on his advice.
Nurse 1A
Supervision with others enabled nurses to learn from each other. However, supervision was fortnightly,
and this meant that some of the advice and support provided was out of date by the time the supervision
session came along:
Supervision would be once a fortnight in the end, so you were going over things that were a couple
of weeks old and you’d seen the patient again since, that was the only tricky thing.
Nurse 3B
Nurses tried to have patient paperwork ready for each supervision call. Nurses were very busy, rushing
from place to place, so did not always find this easy. However, the guide to how to structure EPC
(see Appendix 2) was found to be particularly useful:
I think it was useful because we had the record of the delivery, so after each session, there was a
space to document what you might have done with that particular patient, anything, and your scores,
your GAD or PH [PHQ-9], so you had all that information there with you, so as long as you had that
with you and you’d completed it in time with your supervision call, then it was fine.
Nurse 6D
Views and experiences of delivering enhanced psychological care
Working with patients on enhanced psychological care As some nurses had only seen one EPC
patient, they had very little experience of delivering EPC. Nurses recognised that they would improve their
skills through practice and experience.
Although some nurses said that they had initially struggled to deliver EPC because it was new to them,
and because sometimes it was difficult to engage and motivate patients, they soon found ways to deliver
EPC more smoothly and explain concepts more readily. One nurse who had delivered EPC to three
patients commented:
Within a couple of weeks I think the patients saw very quickly how their mood was related to their
activities and they got it very quickly. So after that actually the time spent with them prior to the
group was more as you say coordinating them to the next phase . . . and actually moving them onto
actually allocating routine activities.
Nurse 2B
When nurses saw improvement in patients, it was not always easy to tease out how much the improvement
was attributable to the provision of BA, because of intense nurse contact at an early stage of the patient’s
cardiac rehabilitation programmes (i.e. 10 days post MI and 4 weeks for surgical patients), early contact with
other patients or because of all of these factors:
We are getting them in early and I think the confidence that they get from that is huge and so it’s
difficult to know. Is it the workbook, the behavioural activation that’s helping them or is it just the fact
that they’re coming into a place where there’s peers, there’s support, they’re getting confidence with
what they can do, so it’s a bit of a mix, isn’t it?
Nurse 7D
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Nurses felt that a lot of what they were doing in terms of spending time discussing mental health issues
was what they would have done pre-study training, but it was now more formalised:
I think just having this process, using the EPC just formalises it a little bit more . . . if you’re specifically
talking about mood . . . in the gym environment, finding the right opportunity and they’ll plod along
and smile, ‘yeah, everything’s great’, and they’re exercising and everything . . . we tend to review
patients halfway through their exercise programme to see how they’re getting on, it might not be
until that point that they actually decide to open up and say, ‘well, actually, you know what, I am
really struggling’.
Nurse 6D
Nurses said that most of the EPC sessions incorporating the BA component took them between 10 and
40 minutes to complete. Time was also required to follow-up patients who had not turned up.
For one nurse, patients sometimes came in regularly to see her just to have an EPC session, before having
started their fitness programme. Although it used up more of her time, she felt that this encouraged them
to keep on coming, and for one man it meant that he was more likely to do the fitness programme:
If they don’t see me, see us, or come into contact, we’re going to lose them. So for him, I’ve probably
done an extra couple so far, but I’m hoping we’re going to try and get him on a programme.
Nurse 1A
For other nurses, EPC was delivered at the same sessions as their fitness programme. Although some
nurses felt that ‘patients that are struggling psychologically are always on our radar’, they were more likely
now to arrange a set time to see the patient for an EPC session, and thus spent more ’quality time’ with
their CADENCE study patients than with their other patients. However, nurses recognised that patients
with mental health problems usually took more time anyway, in their usual practice. In practical terms,
delivering EPC was time-consuming, especially because using the PHQ-9 opened up the possibility of
identifying risk issues:
The components that we have delivered have definitely been more time consuming than our usual
care . . . from the perspective of running through a PHQ-9 form and . . . addressing Question 9
[which asks about suicide thoughts and plans], which can often expand the conversation and, well,
understandably, and so we should be talking about that sort of thing.
Nurse 5C
Although recognised as a challenge, most of the nurses commented that if there was enough time, staff
and administrative resources, integrating EPC into all cardiac rehabilitation would be ‘an ideal situation’.
Although nurses were aware that timely referral to other mental health services was important, some nurses
felt that the intervention had not been delivered successfully unless the patient managed to complete all
their BA sessions. Some nurses perceived BA as being crucial to EPC delivery, rather than as an optional
treatment component. Nevertheless, most nurses did offer a variety of referral options on completion or on
opting out of BA. Several nurses commented that they had patients who had not been keen to visit their GP
to discuss their psychological issues, and had declined referral to other services for their mental health. In
addition, nurses were not informed about whether or not patients they had referred to other mental health
services then attended these services.
Most EPC sessions were held on a face-to-face basis, and nurses preferred this to those held by telephone.
Reasons for preferring face-to-face sessions included these sessions taking less time, nurses feeling that
they gained a lot in terms of understanding how the patient was by seeing them and feeling that the
telephone session flowed less well.
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Nurses from three of the four teams had a joint workload, which meant that they sometimes shared an EPC
patient. This raised the need for nurses to communicate about specific patients. One nurse commented that
this would be aided if there was space for both nurses to write in the patient’s record of delivery sheet and
others mentioned the need to have an overlap in working hours in order to provide nurses time to talk
about the patients that they shared.
Working with the patient materials Nurses viewed the participant handbook as clear and helpful for
them to guide patients through EPC, especially when used alongside the nurse handbook:
The nurse’s handbook and the [patient] workbook are very easy and if we knew we’d got a session
coming up, then I’d look at where we’re at, what are we aiming to do today, we’ve already had the
support previously to help with direction, but I had no problems discussing it.
Nurse 7D
Some patients engaged in the materials more than others, and many nurses commented that patients
identified with case studies in the handbook. However, it was commented that some patients felt that
there was a lot of paperwork and that the handbook could be improved in terms of its look and usability:
I know that some of the booklets that we give, the British Heart Foundation booklets are, I don’t
know, maybe the look of the tools, it didn’t come across as maybe being an easy tool, I know it is
an easy tool to use but there’s quite a lot of information for the patient to maybe read through and
think about as well in the booklet and I just wonder if that could be maybe conveyed in a slightly
different way.
Nurse 5C
Two nurses said that neither of their patients had completed the activity diaries or other homework
materials. This was sometimes because the patients dropped out of the BA element at an early stage,
were referred elsewhere or did not come back. In one case, the patient was happy to talk about the diary
with the nurse at their appointment, but did not want to complete it herself.
Some nurses found explaining and using the weekly activity diary with patients intuitive, possibly because
of their past experience of using food diaries. However, some patients were described as finding the mood
scoring on the diary confusing or as struggling to score themselves realistically, as it scored in the opposite
way to the PHQ-9, which they had also been asked to complete:
The PHQ and GAD-7, it goes from ‘not at all’ being nought, to ‘nearly every day’ being three. So then
you go to the workbook and the workbook goes from lowest mood being one, and then the most
positive you are being 10, so it does the opposite.
Nurse 7D
Another issue that nurses mentioned was the need to better support for patients who struggle with
literacy skills (patients with dyslexia or a low level of education or ethnic minorities). One nurse felt that
there were ways to help these patients to ensure that they were not excluded:
There are ways you can work round things and what you’d probably do with somebody is actually you
talk to them and you fill in their activity sheets for them, . . . [using] pictures and things like that . . .
But I mean, I wouldn’t want to exclude them so we’d adapt it and we’d probably . . . for those who
don’t fill in the questionnaires, you can sometimes it isn’t that they don’t want to fill them in, it’s
because they can’t and say, ‘actually do you want me to, it’s quite a busy form, shall we have a look
at it together?’ and then they’re more than happy to answer questions and go through it.
Nurse 7D
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Finding space and privacy Most of the nurses worked across multiple venues, and many of them
described how they had little or no access to a private place to deliver EPC, so they needed to find a quiet
corner to discuss confidential issues with patients. Although this was not ideal, nurses felt that patients
found it less intimidating than trying to find a small room. In addition, as they often worked alone, it
would have been difficult to leave the fitness room, and remaining in the room allowed them to keep an
eye on other patients. Another option, used by nurses, was to ask the EPC patient to come half an hour
early or to stay late after the class:
Where we do our exercise rehab[ilitation] groups we do it in a room in a leisure centre so there wasn’t
anywhere else to do it, so we just literally met them half an hour earlier than the group and that’s just
dependent on whether the patients decide to come early or not.
Nurse 2B
Integration of enhanced psychological care into existing pathways
Impact of enhanced psychological care delivery on nurses’ time Nurses commented that EPC had an
impact on how they managed and scheduled their time, and had increased the time spent on administration:
Definitely time, you know, the admin, the letters and things, you do to them, and thinking, ‘hang on a
minute, I need to take this time back from work, and do the extra’, it’s juggling all these balls and
keeping clear records of it as well.
Nurse 1A
There was also a feeling among the nurses that more administrative support would have helped:
I know our admin support lady feels, again, run ragged with all of the, she’s a part-time team worker
and had to juggle a whole host of different tasks and I suppose from our point of view that the whole
communicating with GPs and in a timely way . . . even if it is a clinical letter, it can sometimes take
quite an effort to get it to the point of actually being sent to the GP and so I think from our point of
view, we’ve got that never-ending battle of we could do with some more admin support to make the
whole flow of the service easier.
Nurse 5C
As well as impinging on their designated administration time, nurses sometimes shortened their lunch
breaks and delayed going home in order to fit in an EPC session. Nurses also explained how they asked
colleagues to help out at their rehabilitation session, so that they could focus on the EPC patient:
. . . so what we tended to do was if we knew that this lady was coming in for her CADENCE, we
would double up so that one was on the gym floor and one was [seeing the CADENCE patient].
Nurse 6D
Fitting enhanced psychological care around usual care Although nurses had up to three EPC patients
on their caseload at one time, they viewed it as ‘lucky’ that they had not had to see multiple EPC patients
at the same rehabilitation session or on the same day:
Say my numbers doubled overnight, which is pretty, very unlikely, [pause] I’d have to work more hours
to fit them in.
Nurse 1A
But I think we were lucky and I, like I said to [name of other nurse] I don’t know whether it’s fate or
him upstairs that actually did it, that we never had to have that option [more than one patient at the
same session] and it worked out really well and yes, I think, yes we didn’t have to have that option [as]
I think it would have been difficult.
Nurse 2B
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Nurses were concerned about the possibility of needing to see more than one EPC patient at one fitness
session or on the same day, as they felt that they would not have the time to deliver this care. In addition,
one nurse said that to do so would be ‘mind-numbingly brain taxing’ (Nurse 2B), suggesting that they
would also find it mentally exhausting. However, many of the nurses also felt that although they envisaged
that it would be ‘tricky’ if it became necessary to accommodate more patients, solutions would be found:
I guess if you took this on and this became routine, then you’d make time for it because it is going
to impact on the day and it’ll impact probably on the admin time, because yeah, there’s a bit of
paperwork involved and there’s a little bit more documentation. I think, I guess had we had more,
we may have found it more difficult, but it’s just a slightly different way of working, isn’t it?
Nurse 6D
Impact on other staff and patients Nurses varied in their views about how much the provision of EPC
had affected other staff and patients in terms of time: some nurses felt that it only affected patients and
nurses receiving/delivering EPC, whereas others commented that the wider staff workload and patients
were also affected:
No it didn’t impact on other staff time, from a team point of view I think everyone just got used to it so I
don’t, I think it’s very doable . . . So I think we organised it well in the way that actually that time was
allocated for that patient importantly, so, but we still had time for the other patients and plus we could
stay behind and see them afterwards, so I don’t think it compromised anyone else’s care or time.
Nurse 2B
Especially the leisure centre one, because we’re assessing patients, ready to start the rehab programme,
and obviously, I’m tied up with one patient for half an hour some weeks with this gentleman, so
sometimes we do start later and yeah there is an impact on them [other staff] definitely.
Nurse 1A
Although there were clear concerns about how to fit EPC around their usual workload, nurses wanted to
make the point that they felt that EPC was a worthwhile intervention and that they were keen to explore
how their days could be reorganised to enable them to deliver this additional care.
Exploring intervention change Many nurses believed that there were patients who scored much lower
than the threshold score of ≥ 10 on the PHQ-9 who might benefit from EPC:
We’ve seen a hundred or so people to actually screen them and yes, lots of them are under five [score
on PHQ-9] but there is quite a few of them between, that’s a seven or eight who I personally think
would have benefitted from coming onto CADENCE. So yes certainly from my point of view and
speaking to my colleague she found the same thing that we look at people and say they would’ve
been perfect but they do not fit the criteria.
Nurse 2B
Even though people hadn’t got a high score, you could just pinpoint, you just thought ‘oh, I wish I
could have offered it to so and so or so and so’, you know when you just feel that they might be the
sort of person that would actually embrace it a little bit and it would help them move a little bit
further emotionally as well. But obviously they didn’t fall within the criteria so.
Nurse 7D
This nurse felt that everyone should be offered EPC as a tool that could aid recovery:
I think it’s a tool that can enhance people’s recovery and I mean a lot of people won’t want it because
they’re fine, but you might find that you get more people take it up that may be aren’t quite on the
scoring that you’d offer it to but might be just underneath it that are struggling and so that’s how I
think I could see it.
Nurse 7D
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However, nurses also recognised that they could be ‘quite inundated’ (Nurse 1A) if they included patients
who scored < 10. Their limited capacity led to discussions about EPC being delivered in a group setting.
Nurses could see that there were advantages to providing at least some elements of EPC in a group setting
(social network support and managing larger patient numbers, including those with a lower PHQ-9 score
who could benefit). The benefits of patients having opportunities to talk to each other about their
experiences were clearly expressed by nurses:
Patients get a huge amount of benefit just in talking to each other, don’t they, and so the problem,
the trouble solving, the solutions, ‘oh I do this’, and just seeing how other people are getting on, the
little supportive networks that they strike up when they’re actually in the waiting room waiting for
us to assess them and they’ve already got their own counselling and social network going on there,
so I do recognise the power of actually getting them together as a group.
Nurse 5C
Two nurses felt that an introductory EPC session in a group setting would work well within the short talks
that were delivered after a fitness session and given either by the nurse on stress, anxiety and depression,
or by the psychologist on emotional impact. These talks were well attended by patients and offered to
everyone. However, it was also recognised that group sessions could be off-putting for some; not all
patients would want to discuss personal views and experiences in front of other patients. One nurse also
acknowledged that there were patients who could dominate group sessions, and other patients could
become ‘disgruntled’ by this, so the sessions would need to be skilfully managed. Running EPC in the
group setting might also ’lose that element of being able to explore deeper issues when it’s not one to
one’ (Nurse 6D). Thus, it was felt that there should be a one-to-one element on offer too, especially for
those who had more complex issues that they needed to discuss.
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Chapter 6 Discussion
Context
The CADENCE study was undertaken in response to a 2013 NIHR HTA programme commissioning brief,
which invited research addressing a specific question: ‘What is the clinical and cost-effectiveness of
enhanced care for new-onset depression post cardiac event?’. In the brief, an intervention was envisaged
that involves enhanced non-pharmacological care for depression tailored to adults with new-onset
depression occurring soon after an acute cardiac event, and who were eligible for cardiac rehabilitation in
the recovery phase. The intervention was required to be easily deliverable in the NHS and integrated within
existing UK cardiac rehabilitation delivery. The proposed comparator treatment was envisaged as targeting
patients receiving standard cardiac rehabilitation and the psychological care routinely provided in this
setting, which national audit data suggest is very limited in size and scope.30 It was advised that referral
and uptake of IAPT services should be an assessed outcome. A feasibility study was envisaged, which
should clarify the comparator and define and manualise the active intervention in the light of current UK
practice. Once developed, it was anticipated that the intervention should be evaluated in an external pilot
RCT to test recruitment, acceptability and possible magnitude of effect. Important outcomes were seen as
validated measures of depression, cardiac risk and adherence to the rehabilitation programme, and a range
of other outcomes were suggested for consideration.
In responding to this brief, our original submission was considered, shortlisted and proposed for funding.
Changes from our original submission were requested with a view to containing costs, and, in response,
we reduced overall research staffing and proposed shortening the overall project duration from 33 months
to 28 months. This involved reducing the length of the longer-term follow-up from 12 months post
randomisation to 8 months post randomisation during the pilot study, and we made explicit the rationale
for these changes, which were accepted by the funders.
In addressing our aim of designing an EPC intervention for the management of patients with new-onset
depressive symptoms attending routine cardiac rehabilitation settings, we successfully undertook a multimethods
feasibility study recruiting cardiac rehabilitation staff and patient participants into a before-and-after observational
study and a qualitative study employing both interviews and observations. This feasibility study preceded an
external pilot RCT, which included a nested qualitative study, evaluating an intervention that had been modified
in light of the findings of the feasibility study.
Feasibility study
We successfully recruited three cardiac rehabilitation teams in the south-west of England, drawing on local
expert knowledge of services and the geographical accessibility of those services. Following screening of
203 potential participants, 30 individuals with ACS (15%) met our eligibility criteria for admission to the
study and, of these, nine agreed to take part. All nine participants completed a follow-up assessment at
5 months. These participants were somewhat younger than the overall group of patients attending initial
screening by cardiac nurses, but all provided routine sociodemographic information, and all undertook the
baseline CIS-R assessment used to determine primary and secondary psychological diagnoses.
In the feasibility study, we restricted follow-up to a single end point at 5 months, and all participants
provided psychological outcome data and data related to smoking status and a range of health outcomes
at baseline and follow-up. All feasibility study participants provided information at follow-up regarding
their experience of care. The burden of study procedures appeared to be broadly acceptable to
patient participants.
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Early direct observations of the cardiac rehabilitation nurses delivering UC indicated variations across
cardiac rehabilitation teams in respect of service delivery. Variation was also observed in the facilities
available for cardiac rehabilitation, the number of patients participating in group sessions and the
availability of private space.
Participating cardiac nurses were successfully trained in delivering the EPC intervention, and in monitoring
and managing patients with depression who were attending cardiac rehabilitation. That training was
supported by the development of a nurse training manual, the content of which highlighted the key
elements of EPC regarding mental health-care co-ordination and BA. Observations of nurse intervention
training indicated that nurses welcomed their new knowledge and skills. Issues were identified relating to
the layout of the patient and nurse handbooks, which were used to guide the content and delivery of the
intervention, and there were early concerns expressed in respect of how long EPC might take to deliver in
a typical ‘routine’ cardiac rehabilitation session. Observations of clinical supervision sessions with nurses
identified concerns relating to the quality of paperwork initially provided to document the care given to
patients, and a need was also identified to develop procedures to alert clinical supervisors and the research
team when a patient was discharged from EPC.
Interviews conducted with patients as part of the feasibility study indicated that participants felt comfortable
with nurses and valued having dedicated one-to-one time to talk about their mental health. Some identified
the rather uncomfortable sense of having been ‘singled out’ for treatment – and, in this context, some
patients felt that a group approach to delivering the intervention might have been preferable.
Interviews conducted with nurses following the training sessions highlighted overall satisfaction with
the organisation and delivery of the training, and with the content and completeness of the supporting
materials provided. Nurses reported that they felt that the training had been effective, resulting in greater
confidence in the management of patients with psychological problems. Nurses reported benefit from the
newly acquired ability to undertake a structured assessment of the patient’s psychological status, including
the assessment of suicide risk. Notwithstanding this, nurses identified significant challenges in integrating
the delivery of EPC within routine cardiac rehabilitation because of time pressures and the availability of
suitable space to allow effective delivery of the EPC intervention. Thus, nurse feedback clearly articulated
that the model of EPC tested within the feasibility study was unsustainable within routine cardiac care.
Transition between feasibility and pilot studies
Findings from the feasibility study directly informed the design and delivery of the subsequent pilot study.
In particular, aspects of the EPC intervention were refined and redesigned prior to the pilot study, and a
range of practical refinements of the pilot study research procedures were proposed.
It was clear that issues pertaining to nurse workload were a major concern, particularly regarding the
ability of nurses delivering routine cardiac care to adopt and implement additional work relating to delivery
of the intervention and the research procedures. For this reason, we refocused the EPC intervention. The
change in the delivery of EPC between the feasibility and pilot phases involved an increased emphasis on
the mental health-care co-ordination component of EPC and a shift from a nurse-led intervention to a
patient-led, nurse-supported programme of self-help BA embedded within cardiac rehabilitation, reflecting
the need to reduce the impact of EPC on nurse time, albeit with nurses trained to support participant
engagement. These changes were expected (and indeed shown) to reduce length of session, although it
remains possible that the reduction in nurse input may reduce the effectiveness of the intervention.
In the transition period, the eligibility criteria for participants recruited into the pilot trial were broadened,
reflecting changing practice within the wider NHS cardiac rehabilitation services through which individuals with
other cardiac conditions are increasingly being managed. In reality, this meant that although participants were
recruited if they had experienced some form of ACS, there was an increasing likelihood that they would also
have other existing cardiac comorbidities (e.g. atrial fibrillation, heart failure). In addition, data collection
procedures were refined, with the case note review paperwork and information on antidepressant use being
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simplified, and additional information being sought regarding participant employment status. As the nurse
handbook and participant handbook developed for the feasibility study were well received, practical
suggestions emanating from the feasibility study informed the revision and some redesign of these materials
(e.g. using colour coding and improving the scripts provided to introduce concepts).
Of significant importance, the assumptions underpinning the accrual of participants into the planned pilot
RCT were deemed unrealistic when considered in the light of the findings of the feasibility study. This was
carefully considered and reviewed in a paper prepared for the TSC scheduled during the transition period
between feasibility and pilot studies. A proposal was submitted to the funders with a view to securing
an extension of funding to allow an additional 3-month period of recruitment in the pilot trial, and an
additional 3-month period for consideration of the findings and writing-up of the results. This funding
request was not agreed. Before commencing the pilot trial, we therefore anticipated that we would not
achieve our original pilot study recruitment target, instead anticipating recruitment of around 43 participants
(instead of the original 64 targeted). This revised participant accrual rate had implications for our sampling
approach within the qualitative study. Thus, we revised our pilot study protocol accordingly, by altering the
randomisation ratio from 1 : 1 to five EPC teams to three UC teams to ensure that a sufficient number of
participants would experience the EPC intervention.
External pilot trial
The aim of the pilot trial was to test the methods and procedures required to undertake a fully powered
evaluation of the clinical effectiveness and cost-effectiveness of cardiac rehabilitation teams implementing
EPC for individuals with new-onset depressive symptoms using cardiac rehabilitation services, compared
with a comparator of usual cardiac rehabilitation care. We successfully recruited eight cardiac rehabilitation
nursing teams, randomising these to one of two trial arms: UC or EPC plus UC. Teams were drawn from a
range of settings in South West England and the East Midlands. Most teams recruited offered centre-based
rehabilitation programmes. The time of our first approach to the teams to the point of participant recruitment
was lengthy (9 months in one area). In two regions, participant recruitment was delayed by over 2 months
from the point that all necessary research training had been completed, as we waited for NHS R&D trust
approvals to be issued. This effectively reduced the recruitment window from 6 months to 4 months for
this team, placing increasing pressure on our ability to achieve our target sample size.
Of the 614 cardiac patients screened for eligibility by the eight teams within a 4- to 6-month recruitment
period, 55 patients were eligible to take part in the trial and, of these participants, 29 provided baseline
data. Of these 29 participants, 27 (93%) provided 5-month data. Of the 21 participants eligible to provide
8-month data, 17 (81%) did so. Participants in both trial arms were broadly comparable in respect of the
range of cardiac diagnoses/events that had precipitated their referral for cardiac rehabilitation.
Twenty-one patients were depressed on assessment at baseline screening by nurses, but were not eligible for
inclusion on account of having pre-existing treatment for depression prior to referral to cardiac rehabilitation.
The requirement for inclusion of only patients with ‘new-onset’ depression (see Rationale for current research)
was set out in the original commissioning brief, and this is an area that future research commissioners might
want to revisit.
Cluster randomisation, balanced by team type and patient throughput at the initial cardiac rehabilitation
assessment, was successfully implemented, although one randomised team withdrew immediately
following randomisation on account of coincidental service changes (a regional reconfiguration of cardiac
rehabilitation service provision), which made participation impractical. At short notice, the withdrawn team
was replaced with another team matching closely in terms of patient throughput and population mix.
The two trial arms were not well balanced in certain patient characteristics. Participants in the UC arm
were older than those in the EPC intervention group. Participants in the EPC arm were more likely to be
from deprived backgrounds, to evidence higher levels of depressive symptoms at baseline, and to report
lower levels of HRQoL than participants receiving UC. Given the small number of participants and the fact
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that randomisation was at the level of the cluster, a balance of participant characteristics between arms
would not have necessarily been expected. We anticipate that this would not prove to be an issue of
concern in a larger, fully powered study.
Two participants (one in the EPC arm and one in the UC arm) were prescribed antidepressants at a
therapeutic dose during the study follow-up period. In addition, three participants were prescribed
amitriptyline in small doses, in the range usually prescribed by GPs for pain or sleep disturbance.
Amitriptyline prescribing is potentially a cause of concern in this group of patients, as older forms of
tricyclic antidepressants such as these are generally considered to be relatively contraindicated on account
of the presence of cardiac disease.
We relied on case note review of cardiac nurse and GP notes to obtain certain clinical data that might
reasonably be assumed to be comprehensively captured in such records. The availability of physiological
and biochemical outcome data varied among participants, generally with greater availability of physiological
data in GP or cardiac rehabilitation notes than of biochemical data (lipid profile). The cardiac diagnoses/
procedures that precipitated referral to cardiac rehabilitation were also inconsistently reported within nurse
and GP notes. A future trial should consider revising procedures to ensure that these data are adequately
captured by, for example, seeking further data from cardiology services.
Participants in both trial arms were offered attendance at broadly similar numbers of rehabilitation
sessions, and similar proportions of participants in both treatment arms attended these sessions. However,
four out of the five participants in the intervention arm who attended one or fewer cardiac rehabilitation
sessions also had higher baseline depression scores (BDI-II scores of ≥ 14). This suggests that some patients
who might have benefited from EPC did not take up that opportunity, although the reasons for this were
not clear. In addition, some patients were not offered EPC in the pilot because of the nurse workload, with
the nurse lacking capacity to offer EPC to more than three participants at any given time. Patient factors
may also be important. Qualitative interviews with trial decliners found that some patients chose not to
take part in the trial as they did not identify themselves as experiencing low mood or were not keen to
receive more information relating to their cardiac event. We also noted that 4 out of 10 EPC participants
who attended at least six rehabilitation sessions had baseline scores below the threshold BDI-II score of 14,
indicative of ‘mild’ depression.
Participants’ use of resources was collected from both self-report questionnaires completed by participants
and a structured review of both GP routine records and cardiac rehabilitation records. Good or very good
agreement between patient and either type of record was observed regarding A&E attendance and hospital
admission, but individual-level agreement was poor in respect of the number of primary care appointments
attended (when compared with GP records). Differences in the mean number of GP attendances between
GP record and self-report data, however, were more similar. For the potential purposes of costing within an
economic evaluation, this provides some evidence to support the use of self-report service use data in this
patient group (and over these recall periods) – so long as loss to follow-up and questionnaire non-completion
could be minimised.
Across the 5-month follow-up period, the mean BDI-II score improved from baseline in both arms of the
trial, with the mean between-group difference in BDI-II score (EPC minus UC, adjusted for baseline scores)
of 1.72 units, but with a wide CI, encompassing zero. We were able to estimate the distribution of BDI-II
scores in our study population, although, being a single study, future research might want to review relevant
available evidence from similar or related populations.82 We also reported additional data on different ways
to calculate and compare depression status at follow-up (e.g. remission, MCIDs). Participants in both trial arms
reported improved scores for anxiety and heart-related quality of life at the 5-month follow-up, although
generic HRQoL, as measured by the EQ-5D-5L, remained unchanged. However, the pilot study sample size was
small and likely underpowered, and this, combined with evidence of baseline imbalance between the two trial
arms and the lack of adjustment for clustering in the data, does not allow us to draw any formal inferential
conclusions regarding the overall direction or magnitude of outcome changes within or between arms.
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Perhaps reflecting the nature of the underlying morbidity, two individuals had recommenced smoking,
one in each trial arm, by 8 months. Participants in both trial arms reported improved scores for anxiety and
heart-related quality of life at 5 months, although generic HRQoL, as measured by the EQ-5D-5L, remained
unchanged. Although participants in both arms reported a positive experience of their cardiac rehabilitation,
there was some evidence of a more positive experience among participants of EPC when compared with UC.
From semistructured interviews with trial participants, it was clear that they viewed one-to-one dedicated
nurse time for psychological care as important to achieving timely recovery from their depression. Participants
saw EPC within cardiac rehabilitation as reflecting a ‘holistic approach’ to care, and the delivery of EPC
occurring shortly after the cardiac event as important. Despite this, it was evident that a clearer explanation
of BA as a key component of EPC was needed, and participants also made it clear that a flexible approach to
delivering the intervention was needed as, in the views of at least some participants, ‘one size does not fit
all’. A small number of interviews with patients who declined participation identified that their reasons
for declining included not feeling that low in mood (despite having questionnaire scores indicative of
depression), not being keen to discuss mood with health-care professionals and having concerns regarding
‘information overload’ at the point of attending cardiac rehabilitation.
Interviews with nurses showed that they felt appropriately equipped to deliver the EPC intervention in spite
of only limited experience in delivering EPC to patients over the course of the pilot trial. The training in
mental health-care co-ordination (including clinical supervision during implementation) and adoption of
the PHQ-9 to measure depressive symptoms (replacing the HADS) was well received by nurses, and was
collectively viewed as improving their ability to effectively manage mental health and risk. BA was seen by
nurses as a viable intervention, although one that was challenging to deliver to some patients and, in
particular, to some individuals who were seen as not being receptive to the approach offered. Although
there was a general perception of nurses that many patients seemed to benefit from EPC, this was
tempered by a view that more of their dedicated time was needed to allow the effective delivery of EPC.
Methods to support economic evaluation
As for the other components of the pilot trial, a principal aim of the economic component was to establish
the data collection methods required to support a definitive economic evaluation. We piloted methods
required to collect resource and service use data among trial participants that would be relevant to costs to
the NHS, costs to social care and personal social services and costs to participants and their carers/families.
Service use data were collected from routine/administrative sources, as well as via participant self-report,
using a SRUQ (the latter being adapted from the CSRI, following input from the PPI group). Our study
identified the estimated cost per participant receiving the EPC intervention, and identified the main
elements contributing to this overall estimate of cost. We identified a total overhead cost of providing EPC
of £13,384; a substantial proportion of this cost (93%) was accounted for by nurse training. Given the
relatively small number of participants, the estimated cost per participant of £904 is likely to be an
overestimate, on account of small numbers. Given the nature of the intervention, it proved difficult to
identify time spent by nurses in ‘delivering EPC’, as this time was distributed across all of the nurse
interaction with the participant rather than in discrete, quantifiable amounts of consultation time.
We successfully gathered information from participants regarding their use of health services across their
period of involvement with the study, with data available for the majority of participants. Therefore, patient
self-report service use data may be sufficient for providing mean attendance rates in trial arms. The five main
categories of health service use on which we captured administrative record data appeared to be intuitively
correct, although data collection was intensive, requiring significant researcher time and effort to conduct
manual case note review of, and data extraction from, GP and cardiac nurse records. Although we did
observe differences between trial arms in resource use estimates, we interpret this with considerable caution
and would make no inference regarding the magnitude or direction of any differences on account of the
small participant numbers involved. In addition, it is important to separately identify high-cost care episodes
(e.g. inpatient admissions) that are unlikely to be related to the intervention or the targeted conditions, but
which could cause spurious cost differences between trial arms; therefore, we captured the reasons for such
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care episodes. The assessment of HRQoL and utility scores using the EQ-5D-5L index scores was undertaken
successfully and would have the basis, in a larger trial, of providing quality-of-life estimates that are
potentially useful for determining trial sample size, based on the expected cost-effectiveness of the
intervention in this population of participants.
Strengths and limitations
Strengths
The CADENCE study brought together an experienced team of researchers and mental health clinicians
who designed and delivered a successful mixed-methods feasibility study and pilot trial in response to a
national commissioning brief issued by the NIHR. In general, the aims of the feasibility and pilot study were
achieved. We successfully recruited three cardiac rehabilitation centres to the feasibility study and eight
centres to the external pilot trial (and an additional replacement pilot trial site). Nurse training was
provided in respect of EPC for patients attending cardiac rehabilitation with depression.
Our qualitative data found that the training was welcomed by the cardiac nurses, who saw this as an
extension of their clinical skill base and knowledge. It was clear that ‘usual psychological care’ was highly
variable between teams. As a consequence of intervention training, the assessment of psychological
symptoms and the risk assessment of potentially suicidal patients were welcomed. The intervention was
both developed and manualised by drawing on a theoretical base previously acknowledged in NICE’s
guidelines33,34 for the management of depression in people with long-term conditions. The intervention
was developed by experts with experience of training NHS therapists in BA working closely with cardiac
nurse specialists, and with the intervention involving regular review of the patient’s psychological state, risk
and regular clinical supervision available to nurses implementing the intervention. The trial was supported
by the development of two manuals (targeting nurse and patient participants), both of which were
subsequently refined following feedback from patients within the trial and our PPI group, as well as from
participating nurses delivering the intervention. Data from qualitative observations and interviews provided
a deeper insight and understanding of our quantitative findings at each stage of the study. The manuals
were modified in the light of feasibility findings in preparation for the external pilot trial. Each EPC session
was structured to include the monitoring of depression and risk by nurses, participant self-monitoring
(including patient self-identification of activities and triggers to depressive behaviours and thinking)
supporting the replacement of negative behaviours in patients with more positive behaviours and the use
of mental health-care co-ordination followed an algorithm developed for the study.
Overall, 29 participants were recruited into the pilot trial, 27 out of 29 participants (93%) were successfully
followed up at 5 months and 17 out of 21 participants (81%) provided data at the 8-month follow-up.
Although we did not meet our original recruitment target (64 participants, subsequently revised to
43 participants), we do believe that recruiting and retaining sufficient participants is possible within the
context of a future, larger, definitive, fully powered RCT. The EPC intervention generally appeared to be
acceptable to participants, with some evidence of higher satisfaction among participants receiving EPC
than among those receiving UC.
In line with the commissioning brief, our intention was to recruit patients attending cardiac rehabilitation
who had evidence of new-onset depression occurring since the cardiac event. Although the overall
prevalence of depression in this group of patients was in line with expectations, approximately one-quarter
of patients (in both the feasibility and pilot studies) had symptoms of depression when initially attending
for cardiac rehabilitation and had received treatment for depression in the 6 months preceding the cardiac
event, and thus were deemed ineligible for the study. In addition, a small number of depressed individuals
were not offered study entry, as the nurse had effectively ‘reached capacity’ in terms of the number of
participants receiving EPC at a particular point in time. We would propose that, in the planning of any
future research, consideration be given to extending recruitment to include all patients with depression
attending cardiac rehabilitation.
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Limitations
Prior to undertaking this work, and during the course of preliminary funding consideration, we agreed a
change from the NIHR commissioning brief, which had originally envisaged a 1-year follow-up period.
Projected study costs and anticipated attrition among this vulnerable group of patients led to this
agreement, and our study design involved primary outcome data collection at 5 months and a second
(final) follow-up at 8 months. However, the CADENCE study proved to be a challenging study, with tight
timelines making necessary changes to the protocol difficult to manage.
Delays encountered in securing trust R&D approval meant that, on occasion, we had nurses who were
trained in delivery of the intervention but who were unable to deliver the study until local trust processes
had been addressed (these delays related to the negotiation of excess treatment costs).103 These delays
were, in some settings, substantial, and were a source of frustration to the research team and the nurse
participants. More significantly, these delays had the potential to undermine the effective delivery of the
intervention. Some nurses experienced delays between training and operationalising their skills, although
the impact of this was ameliorated, by and large, through ongoing clinical supervision once recruitment
commenced. It also limited the number of patients to whom each nurse was able to offer EPC; thus, they
had, by and large, only limited experience of delivering the intervention. Negotiation of excess treatment
costs has been identified as an impediment to the effective delivery of nationally funded research104,105
and a source of concern within the UK health research community; resolving the issue should, we believe,
be a matter of urgency.
Delays were further exacerbated by challenges in managing the range of geographically dispersed
recruitment centres, and in respect of research administration and bureaucracy. Overall, we recruited
29 participants – in comparison with the 64 envisaged in the external pilot trial and the revised target of
43, which we anticipated achieving after a study extension request was declined. In the event, 8 of the
29 participants in the external pilot trial were recruited ‘late’ (i.e. at a point when we could collect only
5-month follow-up data from them before data collection closed). Although we were able to estimate our
primary outcome (response rate at the 5-month follow-up), our estimate of attrition at 8 months should be
interpreted with caution.
We did not recruit the anticipated numbers of participants from ethnic minorities, despite the fact that
some of our recruitment centres (in Bristol and Coventry) were located in areas with an ethnic mix in line
with the sociodemographic profile of England. There was also an imbalance in participant characteristics
and outcomes at baseline between the pilot trial arms in respect of some key features, which is likely to
have arisen by chance as a result of the small numbers of clusters and participants.
Although we achieved our stated aim of testing the adequacy of methods used for collecting economic
data, consistently with our pilot study aims, we did not undertake a full economic evaluation of the
interventions and, hence, for example, we did not collect baseline data on previous patient resource use.
We also did not capture and cost the additional time that patients spent completing their mood–activity
diaries as part of the EPC intervention. As part of a definitive trial, these methodological issues would need
to be resolved.
Challenges were encountered in embedding nurse-led EPC interventions in routine cardiac rehabilitation
care. Although trained in study intervention and research procedures and potentially willing to participate,
nurses found it very difficult to ring-fence dedicated time in which to deliver the intervention. Following
the feasibility study, we refocused the intervention more towards a patient-led intervention, informed by
the principles of BA. We found from our qualitative studies that participants welcomed the intervention,
with some describing substantial personal benefits in respect of increased activity and improved confidence
regarding their health status. Although the EPC tested during the pilot study was designed to reduce the
impact on nurse workload, it was clear that this ‘lighter’ version of EPC still posed significant challenges to
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the nurses attempting to integrate it into routine practice. Evidence for this can be seen in the low fidelity
to care co-ordination in both the feasibility and pilot studies, with fewer than 50% of participants having
such activity documented in their clinical records. This was despite much greater emphasis being placed on
mental health-care co-ordination in the pilot study EPC intervention, suggesting that intervention fidelity
remained problematic.
Findings in context
In June 2017, at the point that this report was being finalised, the BACPR released new guidance on the
standards for core components for cardiac rehabilitation services in the UK.106 The requirement to manage
psychosocial health is more explicitly described, as is the need to access appropriately qualified psychological
practitioners, either embedded within cardiac rehabilitation programmes or through appropriate access
arrangements with existing mental health services. As written, the BAPCR guidance is consistent with the
need for cardiac nurses to be trained to deliver a mental health-care co-ordination role similar to that tested
within our EPC.106 However, embedding BA within existing teams remains aspirational, and would still face
the implementation challenges reported by nurses (albeit from a small number of participating teams).
During the conduct of this research, four important papers have been published, which are of significance.
In 2012, Leung et al.18 reported the findings of a meta-analysis of 22 cohort studies investigating the
timing of depression onset to determine what time frame is associated with greater mortality and cardiac
morbidity. Their work identified that, for most patients, both premorbid and postmorbid depression onsets
were potentially hazardous, and the authors suggested that the question of timing may be irrelevant
with respect to adverse cardiac outcomes. Given this observation, excluding patients with pre-existing
depression from a future trial may be inappropriate.
The recently reported and NIHR-funded COBRA trial50 identified the potential for effective psychological
therapy targeting depression, such as BA, to be delivered without the need for costly and highly trained
professionals. In the context of our findings, cardiac rehabilitation nurses appear to offer potential in the
delivery of BA to their patients, although important operational, structural and workload issues would
need to be addressed to allow them to do so in practice. An alternative approach might be to embed
IAPT-trained psychological well-being practitioners (PWPs) offering BA within cardiac rehabilitation teams,
thus offering the potential for delivering effective therapy, but doing so in a way that addresses the
benefits identified by our trial participants (patients and nurses) of ease of access to psychological support,
and the provision of holistic care as part of routine cardiac rehabilitation care.
Members of this research team have recently updated a Cochrane review seeking to assess the clinical
effectiveness of psychological interventions compared with UC for patients with CHD.57 Including 35 RCTs in
10,703 patients, this study concluded that psychological treatments are effective in treating psychological
symptoms in participants with CHD, although uncertainty remains regarding the people who might benefit
most from treatment.
Finally, although not focusing on the management of depression per se, a recent study has tested the direct
effect of adding a single psychological therapy to an existing cardiac rehabilitation programme. In a RCT,
Blumenthal et al.107 identified that providing cardiac rehabilitation enhanced by stress management training
produced significant reductions in stress and the rate of clinical events (all-cause mortality, fatal and non-fatal
MI, coronary or peripheral artery revascularisation, stroke/transient ischaemic attack and unstable angina
requiring hospitalisation), when compared with standard cardiac rehabilitation. These authors suggested that
stress management should be incorporated routinely into cardiac rehabilitation, thus providing further
support for the incorporation of targeted psychological support in this vulnerable group of patients.
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Implications for future research
Based on the findings from this study, undertaking a fully powered study examining the clinical
effectiveness and cost-effectiveness of EPC for patients with new-onset depression following an acute
cardiac event would represent a major logistical undertaking.
Summary of recommendations for future study designs
Based on our findings, we propose the following recommendations for the design of future research
studies evaluating the impact of psychological interventions within cardiac rehabilitation:
1. Appropriately locating psychological care. The qualitative work identified the importance to both
patients and nurses of having a psychological component to rehabilitation that is clearly embedded
within rehabilitation service delivery – not, for example, developed as a parallel service offered within
psychiatric services.
2. Embedding the CADENCE EPC intervention within current routine cardiac rehabilitation practice is not
realistic. Although cardiac rehabilitation nurses can be successfully trained in the delivery of EPC to
patients, significant barriers to implementation remained, relating to the lack of capacity within existing
cardiac rehabilitation services. As a substantive increase in cardiac rehabilitation nurse capacity is unlikely
to be feasible; a new model of care may be needed. Our data suggest that consideration should be given
to delivering EPC by dedicated mental health workers, possibly such as IAPT-trained PWPs, working in an
integrated manner embedded within routine cardiac rehabilitation services. The issue here is not one of
lack of professional willingness by cardiac rehabilitation nurses to engage in extended roles and develop/
implement psychological skills for the benefit of their patients, but, rather, the evident and limiting
practical constraints rendering their full engagement in EPC impractical. Should PWPs be employed to
deliver EPC, it is important that they are presented to patients as a core component of the cardiac
rehabilitation programme (i.e. not as another onward referral), and that the acceptability of this approach
be tested in future research.
3. Refocusing of the EPC intervention from a nurse-led to a more patient-focused intervention and revision
of the intervention materials. As a result of our feasibility study findings, we altered EPC to a patient-led,
nurse-supported programme and tested this in the external pilot trial (in response to the issues identified
in point 2 above). Some modification of the written material used to support the delivery of EPC during
the feasibility study was necessary, but, having made these modifications, the revised material appeared to
be acceptable to nurses and patients engaged in the CADENCE study. Notwithstanding this, some further
refinement and simplification of patient materials may still be required to aid engagement with written
materials. Newer modes of intervention delivery (e.g. online materials) may also prove to be worthy of
exploration. Depending on the availability of dedicated therapists within the cardiac rehabilitation services
as in point 2 above, the revised, patient-focused intervention appeared to offer potential as a means of
delivering EPC to this population of patients, and one which may be worthy of fuller evaluation in a
larger study.
4. Need for longer follow-up period. Longer periods of follow-up (of 12 months or longer), as envisaged
in the original commissioning brief, are desirable from a scientific point of view (e.g. in respect of
monitoring infrequent patient safety-related issues and clinical adverse events), but their adoption would
add considerably to the cost, and participant attrition rates may increase if longer follow-ups are adopted
in a future trial. Although the CADENCE pilot trial proved to be a logistically challenging study to deliver,
we believe that the added costs and risks of attrition are worthwhile when balanced against the need
for robust evidence on the longer-term effectiveness of enhancing psychological care within cardiac
rehabilitation services.
5. Adoption of the BDI-II as the primary outcome measure. The BDI-II appeared to be suitable for assessing
the severity of depression, with options to examine the change in symptoms from baseline as a continuous
measure, and also to examine the proportion of individuals entering remission during the course of the
trial (going from scores of ≥ 14 to < 14) or those experiencing clinically important changes in symptoms.
Several other outcomes we worked with might also be considered as competing for ‘primary outcome’
status in a future trial, such as depression status determined by use of the PHQ-9 measure (as adopted in
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the recently published ‘COBRA’ trial). However, it is important that the primary outcome measure
assessing depression is different from tools used clinically to monitor mood as part of a psychological
intervention. The decision on exact primary outcome is not an absolute issue, and researchers undertaking
a future larger study would wish to review the issue carefully in the light of other relevant published
evidence available at the time.
6. Use of a cluster intervention design. If EPC (as tested in our pilot study) was evaluated in a definitive
trial, a cluster randomised design is required to mitigate the risk of contamination within participating
study centres (clusters), arising as clinicians delivering the intervention might not be able to fully ‘turn
on’ or ‘turn off’ EPC delivery in the management of individual patients. However, should trials embed
PWPs within cardiac rehabilitation teams, cluster randomisation may not be necessary, which in turn will
reduce the size, logistical challenges and costs of a future trial.
7. Patient inclusion criteria. All depressed patients attending cardiac rehabilitation following an acute
cardiac event, not just those with new-onset depression following the recent acute cardiac event,
should be considered for study entry.
8. Study size and logistical challenges. When considered in the light of a power calculation (reported in
Sample size for a future definitive study) supporting the design of a future definitive study, it seems
likely that recruitment of participating teams would need to involve a substantial proportion of all
available cardiac rehabilitation teams currently operating in the UK. Given this, it seems likely too that
such a study would require the early and full involvement of the NIHR Clinical Research Network,
drawing on its existing structures to support the geographically dispersed recruitment process.
9. Economic evaluation methods. To avoid spurious differences in costs between trial arms, for high-cost
care episodes (e.g. inpatient admissions), greater efforts should be made to collect and corroborate
administrative record data, but also to prespecify research processes for deciding whether or not such
episodes are related to the intervention and targeted condition(s). For less costly, but more frequent,
care episodes (such as general practice attendances) and where case note review is highly resource
intensive, patient self-report service use data may be sufficient for providing mean attendance rates in
trial arms, so long as reasonably high levels of participant follow-up can be assured. Future resource
and service use data collection for similar interventions should always give scope for patients and carers
to report their time and other costs involved in receiving care or rehabilitation.
Reflections on the study findings from a PPI perspective are provided in Appendix 14.
Sample size for a future definitive study
Sample size for a cluster randomised trial
On the basis of our presented findings, a future definitive trial would need to consider a number of design
parameters. We suggest that ICCs in the order of 0.025 and 0.05 would be a reasonable initial approach.
In the CADENCE study, we estimated the ICC to be 0.047, based on national audit data made available
through the NACR – a better basis for estimation than data obtained from a single pilot trial. Future
estimates of the ICC would be wise to draw on the most currently available data at the time of
undertaking the study.
An adequately powered definitive cluster RCT of the intervention should include 50 cardiac teams (clusters)
and 650 participants (13 participants recruited within each cardiac team), randomising 25 cardiac teams and
325 participants to each trial arm. On average, it took a cardiac team 1.38 months to recruit a participant
to our pilot study; therefore, for each team to recruit 13 participants, the length of recruitment for the
definitive trial should be 18 months (i.e. 13 × 1.38).
The sample size was large enough to detect an effect size of 0.35 SD units on the BDI-II, with 90%
power at the two-sided 5% level of significance. The sample size allows for within-cardiac team clustering,
specifying an intracluster (intracardiac team) correlation coefficient of 0.05, and that 13 participants are
recruited in each cardiac team cluster. The calculation assumes 80% follow-up at the participant level at
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8 months. This level of follow-up was assumed because 17 out of 21 participants (81%) eligible to be
followed up at 8 months provided such data.
The clinically meaningful effect size for the BDI-II (the MCID) was defined as a 17.5% reduction in the
mean score. In our pilot study, the mean BDI-II score for the control group at the 8-month follow-up was
estimated to be 7.0; a clinically meaningful reduction on the BDI-II scale is therefore 1.225 units (i.e.
7.0 × 0.175). Based on the estimated SD of the BDI-II score (3.5), the corresponding clinically meaningful
effect size is 0.35 (i.e. 1.225/3.5) SD units.
The mean and SD of the BDI-II score in the control arm at 8 months was based on only eight participants.
The 95% CIs were 4.1 to 9.9 for the mean and 2.3 to 7.1 for the SD. We used these ranges to select
values for the mean (6, 7.4, 8) and the SD (3, 3.7, 5) of the BDI-II scores, in order to assess how sensitive
our sample size calculation is to uncertainty in these parameters. Sample sizes for a cluster RCT are shown
in Appendix 15 for all nine combinations of the assumed mean and SD values.
Patient and public involvement contributions to this work
Reflections on the study findings from a PPI perspective are presented in Appendix 14.
Our PPI representatives actively contributed to many of the key discussions that took place during the
lifetime of the project. They regularly attended project management meetings and also met separately to
discuss important issues, often in preparation for a team meeting.
The PPI group were very supportive of the idea of providing EPC to cardiac patients, given the patchiness
of existing psychological input in cardiac rehabilitation and the lack of availability of this in many cases.
However, the PPI group raised several issues in their discussions.
Context of patients’ lives
One of the issues that was raised by the PPI group was the importance of seeing the relationship between
a patient’s cardiac event and depression in the wider context of their lives, for example, the social support
available to them and other stressful events that they may be experiencing. The group also pointed out
that depressive symptoms might be accompanied by other symptoms, such as those associated with
post-traumatic stress. This comment appears to be supported by some of the evidence in the qualitative
research, when patients reported feelings of being ‘shell shocked’ and suffering from panic attacks.
Given that the cardiac nurses in the trial made the initial assessment of ‘new-onset depression’, the group
wondered if the limited training given to the cardiac nurses would allow them to recognise and deal with
these issues. The PPI group thought that the timing of the intervention and the level of depression that
would be used as a recruitment criterion were important to maximising the benefit to patients.
Behavioural activation
The group felt very strongly that the results of the work carried out and the qualitative interview results
supported the supposition that cardiac patients would benefit from EPC, but it was difficult to comment
on the specific effectiveness of BA. This is because of the small number of people involved in the trial.
Patient and public involvement group members noted that the results from the qualitative study indicated
that having someone to talk to about their psychological problems was important to patients. The value
of the ‘listening ear’, as one interviewee put it, should not be underestimated. The findings from the
qualitative work highlight the importance of the nurse–patient relationship. This may have been enhanced
by the nurse training in BA and the addition of extra listening time given to the patient. The group felt that
the available evidence suggested that this was beneficial to patients.
An issue raised by one of our PPI members, which may need to be taken into account in future, is the fact
that many medications prescribed to cardiac patients may have significant side effects, which may impair
the patient’s ability to engage with BA. Such medications can contribute to a general feeling of being ‘ill’
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and/or fatigued. There was a concern that this might have a negative impact on people’s ability to
successfully undertake BA, given the central focus on activity and that this is an issue that needs
further exploration.
Cardiac nurses
The PPI group felt that they could see a clear benefit to the initial support being provided by cardiac nurses
rather than requiring a referral to another service, although this option should be available if a patient
needs more specialist help.
The group noted that the BA training that the nurses received appeared to enhance their knowledge and
skills, giving them greater confidence with which to explore and discuss the wider psychological impact of
a cardiac event. This suggests that psychological training for nurses could improve psychological outcomes
for patients.
Resources
The PPI group was concerned about the lack of resources to deliver BA, both in terms of the lack of an
appropriate room in which to carry out BA and the workload of the nurses. They were concerned that
these factors might significantly impair the effectiveness of the intervention. The change from a nurse-led
intervention in the feasibility study to a patient-led intervention in the pilot was carried out for several
reasons, but a key one was the finding from the feasibility study that nurses were struggling to deliver the
intervention. The PPI group expressed initial concerns that this change may place more of a burden on
patients who are already struggling to cope with a traumatic event. However, the group felt happy with
the changes that were eventually made, and did not feel that they affected patients adversely.
Concluding comments
The group were mindful of the provisional nature of the findings from the study. However, the following
points were emphasised as key messages in reporting this work from a patient perspective:
l There is clearly a need for psychological support to be offered to patients as part of routine
cardiac rehabilitation.
l It was seen as beneficial that initial support can be provided by cardiac nurses rather than requiring
a referral to another service. However, having trained psychological counsellors based within
rehabilitation teams would also achieve this effect, and may deal with the issue of training and
workload for nurses mentioned above.
l The opportunity to share experiences between patients was clearly valuable.
l The ability to spend time talking one to one with someone about the psychological consequences of a
cardiac event was something that patients valued.
l The need to be able to get back in touch with someone if problems arose later on is important,
for example being given some contact numbers on completing the rehabilitation.
l Behavioural activation seems to be a promising approach to meeting the needs described above.
l The need to provide nurses with adequate training, time, resources and support in order to carry out
this role was also something that the group felt was very important.
Appendix 15 is largely informed by data collected in our pilot trial design and findings. Our primary sample
size calculation indicates that we would need to recruit 50 cardiac teams from the current 303 cardiac
rehabilitation teams in the UK (based on the most recent 2013–14 data).26 We believe that engagement
with key stakeholders, such as the BACPR and the NIHR Clinical Research Network, will be essential to
achieve this. Although the original brief suggested embedding the intervention in routine cardiac
rehabilitation, this proved to be difficult on account of time and workload constraints of cardiac nurses.
In contrast, embedding IAPT-trained PWPs within cardiac teams to support the delivery of the intervention
may help to overcome this important barrier to recruitment, and may also allow consideration of an
individually randomised trial design.
DISCUSSION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
106
The planned definitive cluster RCT would need to recruit a total of 650 patients over a recruitment period
of 18 months. The feasibility and pilot studies only included patients with new-onset depression. Widening
the inclusion criteria to those with pre-existing depression is likely to increase the recruitment rate.
Sample size for an individual randomised trial
An adequately powered definitive RCT of the intervention, such as psychological care delivered by a
PWP, in which individual patients are randomised, would require a total of 34 cardiac teams (sites) and
442 participants (13 participants recruited per team), with 221 participants randomised to each trial arm.
The sample size is large enough to detect an effect size of 0.35 SD units on the BDI-II with 90% power at
the two-sided 5% level of significance, allowing for a 20% loss to follow-up at 8 months.
Conclusion
Cardiac rehabilitation nurses can be trained to deliver EPC, as developed by the CADENCE study. Although
valued by both patients and nurses, organisational and workload constraints posed significant barriers to
implementation within UK cardiac rehabilitation services. We also obtained important data that inform
definitive research regarding participant recruitment and retention, and optimal methods of data
collection. There remains a need to develop and test new models of psychological care within cardiac
rehabilitation. This research provides definitive recommendations for how this might be progressed.
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Appendix 1 Feasibility study: topic guides used
for qualitative interviews
Patient participants
l Background and illness history (about the cardiac event, discharge home – well-being physically and
mentally after discharge).
l Expectations and decision to come for cardiac rehabilitation (decision to attend cardiac rehabilitation,
appropriateness of cardiac nurse assessing mood and providing support for low mood).
l Experiences of receiving BA sessions and care co-ordination (number of sessions completed, areas
covered in BA sessions, areas helpful/unhelpful, what effect BA had on mood, sessions by telephone
rather than face to face and physical environment for EPC delivery).
l Using the participant handbook and BA materials (how the handbook was used, what areas were
helpful/could be improved).
l Identifying links between mood and activity level (understanding BA, making changes to behaviour).
l Relationship with the cardiac nurse (e.g. relaxed, formal, etc., perception of nurse’s knowledge/skills to
assess mental health and deliver BA treatment).
l Treatment adherence (session attendance, what helped to stay engaged).
l How EPC has affected physical and mental well-being (current mental and physical well-being, how
best to support mental health, recommending EPC to others and suggestions about more effective
EPC delivery).
l Any other treatments received or referrals made during the study and impact on mood.
Nurses
Interview 1 (post training)
l Experiences of the EPC training (how well did it support EPC delivery, teaching style, length).
l Views of the nurse handbook and participant handbook (layout, content, how they will use them, any
improvements required).
l Implementing training (how knowledge gained will help to integrate EPC delivery into current practice,
any gaps in training, most helpful areas, any changes required in the training).
l Views of EPC (positive aspects, concerns, anything else needed to support delivery).
Interview 2 (after delivering the intervention)
l Experiences of delivering BA (addressing low mood, understanding and explaining BA, areas useful or
struggling with; telephone vs. face-to-face delivery).
l Using the materials (e.g. the nurse handbook and participant handbook, mood diaries, other tools).
l Training (extent to which training was tailored to deliver EPC, any areas needing more input).
l Managing mental health risk issues and care co-ordination.
l Support (feedback on supervision sessions).
l Impact on relationship with patients and perceived mental health role.
l Practicalities (finding space, time to deliver EPC, managing nurses’ workloads).
l Impact of integrating EPC on the existing service on wider team(s) (factors that hinder/help/improve
smooth delivery).
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Appendix 2 Record of enhanced psychological
care delivery
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Session 1 
Session Checklist 
Tick if done 
( ) Space for comments and reﬂecons 
ASSESS THE PATIENT’S MOOD AND RISK 
Ask the paent to ﬁll in a PHQ-9 and GAD-7    
Feedback scores to paent and discuss what 
these mean  
 
PHQ-9 score:                               GAD-7 score: 
 
Discuss thoughts of: life not being worth living 
and harming/neglecng self or others 
Check response on Item 9 of the PHQ 
If appropriate: 
 Ask the standard risk assessment 
quesons 
 Take acon according to level of risk  
 
 
 
Risk assessment: 
Risk to self? (Y/N)                             Risk to others? (Y/N)  
  
If ‘Yes’: 
  Level of risk idenﬁed (A, B1, B2, C): 
  Acon taken: 
DISCUSS LOW MOOD AND TREATMENT OPTIONS 
Discuss low mood and depression 
 
 
 
Explain treatment opons for low mood 
 Supported self-help (Cadence BA book) 
 Consulng their own GP  
 Referral to local IAPT services 
 Referral to specialist psychology services 
 Referral to other services 
 
Paent preference(s): 
 
 
 
INTRODUCE THE SUPPORTED SELF-HELP (CADENCE BA) WORKBOOK – if the paent wishes to try 
this 
Hand the paent the Cadence Paent Pack 
 
Comments/reﬂecons: 
 
 
 
Introduce the Behavioural Acvaon model, talk 
through main secons of the paent workbook 
and the accompanying tools 
 
Explain what happens next 
 Encourage the paent to read workbook 
secons and complete tools at home 
 Refer the paent to the ‘Things to do’ checklist 
 Discuss the self-help book at next appointment 
(or telephone call) 
 
CARE COORDINATION ACTIVITY – if the paent does not wish to try the self-help workbook 
Discuss alternave treatment(s) for low mood 
and take relevant acon – such as:  
Agreed plan and acons taken: 
 
 Connue to monitor the paent’s mood 
 Write to or telephone the paent’s GP  
 Provide informaon for the paent to self-refer 
to local IAPT service, or make a referral yourself 
 
 Arrange a specialist psychological therapy 
referral  
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Supervisor name: 
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Session 2 
 
Session checklist 
Tick if done 
( ) Space for comments and reﬂecons 
RE-ASSESS THE PATIENT’S MOOD AND RISK 
Ask the paent how their mood has been since 
their last appointment. Ask them to ﬁll in a 
PHQ-9 and GAD-7 if they have not already 
done this. 
Feedback scores to paent and discuss what 
these mean, parcularly any changes in scores 
 
PHQ-9 score:                               GAD-7 score: 
 
Discuss thoughts of: life not being worth living 
and harming/neglecng self or others 
Check response on Item 9 of the PHQ 
If appropriate: 
 Ask the standard risk assessment 
quesons 
 Take acon according to level of risk  
 
 
Risk assessment: 
Risk to self? (Y/N)                             Risk to others? (Y/N)  
If ‘Yes’: 
  Level of risk idenﬁed (A, B1, B2, C): 
  Acon taken: 
 
CHECK THE PATIENT’S PROGRESS WITH THE CADENCE SELF-HELP WORKBOOK – if they are trying 
this 
How are they geng on with the BA 
workbook? 
 Which secons have they read? 
 Do they have any quesons about it? 
 How are they feeling about the workbook? 
 
Comments/reﬂecons: 
How are they geng on with the exercises? 
 Mood diary compleon 
 Idenfying links between mood and acvies 
 Acvity scheduling  
 Do they have any quesons about the 
exercises? 
 Do you need to explain anything again? 
  
Agree acons for next session: 
 Encourage the paent to read the workbook  
 Encourage the paent to complete their 
Weekly Acvity Record and their PHQ-9 and 
GAD-7 
 Refer the paent to the ‘Things to do’ checklist  
 Review their progress at next appointment 
 
 
 
 
 
 
CARE COORDINATION ROLE 
Discuss other treatment opons, if 
appropriate.  
Review progress with any self-referrals or 
referrals you have already made. 
 
 
Agreed plan and acons taken: 
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Session 3 
 
Session Checklist 
 
Tick if done 
( ) Space for comments and reﬂecons 
RE-ASSESS THE PATIENT’S MOOD AND RISK 
Ask the paent how their mood has been since their 
last appointment. Ask them to ﬁll in a PHQ-9 and 
GAD-7 if they have not already done this. 
Feedback scores to paent and discuss what these 
mean, parcularly any changes in scores 
 
PHQ-9 score:                               GAD-7 score: 
 
Discuss thoughts of: life not being worth living and 
harming/neglecng self or others 
Check response on Item 9 of the PHQ 
If appropriate: 
Ask the standard risk assessment quesons 
Take acon according to level of risk  
 
Risk assessment: 
Risk to self? (Y/N)                             Risk to others? (Y/N)  
If ‘Yes’: 
  Level of risk idenﬁed (A, B1, B2, C): 
  Acon taken: 
 
CHECK THE PATIENT’S PROGRESS WITH THE CADENCE SELF-HELP WORKBOOK – if they are trying this 
How are they geng on with the BA workbook? 
 Which secons have they read? 
 Do they have any quesons about it? 
 How are they feeling about the workbook? 
 
Comments/reﬂecons: 
How are they geng on with the exercises? 
 Mood diary compleon 
 Idenfying links between mood and acvies 
 Acvity scheduling  
 Do they have any quesons about the exercises? 
 Do you need to explain anything again? 
  
Agree acons for next session: 
 Encourage the paent to read the workbook  
 Encourage the paent to complete their Weekly 
Acvity Record and their PHQ-9 and GAD-7 
 Refer the paent to the ‘Things to do’ checklist 
 Review their progress at next appointment 
  
CARE COORDINATION ROLE 
Discuss other treatment opons, if appropriate.  
Review progress with any self-referrals or referrals 
you have already made. 
 
Agreed plan and acons taken: 
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Session 4 – Formal Review of Progress 
 
Session Checklist 
 
Tick if done 
( ) Space for comments and reﬂecons 
RE-ASSESS THE PATIENT’S MOOD AND RISK 
Ask the paent how their mood has been since 
their last appointment. Ask them to ﬁll in a PHQ-9 
and GAD-7 if they have not already done this. 
Feedback scores to paent and discuss what these 
mean, parcularly any changes in scores 
 
PHQ-9 score:                               GAD-7 score: 
 
Discuss thoughts of: life not being worth living 
and harming/neglecng self or others 
Check response on Item 9 of the PHQ 
If appropriate: 
 Ask the standard risk assessment quesons 
 Take acon according to level of risk 
 
Risk assessment: 
Risk to self? (Y/N)                             Risk to  
others? (Y/N)  
  
If ‘Yes’: 
  Level of risk idenﬁed (A, B1, B2, C): 
  Acon taken: 
REVIEW THE PATIENT’S PROGRESS WITH THE CADENCE SELF-HELP WORKBOOK – if they have 
been trying this 
How is the paent geng on with the BA 
workbook and self-help exercises? 
 Discuss their PHQ-9 and GAD-7 scores and paern 
of symptoms over the last 4 weeks 
 How much of the self-help work has the paent 
engaged in? 
 How much of the workbook have they read? 
 Have they been compleng their mood diary? 
 Have they noced any mood-acvity links? 
 Have they idenﬁed their valued acvies? 
 Have they tried scheduling new acvies? 
 
Comments/reﬂecons: 
Does the paent wish to connue with the self-
help materials? 
Would they prefer to try a diﬀerent strategy?  
If so, see ‘Care Coordinaon Role’ secon below 
 Decision following review and discussion: 
If they wish to connue with self-help, agree 
acons for next session: 
 Encourage the paent to read the workbook  
 Encourage the paent to complete their Weekly 
Acvity Record and their PHQ-9 and GAD-7 
 Refer the paent to the ‘Things to do’ checklist 
 Review their progress at next appointment 
 
 
 
 
 
CARE COORDINATION ROLE 
Discuss other treatment opons, if appropriate.  
Review progress with any self-referrals or 
referrals you have already made. 
 
 
Agreed plan or changes to plan, and acons 
taken: 
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Session 5 
 
 
 
Session Checklist 
 
Tick if done 
( ) Space for comments and reﬂecons 
RE-ASSESS THE PATIENT’S MOOD AND RISK 
Ask the paent how their mood has been since their 
last appointment. Ask them to ﬁll in a PHQ-9 and 
GAD-7 if they have not already done this. 
Feedback scores to paent and discuss what these 
mean, parcularly any changes in scores 
 
 
PHQ-9 score:                               GAD-7 score: 
 
Discuss thoughts of: life not being worth living and 
harming/neglecng self or others 
 
Check response on Item 9 of the PHQ 
 
If appropriate: 
 Ask the standard risk assessment quesons 
 Take acon according to level of risk  
 
Risk assessment: 
Risk to self? (Y/N)                             Risk to others? (Y/N)  
  
If ‘Yes’: 
  Level of risk idenﬁed (A, B1, B2, C): 
  Acon taken: 
 
CHECK THE PATIENT’S PROGRESS WITH THE CADENCE SELF-HELP WORKBOOK – if they are trying this 
How are they geng on with the BA workbook? 
 Which secons have they read? 
 Do they have any quesons about it? 
 How are they feeling about the workbook? 
 
Comments/reﬂecons: 
How are they geng on with the exercises? 
 Mood diary compleon 
 Idenfying links between mood and acvies 
 Acvity scheduling  
 Do they have any quesons about the exercises? 
 Do you need to explain anything again? 
  
Agree acons for next session: 
 Encourage the paent to read the workbook  
 Encourage the paent to complete their Weekly 
Acvity Record and their PHQ-9 and GAD-7 
 Refer the paent to the ‘Things to do’ checklist  
 Review their progress at next appointment 
 
 
 
 
 
CARE COORDINATION ROLE 
Discuss other treatment opons, if appropriate.  
Review progress with any self-referrals or referrals 
you have already made. 
 
Agreed plan and acons taken: 
 Discussion with GP 
 Referral to local IAPT service (self-referral or 
nurse referral) 
 Specialist psychological therapy referral 
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Session 6 
 
 
 
Session Checklist 
 
Tick if done 
( ) Space for comments and reﬂecons 
RE-ASSESS THE PATIENT’S MOOD AND RISK 
Ask the paent how their mood has been since 
their last appointment. Ask them to ﬁll in a PHQ-9 
and GAD-7 if they have not already done this. 
Feedback scores to paent and discuss what these 
mean, parcularly any changes in scores 
 
PHQ-9 score:                               GAD-7 score: 
 
Discuss thoughts of: life not being worth living 
and harming/neglecng self or others 
 
Check response on Item 9 of the PHQ 
 
If appropriate: 
 Ask the standard risk assessment quesons 
 Take acon according to level of risk  
 
Risk assessment: 
Risk to self? (Y/N)                             Risk to others? (Y/N)  
  
If ‘Yes’: 
  Level of risk idenﬁed (A, B1, B2, C): 
  Acon taken: 
CHECK THE PATIENT’S PROGRESS WITH THE CADENCE SELF-HELP WORKBOOK – if they are trying this 
How are they geng on with the BA workbook? 
 Which secons have they read? 
 Do they have any quesons about it? 
 How are they feeling about the workbook? 
 
Comments/reﬂecons: 
How are they geng on with the exercises? 
 Mood diary compleon 
 Idenfying links between mood and acvies 
 Acvity scheduling  
 Do they have any quesons about the exercises? 
 Do you need to explain anything again? 
  
Agree acons for next session: 
 Encourage the paent to read the workbook  
 Encourage the paent to complete their Weekly 
Acvity Record and their PHQ-9 and GAD-7 
 Refer the paent to the ‘Things to do’ checklist 
 Review their progress at next appointment 
 
 
 
 
 
CARE COORDINATION ROLE 
Discuss other treatment opons, if appropriate.  
Review progress with any self-referrals or 
referrals you have already made. 
 
Agreed plan and acons taken: 
 Discussion with GP 
 Referral to local IAPT service (self-referral or 
nurse referral) 
 Specialist psychological therapy referral 
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Session 7 
 
 
 
Session Checklist 
 
Tick if done 
( ) Space for comments and reﬂecons 
RE-ASSESS THE PATIENT’S MOOD AND RISK 
Ask the paent how their mood has been since 
their last appointment. Ask them to ﬁll in a PHQ-9 
and GAD-7 if they have not already done this. 
Feedback scores to paent and discuss what these 
mean, parcularly any changes in scores 
 
PHQ-9 score:                               GAD-7 score: 
 
Discuss thoughts of: life not being worth living 
and harming/neglecng self or others 
 
Check response on Item 9 of the PHQ 
 
If appropriate: 
 Ask the standard risk assessment quesons 
Take acon according to level of risk  
 
Risk assessment: 
Risk to self? (Y/N)                             Risk to others? (Y/N)  
  
If ‘Yes’: 
  Level of risk idenﬁed (A, B1, B2, C): 
  Acon taken: 
CHECK THE PATIENT’S PROGRESS WITH THE CADENCE SELF-HELP WORKBOOK – if they are trying this 
How are they geng on with the BA workbook? 
 Which secons have they read? 
 Do they have any quesons about it? 
 How are they feeling about the workbook? 
 
Comments/reﬂecons: 
How are they geng on with the exercises? 
 Mood diary compleon 
 Idenfying links between mood and acvies 
 Acvity scheduling  
 Do they have any quesons about the exercises? 
 Do you need to explain anything again? 
  
Agree acons for next session: 
 Encourage the paent to read the workbook  
 Encourage the paent to complete their Weekly 
Acvity Record and their PHQ-9 and GAD-7 
 Refer the paent to the ‘Things to do’ checklist 
 Review their progress at next appointment 
 
 
 
 
 
CARE COORDINATION ROLE 
Discuss other treatment opons, if appropriate.  
Review progress with any self-referrals or 
referrals you have already made. 
 
Agreed plan and acons taken: 
 Discussion with GP 
 Referral to local IAPT service (self-referral or 
nurse referral) 
 Specialist psychological therapy referral 
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Session 8 – Final Review 
 
 
Session Checklist 
Tick if done 
( ) Space for comments and reﬂecons 
RE-ASSESS THE PATIENT’S MOOD AND RISK 
Ask the paent how their mood has been since 
their last appointment. 
Ask them to ﬁll in a PHQ-9 and GAD-7 if they have 
not already done this. 
 
PHQ-9 score:                               GAD-7 score: 
 
Discuss thoughts of: life not being worth living 
and harming/neglecng self or others 
Check response on Item 9 of the PHQ 
If appropriate: 
 Ask the standard risk assessment quesons 
 Take acon according to level of risk 
 
Risk assessment: 
Risk to self? (Y/N)                             Risk to others? (Y/N)  
If ‘Yes’: 
  Level of risk idenﬁed (A, B1, B2, C): 
  Acon taken: 
REVIEW THE PATIENT’S PROGRESS 
Review the paent’s PHQ-9 and GAD-7 scores 
today and discuss how these have changed over 
the last 8 weeks – these may have improved, 
stayed the same, or deteriorated. 
 
Comments/reﬂecons: 
If the paent scores below 10 on the PHQ-9 and 
below 8 on the GAD-7: 
 Advise the paent to connue their self-help 
Behavioural Acvaon work if this has 
worked for them 
  
If the paent scores 10 or more on the PHQ-9 
and/or 8 or more on the GAD-7, but they have 
improved by 50% or more on both measures since 
Session 1: 
 Advise the paent to connue their self-help 
Behavioural Acvaon work if this has 
worked for them 
 Discuss whether they would like to receive  
any addional specialist help (see ‘Care 
Coordinaon Role’ secon) 
  
If the paent scores have improved only slightly 
(i.e. by less than 50% and/or less than 3 points on 
the PHQ-9 or GAD-7) since Session 1: 
 Discuss the possibility of addional specialist 
help (see ‘Care Coordinaon Role’ below) 
 If the paent wishes to discuss medicines 
with their GP, encourage them to do this. 
  
If the paent’s scores on the PHQ-9 or GAD-7 have 
not changed (i.e. their scores remain within 3 
points of those they ﬁlled in at Session 1): 
 Encourage the paent to discuss medicines 
with their GP 
 Discuss the possibility of addional specialist 
help (see ‘Care Coordinaon Role’ secon) 
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If the paent’s scores on the PHQ-9 or GAD-7 have 
deteriorated by 3 or more points since Session 1, 
and parcularly if they move into the severe 
depression range (PHQ-9 score of 20 or more): 
 Consider referral to specialist psychological 
therapy 
 Discuss this with your designated Cadence 
Clinical Supervisor as soon as possible 
 Inform the paent’s GP 
  
CARE COORDINATION ROLE 
Discuss other treatment opons, if appropriate.  
Review progress with any self-referrals or 
referrals you have already made. 
Agreed plan and acons taken: 
 Discussion with GP 
 Referral to local IAPT service (self- or nurse 
referral) 
 Specialist psychological therapy referral 
  
DISCHARGE LETTER – UPDATE THE PATIENT’S GP 
Write to the paent’s GP at the end of their 
Cadence Programme, explaining: 
 What has happened 
 How their paent has progressed 
 Any plans for further input from specialists. 
 
 
Clinical supervision notes 
Supervisor name: 
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Appendix 3 Pilot study: session plan for nurses
delivering enhanced psychological care within a
cardiac rehabilitation programme
F irst cardiac rehabilitation session: explain to participant the options available, that is, supported self-helpBA manual, with or without onward referral to relevant mental health-care services, depending on
individual preferences. Agree mental health treatment plan and take relevant action. This might include:
l agreeing to discuss the self-help BA book next time you meet (or arranging a special follow-up
telephone appointment)
l writing to or telephoning the patient’s GP
l giving out details of the local IAPT service or making a referral yourself
l arranging a specialist cardiac psychological therapy referral.
All remaining sessions: content tailored depending on whether the participant has decided to follow
self-help BA manual. These sessions can be brief depending on patient progress.
l Care co-ordination only. Review mood since last appointment, using PHQ-9 and GAD-7 if preferred.
Check that the patient’s mood is not deteriorating further, that they are safe and to see if the action
you agreed with the patient to take has been followed up (i.e. did the participant make the GP
appointment?).
l Self-help BA manual. At each session assess symptoms and risk, review treatment choices, support BA,
and future planning. BA support is aimed at helping participants to engage with the self-help manual,
explaining ideas and methods as required.
At the mid-point (around 4 weeks) dedicated clinic time should be allocated to reviewing progress and
carefully review treatment options.
At the final session (around weeks 6–8) dedicated time should be allocated to reviewing progress, and
structured details of the care received will be sent to their GP. Participants failing to respond to self-help
BA will be referred on to their preferred management option.
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5
Q
uick
guide
for
nurses
referring
patients
to
the
research
team
Who is eligible for the study? 
‘YES’    ‘NO’    
Adults (age 18 or over) who meet ALL of these criteria 
may be eligible for the study: 
 
Patients who meet ONE OR MORE of these criteria cannot 
be included in the study: 
 
• Is eligible to attend an NHS cardiac rehabilitation programme  
(hospital- or community-based) 
 
• Scores 10 or over on the Patient Health Questionnaire (PHQ-
9) at their initial assessment in the community 
 
 
IF THE PATIENT IS ELIGIBLE SO FAR ... 
 
Please now check the ‘NO’ column too   
 
• Was being actively treated for depression (psychological or drug 
therapy) during the 6 months preceding their acute cardiac event 
• Is actively suicidal – i.e. currently reports intentions of imminent  
suicide or self-harm (categorised as ‘Level C’ using the study self-
harm protocol questions) 
• Has major alcohol or drug dependency problems 
• Has poorly controlled symptoms of bipolar disorder or psychosis 
• Does not have sufficiently good communication skills to engage 
with psychological therapy and research consent processes, even 
with the support of an interpreter (for non-English speakers). 
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How do I refer an eligible patient to the study team? 
• It should only take a short amount of your time to introduce the study!  
• You will find copies of all the necessary study leaflets and forms in your referral folder (see guidance overleaf) 
• If you need more paperwork, or have any questions about the referral process, please telephone us on XXX.  
If the patient meets the eligibility criteria for the Cadence Study and has accepted a local cardiac rehabilitation programme … 
1. Please follow the steps shown in Section 4 of your referral folder to briefly introduce the study to the patient. 
2. If the patient is happy to speak to a researcher to find out more about the Cadence Study, please use the referral paperwork in Section 4. 
 
If the patient meets the eligibility criteria for Cadence but he/she has: 
(i) declined cardiac rehabilitation; OR  
(ii) accepted cardiac rehabilitation but declined trial entry … 
1. Please follow the steps shown in Section 5 of your referral folder to briefly introduce the qualitative study to the patient. 
2. If the patient is happy to speak to a researcher to find out more about taking part in an in-depth interview, please use the referral paperwork in 
Section 5. 
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If the patient accepts cardiac rehabilitation and is eligible for the study: 
STEP 
1 
Ask the patient: would he/she consider taking part in the Cadence Study?                    
 (Hand the patient a copy of the ‘Cadence Study Patient information leaflet’) 
                                                       ‘YES’     
STEP 
2 
If the patient  IS  interested in finding out more about the Cadence Study: 
 Complete the ‘Nurse referral form’ yourself 
 AND 
  
Ask the patient to complete the ‘Permission to release personal details form’ 
  Explain that the researcher will contact the patient  
by telephone (in the next few days) to explain the study 
in more detail and answer any questions they have 
  
STEP 
3 Fax copies of BOTH completed forms to the Cadence team on XXX  
  
STEP 
4 
Record details of your approach to the patient 
on the ‘Screening Log Sheet’ and in your nursing notes 
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Appendix 6 Baseline patient questionnaire
 
 
 
 
 
 
Trial ID 
 
    
   
 
BASELINE QUESTIONNAIRE 
(Pilot trial phase: Baseline assessment) 
 
 There is no need to write your name on the questionnaire 
 Please take your time and read each of the questions carefully 
 If you are unsure about how to answer a question, please give the best 
answer you can 
 There are no ‘right’ or ‘wrong’ answers –  please answer as honestly as 
you can 
 Ask the researcher if you need any help 
 
 
Thank you 
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Section 1: 
About You 
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This section asks some questions about you. Your answers will only be used 
for the purposes of this study. 
1.  What gender (sex) are you?                                                      (Please tick one box)  
 
Male 
 
Female 
 
2.  How old are you?                                         (years)  
3.  What is your ethnic group? 
Please choose one section from A to E, and then tick the appropriate box to indicate your cultural background.   
A. White 
 
  British 
  Irish 
  Any other White background 
         (please write in) 
 
B. Mixed 
 
  White and Black Caribbean 
  White and Black African 
  White and Asian 
  Any other Mixed background 
        (please write in) 
C. Asian or Asian British 
 
  Indian 
  Pakistani 
  Bangladeshi 
  Any other Asian background 
        (please write in) 
D. Black or Black British 
 
  Caribbean 
  African 
  Any other Black background 
         (please write in) 
 
E. Chinese or other ethnic group 
  Chinese 
  Any other – please write in 
 
 
4.  What is your preferred language? 
 English  
 Other (please specify)  
 
5.    Which of the following best describes your current situation with regard to 
       smoking?  (Please tick one box) 
        
 I have never smoked (Please go on to the next page) 
 
 I am an ex-smoker (Please go to Question 6 below) 
 I am a smoker (cigarettes, cigars or pipe) (Please go to Question 7 below) 
 
 
6.   If you are an ex-smoker, when did you quit smoking? 
Date you quit smoking:  
 (Please go on to Section 2 on the next page) 
 
 
7.   If you are a current smoker, how much do you smoke? 
Number of cigarettes per day  
Number of cigars per day  
Pipe – ounces or grams of tobacco per week  
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Section 2: 
Your current state of health
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 DUE TO COPYRIGHT RESTRICTIONS WE ARE UNABLE TO 
REPRODUCE THESE QUESTIONNAIRES IN THIS APPENDIX 
 
 EQ-5D-5L – this includes five different statements about health status 
TODAY, with respondents given the opportunity to rate them on one of 
five levels. 
 
 EQ-VAS – this includes a visual analogue scale (0–100) regarding how 
good or bad your health status is TODAY. 
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Section 3: Your emotional health 
 
 
 
This section asks about different aspects of your emotional or mental health over 
recent weeks (including today). It includes three pre-printed questionnaires: 
 
DUE TO COPYRIGHT RESTRICTIONS WE ARE UNABLE TO 
REPRODUCE THESE QUESTIONNAIRES IN THIS APPENDIX 
 
 BDI-II – this includes 21 different groups of statements and you need to 
pick one statement from each group that best describes how you have 
been feeling during the past two weeks. 
 
 BAI – this includes 21 different symptoms and you need to indicate how 
much you have been bothered by each symptom during the past week. 
 
 BADS-SF – this includes 9 different statements and you need to indicate 
how much each statement has been true for you in the past week. 
 
Please follow the instructions on each questionnaire – if you are not sure what 
to do or need help filling in the answers, please ask the researcher. 
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Section 4: 
Looking after your emotional health 
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1.  Do you believe that you have low mood?  
 
Yes
 
 
 
No
 
 
 
If you answered ‘Yes’ to Question 1, please answer Questions 2 and 3 below and Questions 4 
to 7 on the next page.  
 
If you answered ‘No’ to Question 1, please answer move on to Section 5 (Page 21). 
 
We would like to know about your preferences for dealing with your low mood. We would 
also like to know how strongly you hold these preferences. 
Please tick one option for each question 
 
2.  At this stage in your recovery, do you want any professional help for your low mood? 
 I would strongly prefer to receive some form of help for my low mood   
 I would prefer to receive some form of help for my low mood  
 I would prefer not to receive any help for my low mood at this stage –  
I would prefer to see if the symptoms resolve naturally  
 I would strongly prefer not to receive any help for my low mood at this stage – 
I would strongly prefer to see if the symptoms resolve naturally  
 
If you were to seek treatment for your low mood at this stage: 
 
3.  What TYPE of professional help would you prefer?  
 I would strongly prefer help that is not drug-based (such as a talking therapy)  
 I would prefer help that is not drug-based (such as a talking therapy)  
 I would prefer a drug-based treatment  
 I would strongly prefer a drug-based treatment  
 I don’t mind what type of help I receive  
 
We would like to know whether you are receiving any help or treatment for your low mood. 
1. Are you currently taking any anti-depressant medication (medicine to help with low mood)? 
 Yes Please go to Question 5 
 No Please go to Question 7 
 Not sure Please go to Question 7 
 
2. Is your medicine for low mood prescribed by a qualified doctor? 
 Yes 
 No 
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 3. For how long have you been taking your medicine for low mood? 
 Less than 6 weeks 
 6 weeks to 3 months 
 More than 3 months 
4. Within the past 6 months, have you received any help for your low mood from:  
please tick all that apply) 
 Your general practitioner (GP) 
 A hospital doctor or psychiatrist 
 A therapist (such as a psychotherapist, CBT counsellor, psychologist, nurse or 
support worker) 
 Another health or social care professional (please specify below) 
 I have not received any help for my low mood 
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Section 5: 
Your heart problem and how this affects you 
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Below is a list of common heart problems and heart-related procedures.  
Please work down the list and, for each problem/procedure in turn, circle ‘No’ or 
‘Yes’ in Column A to say whether you have ever been told by a doctor or nurse that 
you have had that heart problem or procedure.  
If you don’t know whether you have had a problem or procedure or not, please circle 
‘Not sure’. If you would like help to decide, please ask the researcher.  
If you think you have had a problem or procedure, please tell us in Column B when 
this happened. If you know the month and year, please write that in. If you cannot 
remember the exact month and year, please give your best guess of how long ago it 
happened (e.g. ‘3 months ago’). 
 
 Column A Column B 
Heart problem or procedure 
Have you ever had 
this heart problem or 
procedure? 
If ‘Yes’, 
when did 
this 
happen? 
Myocardial infarction (‘heart attack’) No Yes Not sure  
Angina No Yes Not sure  
Hospital admission with non-cardiac chest pain 
(‘non-heart’ chest pain)  No Yes 
Not 
sure  
Heart failure  No Yes Not sure  
Arrhythmia   
(‘slow, fast and/or irregular heart beat’) No Yes 
Not 
sure  
Percutaneous Coronary Intervention or PCI  
(‘balloon inflation of artery’, with or without a 
‘stent’) 
No Yes Not sure  
Coronary Artery Bypass Grafting or CABG  
(‘heart bypass’) No Yes 
Not 
sure  
Valve surgery No Yes Not sure  
Any other heart problem or procedure 
(please specify below) No Yes 
Not 
sure
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Section 6: 
Other health problems 
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Below is a list of common health problems. Please work down the list and, for each 
health problem in turn, circle ‘Yes’ or ‘No’ to indicate whether you currently have 
that problem.  
If you do have a particular health problem, please indicate: (a) whether you receive 
medication or some other type of treatment for the problem; and (b) whether the 
problem limits any of your activities.  
 
Problem 
Do you have 
this health 
problem? 
 If you do have this health problem: 
 Do you receive 
treatment for it? 
 Does it limit 
your activities? 
Asthma No Yes  No Yes  No Yes 
Lung disease,                 
(including chronic obstructive 
pulmonary disease or COPD) 
No Yes  No Yes  No Yes 
High blood pressure No Yes  No Yes  No Yes 
Diabetes No Yes  No Yes  No Yes 
Ulcer or stomach disease No Yes  No Yes  No Yes 
Bowel disease No Yes  No Yes  No Yes 
Kidney disease No Yes  No Yes  No Yes 
Liver disease No Yes  No Yes  No Yes 
Anaemia or other blood 
disease 
No Yes  No Yes  No Yes 
Cancer No Yes  No Yes  No Yes 
Nervous system disease       
(e.g. epilepsy, Parkinson’s, 
dementia) 
No Yes  No Yes  No Yes 
Arthritis No Yes  No Yes  No Yes 
Back pain No Yes  No Yes  No Yes 
Mental health problems No Yes  No Yes  No Yes 
Skin disease                          
(e.g. psoriasis) No Yes  No Yes  No Yes 
Hearing or visual 
impairment No Yes  No Yes  No Yes 
Any other health problems (please write in) 
 For each health problem you list: 
 Do you receive 
treatment for it? 
 Does it limit 
your activities? 
  No Yes  No Yes 
  No Yes  No Yes 
  No Yes  No Yes 
  No Yes  No Yes 
  No Yes  No Yes 
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You have now reached the end of the study questionnaire. 
 
Thank you for completing the information. 
APPENDIX 6
NIHR Journals Library www.journalslibrary.nihr.ac.uk
162
Appendix 7 Standard operating procedure for
adverse event reporting
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Appendix 8 Five-month follow-up patient
questionnaire
 
 
 
 
Trial ID 
 
 
 
     
    
 
 
 
 
 
 
FOLLOW-UP QUESTIONNAIRE 
 
(Pilot trial phase: 5 month follow-up) 
 
 There is no need to write your name on the questionnaire 
 Please take your time and read each of the questions carefully 
 If you are unsure about how to answer a question, please give the best 
answer you can 
 There are no ‘right’ or ‘wrong’ answers –  please answer as honestly as 
you can 
 Ask the researcher if you need any help 
 
Thank you 
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Section 1: 
 
About You 
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This section asks some questions about you. Your answers will only be used 
for the purposes of this study. 
 
1.  What gender (sex) are you?                                                 (Please tick one box) 
 Male  Female 
 
2.  How old are you?                                         (years)  
 
3.    Which of the following best describes your current situation with regard to  
       smoking?  (Please tick one box) 
       
 
I have never smoked (Please go on to the next page) 
 
 
I am an ex-smoker (Please go to Question 4 below) 
 
 
I am a smoker (cigarettes, cigars or pipe) (Please go to Question 5 below) 
 
4.   If you are an ex-smoker, when did you quit smoking? 
Date you quit smoking:  
  
(Please go on to Section 2 on the next page) 
 
5.   If you are a current smoker, how much do you smoke? 
Number of cigarettes per day 
 
Number of cigars per day 
 
Pipe – ounces or grams of tobacco per week 
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Section 2: 
Your current state of health 
 
This section asks for your views on your current state of health. Under each 
heading, please tick the ONE box that best describes your health TODAY. 
 
DUE TO COPYRIGHT RESTRICTIONS WE ARE UNABLE TO 
REPRODUCE THESE QUESTIONNAIRES IN THIS APPENDIX 
 
 EQ-5D-5L – this includes five different statements about health status 
TODAY, with respondents given the opportunity to rate them on one of 
five levels. 
 
 EQ-VAS – this includes a visual analogue scale (0–100) regarding how 
good or bad your health status is TODAY. 
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Section 3: Your emotional health 
 
 
 
This section asks about different aspects of your emotional or mental health over 
recent weeks (including today). It includes three pre-printed questionnaires:   
 
DUE TO COPYRIGHT RESTRICTIONS WE ARE UNABLE TO 
REPRODUCE THESE QUESTIONNAIRES IN THIS APPENDIX 
 
 BDI-II – this includes 21 different groups of statements and you need to 
pick one statement from each group that best describes how you have 
been feeling during the past two weeks. 
 
 BAI – this includes 21 different symptoms and you need to indicate how 
much you have been bothered by each symptom during the past week. 
 
 BADS-SF – this includes 9 different statements and you need to indicate 
how much each statement has been true for you in the past week. 
 
Please follow the instructions on each questionnaire – if you are not sure what 
to do or need help filling in the answers, please ask the researcher. 
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We would like to know whether you are receiving any help or treatment 
for low mood. 
1. Are you currently taking any anti-depressant medication 
(medicine to help with low mood)? 
 Yes Please go to Question 2 
 No Please go to Question 4 
 Not sure Please go to Question 4 
 
2. Is your medicine for low mood prescribed by a qualified doctor? 
 Yes 
 No 
 
3. For how long have you been taking your medicine for low mood? 
 Less than 6 weeks 
 6 weeks to 3 months 
 More than 3 months 
 
4. Within the past 6 months, have you received any help for low 
mood from: (please tick all that apply) 
 Your general practitioner (GP) 
 A hospital doctor or psychiatrist 
 A therapist (such as a psychotherapist, CBT counsellor, psychologist, 
nurse, or support worker) 
 Another health or social care professional (please specify below) 
  
 I have not received any help for my low mood 
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Section 4: 
Your heart problem and how this affects you 
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Below is a list of common heart problems and heart-related procedures.  
Please work down the list and, for each problem/procedure in turn, circle ‘No’ 
or ‘Yes’ in Column A to say whether you have ever been told by a doctor or 
nurse that you have had that heart problem or procedure.  
If you don’t know whether you have had a problem or procedure or not, please 
circle ‘Not sure’. If you would like help to decide, please ask the researcher. 
If you think you have had a problem or procedure, please tell us in Column B 
when this happened. If you know the month and year, please write that in. If 
you cannot remember the exact month and year, please give your best guess 
of how long ago it happened (e.g. ‘3 months ago’). 
 Column A Column B 
Problem or procedure 
Have you ever 
had this heart 
problem or 
procedure? 
If ‘Yes’, 
when did 
this 
happen? 
Myocardial infarction 
(‘heart attack’) No Yes 
Not 
sure  
Angina No Yes Not sure  
Hospital admission with non-cardiac chest pain 
(‘non-heart’ chest pain)  No Yes 
Not 
sure  
Heart failure  No Yes Not sure  
Arrhythmia  
(‘slow, fast and/or irregular heart beat’) No Yes 
Not 
sure  
Percutaneous Coronary Intervention or PCI 
(‘balloon inflation of artery’, with or without a 
‘stent’) 
No Yes Not sure  
Coronary Artery Bypass Grafting or CABG  
(‘heart bypass’) No Yes 
Not 
sure  
Valve surgery No Yes Not sure  
Any other heart problem or procedure 
(please specify below)  
No Yes Not sure  
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Section 5: 
Other health problems 
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Below is a list of common health problems. Please work down the list and, for 
each health problem in turn, circle ‘Yes’ or ‘No’ to indicate whether you 
currently have that problem. If you do have a particular health problem, 
please indicate: (a) whether you receive medication or some other type of 
treatment for the problem; and (b) whether the problem limits any of your 
activities.  
 
Problem 
 
Do you have 
this health 
problem? 
 If you do have this health 
problem: 
 Do you 
receive 
treatment for 
it? 
Does it limit 
your 
activities? 
 
Asthma No Yes  No Yes No Yes 
Lung disease, including 
chronic obstructive 
pulmonary disease 
No Yes  No Yes No Yes 
High blood pressure No Yes  No Yes No Yes 
Diabetes No Yes  No Yes No Yes 
Ulcer or stomach 
disease No Yes  No Yes No Yes 
Bowel disease No Yes  No Yes No Yes 
Kidney disease No Yes  No Yes No Yes 
Liver disease No Yes  No Yes No Yes 
Anaemia or other blood 
disease No Yes  No Yes No Yes 
Cancer No Yes  No Yes No Yes 
Nervous system disease   
(e.g. epilepsy, 
Parkinson’s, dementia) 
No Yes  No Yes No Yes 
Arthritis No Yes  No Yes No Yes 
Back pain No Yes  No Yes No Yes 
Mental health problems No Yes  No Yes No Yes 
Skin disease (e.g. 
psoriasis) No Yes  No Yes No Yes 
Hearing or visual 
impairment No Yes  No Yes No Yes 
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In this section, please list any other health problems you have that are not 
already included in the lists on the previous pages... 
 
 
Any other health problems (please write in) 
 For each health problem you 
list: 
 Do you 
receive 
treatment for 
it? 
Does it limit 
your 
activities? 
  No Yes No Yes 
  No Yes No Yes 
  No Yes No Yes 
  No Yes No Yes 
  No Yes No Yes 
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Section 6:  
Your experience of cardiac rehabilitation 
services 
 
In this section, we would like to hear your views of the care you 
received from your local NHS cardiac rehabilitation service 
during the last 5 months (after you left hospital following your heart 
attack or heart procedure). 
 
In this section, there is: 
 
 A pre-printed ‘Client Satisfaction Questionnaire (CSQ-8) – 
this includes 8 questions and you need to circle one answer 
for each question. Please give us your honest opinions about 
the care you received from your local cardiac rehabilitation 
service. 
 
 The NHS ‘Friends & Family Test’ questions – these focus 
specifically on any help you received for your mood or 
emotional health as part of your cardiac rehabilitation 
programme. 
 
Please follow the instructions on each sheet – if you are not sure 
what to do or need help filling in the answers, please ask the 
researcher. 
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Now, we would like you to think about any help or support you 
received to help with your mood or emotional health as part of 
your NHS cardiac rehabilitation programme. 
 
How likely are you to recommend this help or support to friends and family, if 
they needed similar care or treatment? 
 
 
 Extremely likely 
 Likely 
 Neither likely nor unlikely 
 Unlikely 
 Extremely unlikely 
 Don’t know 
 OR 
 I did not receive any help or support for my mood or emotional health as part of my cardiac rehabilitation programme 
 
What was good about your experience? 
 
 
 
 
 
What would have made your experience better? 
 
 
 
 
 
 
 
Thank you for completing these questions.  
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Section 7: 
Other services you have used 
 
 
Finally, the researcher would like to ask you some questions about 
any other services you may have received during the last 5 
months. 
 
Please let the researcher know that you have reached this section 
of the questionnaire. 
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Date: _______________           Trial ID: _____________________   
Instructions 
 
This schedule should be completed in interview with the service user. 
 
The schedule covers the respondent’s use of all services, excluding cardiac 
rehabilitation: 
 
-  At 5-month follow-up, ask about use of services since the 
baseline interview 
 
Please tell the patient that you want to know about their use of all services 
except the study interventions – cardiac rehabilitation and Cardiac 
Nurse-provided Behavioural Activation.  
 
Use circles to select options from lists. 
 
Numbers, zeros or missing data codes should be placed in every cell. 
 
Trial ID  
 
Date of interview: dd mm 20 yy 
 
Period(s) covered (tick all that 
apply) Exact dates included in this schedule: 
 
Starting: 
 
Ending: 
Baseline to  
5-month follow-up 
 
 
555 Not applicable 
666 Research worker unable to evaluate 
999 Not completed  
 
Code missing data as follows:
DOI: 10.3310/hta22300 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 30
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Richards et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
185
Section A: Hospital Services 
A1 – Have you stayed in a hospital overnight since you were last interviewed, about  
5 months ago? 
 
1 Yes Go to A2 
0 No Go to A3 
666 Research worker unable to evaluate Go to A3 
999 Not completed  Go to A3 
 
A2 – If yes, record details below 
 
Reason for hospital stay? Type of hospital ward  (if known) Number of nights 
 
 
 
 
 
A3 – Have you been to hospital for an outpatient/day patient appointment since you 
were last interviewed (about 5 months ago)? 
 
1 Yes Go to A4 
0 No Go to A5 
666 Research worker unable to evaluate Go to A5 
999 Not completed  Go to A5 
 
A4 - If yes, record details below 
 
Reason for hospital appointment(s) Hospital department Seen by Consultant? 
Number of 
appointments 
  Yes/no  
  Yes/no  
  Yes/no  
  Yes/no  
 
A5 – Have you visited an Accident and Emergency (A&E) department, NHS walk-in 
centre or used other urgent advice or treatment services, since you were last 
interviewed (about 5 months ago)? 
 
1 Yes Go to A6 
0 No Go to B1 
666 Research worker unable to evaluate Go to B1 
999 Not completed  Go to B1 
 
A6 - If yes, record details below 
 
Service used (A&E, 
NHS Walk-in, 111 call) Reason for seeking urgent care 
Attended or 
phone call Ambulance 
Number of 
times used 
  Yes/no Yes/no  
  Yes/no Yes/no  
  Yes/no Yes/no  
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Section B: Community-based health, social and complementary services 
 
B - Which of the following community-based professionals or services have you had 
contact with (since you were last interviewed about 5 months ago? 
 
  Number of 
contacts 
Average 
duration in 
minutes per 
contact 
Did you have to pay 
for these 
contact/visits 
yourself? 
If Yes, how much per 
contact (£) 
1 General practitioner – at the surgery    
2 General practitioner – at your home    
3 General practitioner – telephone  advice/call    
4 Practice nurse (nurse seen in GP surgery)    
5 District nurse, health visitor    
6 Community psychiatric nurse in the community    
7 Psychiatrist in the community    
8 Occupational therapist in the community    
9 
Other therapist or counsellor? 
 please state what type: 
  
 
10 Social worker    
11 Marriage counselling service e.g. Relate    
12 Advice service e.g. Citizen’s Advice Bureau    
13 Helpline e.g. Samaritans, MIND    
14 Day centre/drop-in centre    
15 Chiropractor/osteopath    
16 Acupuncture    
17 Other – give details:    
18 Other – give details:    
19 Other – give details:    
 
NB. Have a ‘flash card’ to hand to the interviewee with these printed on 
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Section C: Medication for mental health problems 
C1 – Have you been prescribed any medication for mental health problems since you were last interviewed 
about 5 months ago? Include e.g. medications for depression, anxiety, psychosis, and sleep problems.      
1 Yes Go to C2 
0 No Go to D1 
666 Research worker unable to evaluate Go to D1 
999 Not completed  Go to D1 
 
C2 – If yes, record details below 
Name of 
the 
medication 
(use codes – 
see over; 
or details if 
code= ‘other’) 
Dose
* 
Units 
(use code) 
Frequency 
(use code) 
Was this 
medication 
prescribed 
to you? 
Has the 
medication 
been 
dispensed?
** 
Have you 
started 
taking the 
medication? 
Date 
Started 
Continuing at 
interview? 
Date 
Stopped 
e.g. 5 80 1 2 Yes Yes Yes 01/04/2007 Yes 555 - NA 
    Yes/no Yes/no Yes/no  Yes/no  
    Yes/no Yes/no Yes/no  Yes/no  
    Yes/no Yes/no Yes/no  Yes/no  
* For current medication ask for current dose; for medication no longer taken ask for final dose.  
** Has the patient actually collected (or received) the medication from their pharmacy – i.e. have they ‘cashed in’ 
their prescription? 
 
Section D: Your employment and time off work 
FIRSTLY, THINKING ABOUT YOUR SITUATION BEFORE YOUR CARDIAC EVENT OR 
DIAGNOSIS …   
D1 – What was your employment status before you had your cardiac-related event or diagnosis?  
1 Full-time employment (30+ hours per week) Go to D2 7 Voluntary worker Go to D3 
2 Part-time employment (<30 hours per week) Go to D2 8 Unemployed & looking for work Go to D3 
3 Employed but unable to work Go to D2 9 Unemployed & not looking for work (e.g. housewife) Go to D3 
4 Part-time employment & part-time student Go to D2 10 Unemployed & unable to work for medical reasons Go to D3 
5 Full-time student Go to D3 11 Medically retired Go to D3 
6 Part-time student Go to D3 12 Retired  Go to D3 
666 Research worker unable to evaluate Go to D3    
999 Not completed  Go to D3    
 
D2 – How many HOURS did you normally work during a typical working week? 
 
1 Hours Number of hours 
666 Research worker unable to evaluate  
999 Not completed  
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NOW, THINKING ABOUT HOW THINGS ARE TODAY …  
 
D3 – What is your CURRENT employment status? 
1 Full-time employment (30+ hours per week) Go to D4 7 Voluntary worker Go to D8 
2 Part-time employment (<30 hours per week) Go to D4 8 Unemployed & looking for work Go to D8 
3 Employed but currently unable to work Go to D7 9 Unemployed & not looking for work (e.g. housewife) Go to D8 
4 Part-time employment & part-time student Go to D4 10 Unemployed & unable to work for medical reasons Go to D8 
5 Full-time student Go to D8 11 Medically retired Go to D8 
6 Part-time student Go to D8 12 Retired  Go to D8 
666 Research worker unable to evaluate Go to D8    
999 Not completed  Go to D8    
 
D4 – If you ARE currently working, how many HOURS PER WEEK do you work? 
 Number of hours currently working per week Number of hours Go to D5 
 555 Not applicable (not currently working)   
 666 Research worker unable to evaluate   
999 Not completed   
 
D5 – On what date did you RETURN to work? 
 Date returned to work DD/MM/YYYY Go to D6 
 555 Not applicable (not currently working)   
 666 Research worker unable to evaluate   
999 Not completed   
 
D6 – Did you return to the SAME working pattern as previously, or to a DIFFERENT 
working pattern? 
1 Returned to the same working pattern  as before the cardiac event Yes/no Go to D7 
2 Returned permanently to fewer hours per week Yes/no  
3 Had a phased or graded return to work? Yes/no  
 
If you had a phased or graded return to work, please can you describe this in more 
detail: 
 
 Number of hours worked 
per week For how many weeks? 
 e.g. 15 hours e.g. 4 weeks 
Initially   
then   
then   
then   
 
Note to interviewer:  
Please ask the patient 
to talk through their 
phased or graded 
return to work. 
 
 
 
Go to D7 
 555 Not applicable (not currently working)   
 666 Research worker unable to evaluate   
999 Not completed   
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D7 – If you have been ABSENT from work in the last 5 months, how many of these 
absence days would you say were mainly due to mental health (mood) problems? 
 
1 Days Number of days 
666 Research worker unable to evaluate  
999 Not completed  
 
 
D8 – In total, How many DAYS have OTHERS IN YOUR FAMILY had to be absent from 
work due to YOUR ILL HEALTH since you were last interviewed about 5 months ago? 
 
1 Days Number of days  
 666 Research worker unable to evaluate  
999 Not completed  
 
 
Section E: Your feedback about this interview about your service use 
and employment 
E1 – Thinking about the questions just asked - about your use of health services and 
other professionals - were there any particular questions which you found unclear, or 
very difficult to answer? 
 
Please tell us which ones and why? 
 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
 
E2 – Are there any other services or professionals that you have seen due to your 
health which this questionnaire has not asked about? 
 
If ‘Yes’, which services or professionals? 
…………………………………………………………………………………………
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………………………………………………………………………… 
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CODES for medication question 
 
 Antidepressants  Antipsychotics (cont'd) 
1 Agomelatine/valdoxan 41 Benperidol/Anquil 
2 Amitriptyline/Triptafen 42 Chlorpromazine hydrochloride/Largactil 
3 Amoxapine/Asendis 43 Clozapine/Clozaril/Denzapine/Zaponex 
4 Citalopram/Cipramil 44 Flupentixol/Depixol/Fluanxol 
5 Clomipramine 45 Haloperidol/Dozic/Haldol/Serenace 
6 Dosulepin/Dothiepin/Prothiaden 46 Levomepromazine/Nozinan 
7 Doxepin/Sinequan/Sinepin 47 Olanzapine/Zyprexa 
8 Duloxetine/Cymbalta/Yentreve 48 Paliperidone/Invega 
9 Escitalopram/Cipralex 49 Pericyazine 
10 Fluoxetine/Prozac 50 Perphenazine/Fentazin 
11 Flupentixol/Fluanxol/Depixol 51 Pimozide/Orap 
12 Fluvoxamine/Faverin 52 Prochlorperazine 
13 Imipramine/Tofranil/Triptafen 53 Promazine 
14 Isocarboxazid 54 Qeutiapine/Seroquel 
15 Lofepramine/Gamanil/Feprapax/Lomont 55 Resperidone/Risperdal 
16 Maprotiline/Ludiomil 56 Sulpiride/Dolmatil/Sulpol 
17 Mianserin 57 Trifluoperazine/Stelazine 
18 Mirtazepine/Zispin 58 Zuclopenthixol acetate/Clopixol acuphase 
19 Moclobemide/Manerix 59 Zuclopenthixol/Clopixol 
20 Nortriptyline/Allegron/Motival 60 Other antipsychotic (please specify) 
21 Paroxetine/Seroxat  Sleeping tablets/medication for anxiety 
22 Phenelzine/Nardil 61 Alprazolam 
23 Reboxetine/Edronax 62 Buspirone/Buspar 
24 Sertraline/Lustral 63 Chloral hydrate/welldorm 
25 Tranylcypromine 64 Chlorazepate/Tranxene 
26 Trazodone/Molipaxin 65 Chlordiazepoxide 
27 Trimipramine/Surmontil 66 Clomethiazole/Heminevrin 
28 Tryptophan/optimax 67 Diazepam 
29 Venlafaxine 68 Flurazepam/Dalmane 
30 Venlafaxine XR 69 Loprazolam 
31 Other antidepressant (please specify) 70 Lorazepam 
 Mood stabilizers 71 Lormetazepam 
32 Carbamazepine/Tegretol 72 Meprobamate 
33 Lamotrigine/Lamictal 73 Nitrazepam 
34 Lithium carbonate/Comcolit, Liskonum 74 Oxazepam 
35 Lithium citrate/Li-Liquid, Priadel 75 Temazepam 
36 Valproate/Depakote, Convulex 76 Triclofos sodium 
37 Other mood stabilizer (please specify) 77 Zaleplon/Sonata 
 Antipsychotics 78 Zolpidem/Stilnoct 
38 Aripiprazole/Abilify 79 Zopiclone/Zimovane 
39 Amisulpride/Solian 80 Other sleeping tablet/medication for anxiety (please specify) 
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Units 
 
1 Milligrams (mg) 6 Inhalers 
2 Microgram (mcg) 7 Bottles 
3 Grams (g) 8 Packs 
4 Millilitres (ml) 9 Other – give details 
5 Tubs/tubes   
 
Frequency 
 
1 Once daily 7 As needed, about three times a week 
2 Twice daily 8 As needed, about twice a week 
3 Three times daily 9 As needed, about once a week 
4 Four times daily 10 As needed, about once a fortnight 
5 Once weekly 11 As needed, about once a month 
6 Once per fortnight 12 Other – give details 
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Appendix 9 Trial Steering Committee paper
reviewing participant recruitment
A review of participant recruitment and sample size in light of feasibility
study findings: implications for the pilot RCT
HTA CADENCE study: enhancing psychological care in cardiac rehabilitation services [ISRCTN 34701576].
Authors: Dr Suzanne Richards, Dr Fiona Warren, Professor Obi Ukoumunne on behalf of the
CADENCE investigators.
Aim
This paper reviews the data on patient participant recruitment to the feasibility phase of the CADENCE
study. It aims to review our original estimates of participant recruitment in light of feasibility study findings,
and to estimate the likely recruitment into the pilot RCT.
Feasibility study data collection
Reviewing the assumptions underlying patient recruitment
The patient throughput into the feasibility study teams was lower than anticipated. The latest data for the
period 23 September to 10 March 2015 identified 159 patients screened by one of the teams participating
in the feasibility study. National Audit (2011–12) estimated that approximately 17 patients per month per
team would be assessed, i.e. a total of 272 patients during our recruitment phase.
Patient throughput into the feasibility study is lower than national data would suggest, at around 59%
(159/272).
National audit data also estimated that around 17% of patients report depressive symptoms during
their initial cardiac rehabilitation assessment as assessed using the Hospital Anxiety and Depression
Scale. This figure includes patients with existing and new onset depression. Our feasibility data has broadly
confirmed this figure.
21% (34/159) of patients assessed during the feasibility study were found to have depressive symptoms
(score 10 or more on the PHQ-9) during their initial cardiac rehabilitation assessment, of whom 7 were
receiving active treatment for pre-existing depression and 1 was deemed ineligible for cardiac rehabilitation
at the point of assessment.
27/159 (17%) met the CADENCE study definition of ‘new onset’ depression.
We assumed that all eligible patients would be offered treatment, and that around 50% of those offered
study entry would agree to take part and enter the observational study. In reality, this estimate was
too high.
5/26 (19%) of the patients eligible for feasibility study were not offered study entry. Of those offered study
entry 9/26 (35%) agreed to take part. When considering only those offered study entry, approximately
43% (9/21) accepted the invitation to take part; this figure is closer to that estimated a priori.
For the purposes of sample size estimation, we assumed a conservative loss to follow-up rate of 50%.
In reality, most depression trials (including our own trials e.g. COBRA, COBALT, TREAD) which collect data
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via researcher interviews report a loss to follow-up of < 20%. The estimation of patient attrition was not a
stated aim for the feasibility study, but rather a goal for the pilot study. Notwithstanding this, we will be
able to report preliminary data on this parameter arising from the feasibility study:
Due to the slower than anticipate patient recruitment, we will be unable to estimate the loss to
follow-up rate at five months until late August 2015. As of 01/04/15, all three patients (100%) who
were due to be followed up for the observational study completed their assessments.
Estimating patient recruitment in the pilot study
Analyses of projected CADENCE participant recruitment are based on recruitment data derived from four
cardiac rehabilitation (CR) teams (RD&E, Mid Devon, Exeter and Exmouth) as of 11th March 2015. This
translates into a combined recruitment period (i.e. adding the recruitment periods of the four teams
together) of 16 months; equivalent to 64 team–weeks, i.e. 1 month= 4 weeks. During this period, there
were 159 screenings of potential participants, resulting in recruitment of 9 participants to the trial. Based
on these data, it takes approximately 7.1 ‘team–weeks’ to recruit each participant.
The pilot study will recruit eight teams (i.e. an additional four teams). If the eight teams recruit at the
same rate as the existing four feasibility teams:
Over a 6-month period with all 8 teams recruiting (26 weeks; 208 team–weeks) we would anticipate
recruiting approximately 29 participants.
If the recruitment period were to be extended to 9 months (39 weeks; 312 team–weeks) we would
anticipate recruiting approximately 44 participants.
Revisiting the pilot study sample size calculation
Estimating patient recruitment in the pilot study
The table below summarises the margin of error with which the follow-up rate can be estimated for
different hypothetical samples sizes (number of participants). The margin of error (based on the width of
the 95% confidence interval for the follow-up rate) is shown under scenarios where the follow-up rate is:
(a) 50%, (b) 80%.
Sample size for CADENCE pilot study: margin of error for estimating follow-up rate in
different scenarios
Sample size
Margin of error (based on width of 95% CI)
Follow-up is 50% Follow-up is 80%
67 ± 12% ± 9.6%
64 ± 12.3%a ± 9.8%
57 ± 13% ± 10.4%
49 ± 14% ± 11.25%
43 ± 15% ± 12%
38 ± 16% ± 12.8%
34 ± 17% ± 13.5%
30 ± 18% ± 14.4%
27 ± 19% ± 14.25%
25 ± 20% ± 15.7%
a This was the sample size estimate scenario used in the CADENCE protocol.
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The 80% follow-up rate is realistic. With the 64 participants we are targeting, we can estimate a follow-up
rate of 80% with margin of error ± 9.8%. If recruitment was lower than expected, say 43 participants, we
could still estimate this follow-up rate with margin of error ± 12%. If recruitment was 29 participants, as
we would currently project from our feasibility data, we would only be able to estimate the follow-up rate
with a margin of error around ± 14.4%.
Ensuring sufficient data are available for the purposes of the qualitative
interview study
In addition to ensuring that the pilot study has sufficient power to quantify the primary outcome (follow-up
rate), sufficient numbers of patients must also be enrolled in the trial to support sampling for the qualitative
study. Here we propose interviewing 10 ‘decliners’, i.e. people who elect not to take part in the trial, and
30 patients who take part. Trial participants from the following groups will be interviewed: 10 participants
receiving usual care, 20 receiving the trial intervention (12 completers and 8 non-completers).
The (cluster) randomisation ratio in the pilot trial is 5 intervention teams: 3 control teams, equating to
40 and 24 participants per arm respectively, assuming the original target of 64 participants is achieved, or
27 and 16 participants respectively assuming a lower target of 43 participants is set.
Recommendations for pilot study recruitment
Based on the feasibility study data, the following recommendations are proposed:
l A 6-month recruitment period will not be long enough to recruit sufficient participants to estimate the
pilot study primary outcome (follow-up rate) with the required precision.
l A 9-month recruitment period (i.e. the initial 6-month period plus a 3-month extension) is the
minimum required to achieve the revised target of 43 trial participants if the conditions of the feasibility
study are replicated in the pilot trial. This target is, however, challenging from the perspective of
sampling for the qualitative study and may pose a threat to the quality of the qualitative research.
We acknowledge that the feasibility assumptions are conservative (e.g. participant throughput, consent
rates) and may alter in favour of enhanced recruitment as the trial methods are refined, and more diverse
(larger) cardiac rehabilitation teams are recruited to the pilot study. However, we cannot predict potentially
enhanced recruitment based on the feasibility data available.
Granting a 3-month extension to the pilot study participant recruitment period should allow us to meet
our minimum sampling requirements for both the trial and qualitative research. Should our feasibility
estimates prove too conservative, and recruitment be quicker than anticipated, this extension may allow us
to achieve close to our original target of 64 patients.
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Appendix 10 Statistical analysis plan with
health economics
1. Background
Sample size: eight cardiac rehabilitation (CR) teams will be randomised in a 5 : 3 ratio to either the
intervention [comprehensive CR programme (CCRP) plus enhanced psychological care (EPC)] or usual care
(CCRP only; Cadence Protocol Section 4.1). EPC consists of behavioural activation (BA) plus care co-ordination
by the CCRP team. Randomisation will be balanced (to the extent possible) by team type (community or
hospital) and patient throughput (categorised as low/high, cut-off point was determined post hoc after
scrutinising the mean monthly throughput across CR teams, and was classed as low: 22 patients/month or
fewer; high: more than 22 patients/month, based on a natural break in the distribution of team throughput).
Trial participants will be assessed at baseline, 5 months and 8 months. Should any teams withdraw post
randomisation, such teams will be replaced by another team with characteristics that match as closely as
possible those of the withdrawn team. Participants within any replacement teams will be included in
descriptive analyses but not in between-group comparisons, should such analyses be performed.
2. Process data related to patient throughput
Patient throughput will be summarised from the initial point of stages 2 and 3 of the CR referral pathway
(Cadence Protocol Section 1) through to follow-up of trial participants at 8 months. For each trial arm,
we will record the following:
i. number of referrals for stage 2–3 of CR referral pathway
ii. number of patients that attend the initial nurse assessment for CCRP (stage 2–3 of CR
referral pathway)
iii. number that have depression based on the PHQ-9 (score 10 or above)
iv. number with specific new-onset depression (defined as not being in receipt of active therapy for
depression in the 6-month period prior to occurrence of a cardiac event)
v. number that are eligible for the trial (that is, no other exclusion criteria are met)
vi. number invited to participate in the trial
vii. number that agree to be contacted by the study researchers
viii. number that are recruited
ix. number that provide baseline data
x. number followed up at 5 months
xi. number followed up at 8 months.
Subsets (ii)–(ix) are natural subsets nested within the previous subset. Subsets (x) and (xi) above are subsets
of (ix), but (xi) is not a subset of (x) because of intermittent non-attendance at follow-up.
In addition, we will record the number of participants randomised to CCRP only (control) who elect to not
attend subsequent intensive rehabilitation as a binary variable (do/do not attend). All participants allocated to
CCRP + EPC should receive EPC, but may engage to varying degrees with the BA aspect of EPC. Participants
allocated to CCRP only will have no possibility of also receiving EPC/care co-ordination in error as CR teams
allocated to CCRP only will be unable to deliver EPC. Hence, the receipt of EPC differentiates the two arms,
irrespective of the receipt of/engagement with BA in the CCRP + EPC arm.
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We will report:
1. the number of patients who experienced a cardiac event (aged ≥ 18 years with eligibility for CR according
to local protocols: CADENCE Protocol 4.3.1.4) and attended an initial CR consultation
2. the number and percentage of these patients that are eligible for participation
3. the number of eligible patients that are recruited, and this number of patients as a percentage of all patients
who attended a CR consultation (point 1), and as a percentage of all eligible patients (point 2)
4. the number and percentage (with 95% confidence interval) of participants followed up at 5
and 8 months.
To estimate the time that would be required to recruit in a definitive trial the following will each be
reported per week (i.e. 5 working days) per cardiac team: the number of patients who experienced a
cardiac event and attended an initial CR consultation, the number of these patients who are eligible for
participation and the number of eligible patients recruited as trial participants. Separate reporting of these
statistics by trial arm will help identify any obvious recruitment bias resulting from randomising the cardiac
teams before recruiting patients to the trial.
3. Descriptive analyses of trial participants
Numbers of CR team clusters in each of the trial arms will be reported with respect to the descriptive
factors used to balance the teams across the arms. These factors are patient throughput [low or high
(defined in Section 1) used as a surrogate for team size] and team organisation type (hospital or
community); a third team type, mixed hospital and community was subsequently added, following the
realisation that some teams were a mixture of these types.
Participants will be described, separately in each trial arm, with respect to socio-demographic
characteristics (including age, sex, ethnicity, preferred language), clinical condition,1 cardiac risk factors
recorded at patient’s latest clinical assessment prior to recruitment (including body mass index, blood
pressure, HbA1c levels, lipid concentrations, smoking status), clinical diagnosis of depression (using the
revised Clinical Interview Schedule-Revised; CIS-R), Beck Depression Inventory (BDI) score, Beck Anxiety
Inventory (BAI) score and participant treatment preferences (as recorded in the participant baseline
questionnaire). Means and standard deviations (or medians and interquartile ranges) for continuous
variables and percentages for categorical variables (including binarised depressed/non-depressed with
regard to BDI and CIS-R) will be presented to summarise characteristics in each trial arm without formal
tests of significance.
4. Analyses comparing outcomes at 5 months and 8 months between
trial arms
All between-group comparisons will be performed on an intention-to-treat (ITT) basis, using observed data
only. For quantitative outcomes, means and standard deviations will be presented for each trial arm along
with the crude mean difference between arms, the adjusted (for stratification factors and baseline score)
mean difference and confidence interval for the adjusted mean difference (no p-value will be reported).
A 95% confidence interval will also be constructed for the standard deviation (pooled and for each arm
individually) of each outcome as it is a study objective to estimate these. For dichotomous outcomes, the
percentage with the outcome of interest (e.g., percentage who have a subsequent cardiac event) will be
presented for each trial arm along with the crude odds ratio between arms, adjusted odds ratio and 95%
confidence interval for the adjusted odds ratio (no p-value will be reported). No inferential conclusions
(within arm or between arms) will be made.
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The outcomes to be compared are:
i. BDI (continuous), response (50% reduction from baseline; binary), remission (< 14; binary), minimum
clinically important difference (MCID; added post hoc; binary),2 clinically significant and reliable change
(CSRC; binary)3
ii. Beck Anxiety Inventory (continuous)
iii. health-related quality of life – European Quality of Life-5 levels (EQ-5D-5–5L; continuous)
iv. health-related quality of life – HeartQoL (continuous)
v. Client Satisfaction Questionnaire (at 5 months only – frequencies for each item)
vi. Friends and Family Questionnaire (at 5 months only – frequencies)
vii. cardiac mortality (binary)
viii. all-cause mortality (binary)
ix. whether the participant experienced a new cardiac event during follow-up (binary)
x. whether the participant experienced a mental health event during follow-up (Cadence Protocol
Section 4.4.1.5) (binary)
xi. whether the participant was using antidepressant medication at the time of follow-up (binary).
For the BDI and BAI scores, if a patient has up to two missing items, we will replace the missing items with
the average of the reported items in order to generate an overall total score (if there are more than two
missing items the overall score will be considered as missing). Similarly, for the HeartQoL, if there is only one
item missing, this will be replaced by the average of the reported items; if more than one item is missing
the overall score will considered as missing. The EQ-5D-5L score will be calculated using the algorithm
developed by Devlin et al.4 The CSRC is a measure of whether a participant meets two criteria: (i) passing
from above the specified threshold to below the threshold (for the BDI, the remission threshold of 14 was
used) and (ii) establishing that the magnitude of the participant’s change in score is statistically reliable. To
evaluate (ii), the difference between the participant’s scores at baseline and follow-up is calibrated by the
standard error of the difference between the two scores.3 With regard to the CSRC for the BDI, we plan to
use a Cronbach α value of 0.90 and SD of 10.8 as reported for the calibration sample in a previous study.5
Cardiac risk factors (biochemical and physiological) will not be compared descriptively by group. We will
report only the availability of these measures (irrespective of the data source, i.e. GP notes or CR team
notes) during two sections of the follow-up period: baseline to 5-month follow-up, and 5-month to
8-month follow-up (as a post hoc decision, due to lack of data, only availability of data between baseline
and 5-month follow-up).
Cardiac events include the following: myocardial infarction (MI), subdivided where possible into MI with ST
segment elevation (STEMI), and non-STEMI; revascularisation procedure [coronary artery bypass graft
(CABG) or percutaneous coronary intervention (PCI)]; and hospital admission due to other acute coronary
syndrome (ACS) events, e.g. acute angina.
All analyses will be performed using Stata v.14, by a statistician who is unaware of the cluster (CR team)
allocations.
5. Process data related to delivery of intervention
For the CCRP arm, we will summarise patient attendance at and adherence with the programme,
reporting:
i. the time elapsed from point of consent to start of CCRP treatment
ii. the time elapsed from point of consent to start of EPC treatment
iii. the number of CR sessions (a) offered and (b) attended
iv. the number of attended CR sessions with documented evidence of EPC
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v. the time elapsed from point of consent to nurse discharge from psychological care
vi. the time elapsed from point of consent to nurse discharge from CCRP [date of discharge letter to
General Practitioner (GP)]
vii. documentary evidence of psychological care co-ordination activities provided to patients on exit from
CCRP (based on case notes review; presence/absence of discharge letter from CR nurse)
viii. documentary evidence of discussion with participant regarding referral to GP/IAPT (Improving Access
to Psychological Therapies) for mental health condition (binary by referral type)
ix. documentary evidence of referrals made to (a) GP; (b) IAPT and (c) other psychological care services
(binary by referral type)
x. care accessed for depression privately (derived from participant reported Health Economics Service
Resource Use Questionnaire (SRUQ; binary).
For the usual-care arm, we will summarise:
i. care accessed for depression via established NHS mental health pathways, for example, GP, IAPT, other
pathway (binary by type of care)
ii. the time elapsed from point of consent to start of CCRP treatment
iii. the time elapsed from point of consent to nurse discharge from psychological care
iv. the time elapsed from point of consent to nurse discharge from CCRP (date of discharge letter to GP)
v. documentary evidence of psychological care co-ordination activities provided to patients on exit from
CCRP (based on case notes review; presence/absence of discharge letter from CR nurse)
vi. documentary evidence of discussion with participant regarding referral to GP/IAPT for mental health
condition (binary by type of referral)
vii. documentary evidence of referrals made to (a) GP; (b) IAPT; and (c) other psychological care services
(binary by type of referral)
viii. care accessed for depression privately [derived from participant reported Health Economics Service and
Resource Use Questionnaire (SRUQ); binary].
6. Economic evaluation
Reminder of study objectives relating to economic evaluation:
Objective (2c) to establish the data collection methods required to support a definitive economic evaluation
(alongside any definitive fully powered trial).
Economic data collection:
1. Service use data.
2. Cost of providing EPC within CR – preliminary assessment.
6.1. Service use data
l Routine administrative sources (hospital records, GP records).
l Service and Resource Use Questionnaire – [SRUQ; adapted Client Services Receipt Inventory (CSRI) with
input from a Patient and Public Involvement (PPI) group]. The question items will be based on previous
versions of the CSRI questionnaire which was developed for people with mental health problems living in
the community, and has been adapted and used in a number of studies by health economists at University
of Exeter Medical School. It has questions which comprehensively capture information about the use of:
i. hospital care (inpatient, A&E, outpatient)
ii. primary care (GP, practice nurse, telephone/face-to-face/home visits)
iii. use of other care professionals
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iv. receipt of disability or illness-related welfare allowances/payments
v. receipt of informal unpaid care (from relatives or friends)
vi. receipt of medication for specific conditions.
To reflect the likely primary clinical outcomes, most of these questions will focus on items (i) to (vi) above
in relation to mental health problems. It will also aim to link to the planned process evaluation data; for
example, where referral data will be recorded about the psychological services to which patients in this
group have been referred.
The SRUQ will also include a free-text survey question which asks the participant to directly report any
difficulties in understanding or answering the service and resource use questions.
6.2. Cost of providing enhanced psychological care within cardiac rehabilitation
Trial records and dialogue with those directly involved in developing and delivering the intervention.
This will particularly cover the amount of additional time for CR nurses to become trained in delivering the
intervention, and to deliver the BA and care co-ordination components of the intervention.
6.3. Economic ‘data analysis plan’
Since the primary aim is to establish – that is, to try out and refine – the intended data collection methods
required to support a definitive economic evaluation, the ‘data analysis plan’ will comprise the following
elements:
l A full estimation of service and resource use of the pilot RCT participants on the basis of available data
sources and draft questionnaire items, documenting the estimation process and the difficulties
encountered and any unexpected omissions or suspected inaccuracies.
l Descriptive statistics of the completeness of data from the different sources and at different time points
(i.e. item response for those who started completing a follow-up questionnaire).
l Assessment of the validity or accuracy of self-reported service use data, where they can be compared
with routine administrative sources [using kappa scores, percentage where both sources of data agree
(in number of contacts of each type individually), and percentage of participants who overestimated
and underestimated the number of each type of contact compared with case records]. In general,
routine administrative sources will be presumed to be more accurate than self-reported service use
data. However, extreme differences between participant reported and routine administrative data
sources will be sampled and investigated to see if delays or errors in clinical record-keeping or data
entry may explain some of the difference (for example, if a participant recalls a hospital admission
which has not been captured by routine hospital records).
l Qualitative assessment of the difficulty of completing the SRUQ questionnaire. Including assessment of
responses to a free-text survey question which asks the participant to directly report any difficulties in
understanding or answering the service and resource use questions.
l Description of any difficulties encountered in processing the data.
¢ The preliminary assessment of the cost of delivering the EPC intervention within CR will be developed
iteratively by the study’s health economist co-investigator, as a spreadsheet with a number of the
relevant stakeholders (i.e. trial manager, intervention developers, cardiac nurses) and wherever
possible separately identify those costs which are effectively ‘sunk costs’ – and would be unlikely to
be incurred again (or to the same extent), for example, development of the intervention manual; and
are mainly associated with the running of the RCT rather than the delivery of the intervention per se.
The spreadsheet will have rows for those resources or staff time involved in designing and developing the
intervention (meetings, materials/manuals); training cardiac nurses in EPC (nurse time, trainer time, training
materials); any additional cardiac nurse time involved in screening for depression and additional nurse
time to co-ordinate care or deliver BA. Wherever possible, it will separately show the number of units of
resource (e.g. minutes of cardiac nurse time) and the unit price of each type of health-care resource
(e.g. £ per minute of nurse time).
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7. Statistical analysis plan with health economics audit trail
Date of statistical
analysis plan with
health economics
Statistical analysis plan
with health economics
version number
Date presented to trial
management group/Trial
Steering Committee
Significant amendments since
previous version
30 March 2015 3.0 14 April 2015 Addition of template tables
9 May 2016 4.0 9 May 2016 Discussion of how to include
replacement teams in analyses
(Section 1)
To perform descriptive analyses
only, due to small numbers of
patients in each group (Section 4)
To report biochemical/
physiological measurements in
terms of availability only, and not
to report descriptively the
measures themselves (Section 4)
Client satisfaction questionnaire
to be reported as item
frequencies only, i.e. not
linearised and reported as a
continuous outcome (Section 4)
Inclusion of FFT (Section 4)
27 May 2016 4.1 26 September 2016 Definition of cardiac event added
(Section 5)
27 May 2016 4.1 26 September 2016 Addition of health economics
template tables
26 September 2016 4.2 N/A Added MCID for BDI as outcome,
added references
8. Statistical analysis plan with health economics reference list
1. British Heart Foundation. National Audit of Cardiac Rehabilitation. 2012. URL: www.cardiacrehabilitation.
org.uk/docs/2012.pdf (accessed 30 March 2015).
2. Button KS, Kounali D, Thomas L, Wiles NJ, Peters TJ, Welton NJ, et al. Minimal clinically important
difference on the Beck Depression Inventory – II according to the patient’s perspective. Psychol Med
2015;45:3269–79.
3. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in
psychotherapy research. J Consult Clin Psychol 1991;59:12–19.
4. Devlin N, Shah K, Feng Y, Mulhern B, van Hout B. Valuing Health-Related Quality Of Life: AnEQ-5D-5L
Value Set for England. Research Paper 16/01. London: Office of Health Economics; 2016.
5. Brouwer D, Meijer RR, Zevalkink J. Measuring individual significant change on the Beck Depression
Inventory-II through IRT-based statistics. Psychother Res 2013;23:489–501.
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Appendix 11 Pilot study: topic guides for patient
participant and nurse interviews
Pilot topic guide: enhanced psychological care patient participants
l Background and illness history (about the cardiac event, discharge home – well-being physically and
mentally after discharge).
l Expectations and decision to come for cardiac rehabilitation (decision to attend cardiac rehabilitation,
number of sessions attended and cardiac rehabilitation engagement).
l Experiences of care provided by the cardiac nurses for low mood (appropriateness of cardiac nurse
assessing mood, causes of low mood and provision of support for low mood).
l Experiences of receiving BA sessions and care co-ordination (number of sessions completed, areas
covered in BA sessions, areas helpful/unhelpful, what effect BA had on mood, sessions by telephone
rather than face to face and physical environment for EPC delivery).
l Using the participant handbook and BA materials (how the handbook was used, what areas were
helpful/could be improved).
l Identifying links between mood and activity level (understanding BA, making changes to behaviour).
l Relationship with the cardiac nurse (e.g. relaxed, formal etc., perception of nurse’s knowledge/skills to
assess mental health and deliver BA treatment).
l Treatment adherence (session attendance, what helped to stay engaged).
l How EPC has affected physical and mental well-being (current mental and physical well-being, how
best to support mental health, recommending EPC to others and suggestions about more effective
EPC delivery).
l Any other treatments received or referrals made during the study and impact on mood.
l Experience of being part of a research study (e.g. information received from the nurse and from the
researcher, experiences of completing the assessments, any aspects of the study that needed to be
improved for patients).
Pilot topic guide: usual-care patient participants
l Background and illness history (about the cardiac event, discharge home – well-being physically and
mentally after discharge).
l Expectations and decision to come for cardiac rehabilitation (decision to attend cardiac rehabilitation,
what cardiac rehabilitation entailed, number of sessions attended and cardiac rehabilitation
engagement).
l Experiences of usual care provided by the cardiac nurses for low mood (appropriateness of cardiac
nurse assessing mood, causes of low mood and provision of support for low mood and referral to
other services).
l Relationship with the cardiac nurse (e.g. relaxed, formal, etc., perception of nurse’s knowledge/skills to
assess mental health).
l Description of current physical and mental well-being (current mental and physical well-being, reasons
for any improvements/worsening and how best to support mental health).
l Any other treatments received or referrals made during the study and impact on mood.
l Experience of being part of a research study (e.g. information received from the nurse and from the
researcher, experiences of completing the assessments and any aspects of the study that needed to be
improved for patients).
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Pilot topic guide: decliner patients
l Experiences of being approached about the CADENCE study (e.g. how approached, understanding of
study aims and what was involved).
l Reasons for declining research participation (e.g. feelings when asked about participation in study
about low mood, main reasons for choosing not to participate and factors that would have
encouraged participation).
l Previous experiences of research participation and psychological therapy.
l Thoughts on having a talking therapy (e.g. thoughts on BA or other talking therapies, experiences of
treatment in the past).
l Current mental and physical well-being (e.g. current feeling, any receipt of help for low mood and
anything specific to be aware of when treating cardiac patients with low mood).
Pilot topic guide: cardiac rehabilitation nurses
l Experiences of delivering BA (e.g. addressing low mood in usual care, understanding and explaining
BA, areas useful or struggling with, acceptability of BA as a treatment by cardiac nurses, use of EPC
documentation and telephone versus face-to-face delivery).
l Using the materials (e.g. the nurse handbook and participant handbook, mood diaries and other tools,
confidence using the tools with patients and how patients used the materials).
l Training (e.g. extent to which training was tailored to deliver EPC, any areas needing more input).
l Managing mental health risk issues and care co-ordination (e.g. experiences of dealing with patients at
mental health risk, role in care co-ordination and experiences of referral of patients to psychological
care services).
l Support (e.g. feedback on supervision sessions).
l Impact on relationship with patients and perceived mental health role (e.g. advantages and
disadvantages of delivering EPC to patients by cardiac nurses).
l Practicalities (e.g. finding space, time to deliver EPC and managing nurses’ workloads).
l Impact of integrating EPC on the existing service on wider team(s) (e.g. factors that hinder/help/
improve smooth delivery).
l Acceptability and appropriateness of methods for the CADENCE study (e.g. screening process and
referral of patients to study).
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Appendix 12 Ethics committee-approved changes
to the study protocol
Amendment
number Summary of proposed amendment
1 Revised inclusion/exclusion criteria
The TSC met on 24 July 2014 to discuss the study protocol. The TSC recommended a change to the study
inclusion and exclusion criteria in relation to patient participants – patients with early-stage dementia
should not be excluded from study participation if they met all other criteria. A similar view was expressed
with regard to patients with a pre-existing diagnosis of severe mental illness (e.g. schizophrenia or bipolar
depression) whose symptoms of psychosis were well controlled
1 Economic data collection
Routine/administrative sources to include community mental health records to reflect revised inclusion criteria
2 Revision of cluster randomisation ratio
A 5 : 3 randomisation ratio (EPC plus usual care : usual care) was informed by data emerging from our
feasibility study and seeks to ensure that sufficient nurses and patients have EPC exposure to support the
aims of the qualitative study interviews
2 Extension of patient recruitment period in pilot trial phase by 3 months
Propose to recruit 64 patients from eight teams in 9 months, which affects the timeline described in
Section 7 of the protocol
2 Revision of variables used to stratify randomisation
‘team setting’ and ‘average monthly patient flow’ (throughput) are proposed as alternative stratifying
variables
2 Training provided for nurses allocated to the EPC intervention arm
Based on findings emerging from the feasibility phase, it was proposed that there should be the following
training and support for nurses in the trial EPC arm:
l Two-day intensive training in study EPC intervention and self-harm risk management
l Ongoing, regular clinical supervision
l Half-day follow-up training approximately 3–4 months after the initial training days
2 Patient population for pilot trial
l Inclusion criteria were modified to better represent patient groups that are routinely eligible for NHS
cardiac rehabilitation
l Since the study began, patients with other diagnoses (e.g. heart failure) were increasingly being offered
and attending local cardiac rehabilitation programmes. These patient groups may also experience
depression. We therefore proposed to expand the list of example diagnoses in the study protocol to
clarify that these groups of patients would also be eligible for the pilot trial, if they experienced
depressive symptoms at their initial nurse assessment and meet all other study entry criteria
2 Addition of the NHS FFT to trial follow-up questionnaires
In line with current NHS policy to use the FFT to evaluate patient experience of services, we added one
item to our follow-up questionnaires to assess whether patients would recommend the services they
received for their low mood within the cardiac rehabilitation programme to others. The item includes the
standard NHS question stem and 5-point response scale plus two free-text questions: ‘What was good
about your experience?’ and ‘What would have made your experience better?’
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Amendment
number Summary of proposed amendment
2 Changes to qualitative study
It was proposed to conduct one in-depth interview with EPC-trained nurses (rather than two), taking
place towards the end of EPC delivery once the nurse had gained some experience of delivering EPC.
A researcher still observed the training and made detailed field notes. The number of teams in the
intervention arm and the number of nurses predicted to be involved in EPC delivery were amended to
reflect the proposed change in randomisation ratio. We proposed to offer flexibility to patients who
declined study entry (but agreed to a one-off interview) whether their interview was conducted by
telephone or face to face. A similar choice was available for patients who entered the trial and also
agreed to an interview
3 Participant recruitment period in pilot trial returned to 6 months
Owing to the funder confirming that they would not fund an extended recruitment period, we returned
our proposed recruitment period to the original 6 months. The funder’s decision also affects the timeline
described in Section 7 of the protocol
3 Addition of the BADS-SF to trial baseline and follow-up questionnaires
To enable us to measure when and how participants become ‘activated’ over the course of their cardiac
rehabilitation programme or BA treatment, we proposed to add the nine-item BADS-SF questionnaire to
all trial assessments – i.e. baseline, 5-month and 8-month follow-ups. We did not anticipate that this
short scale would add significantly to the length of assessments that participants would be asked to
complete
4 Addition of questions to the SRUQ
Following consultations with the PPI group and nurses, additional questions to the employment history
were added and medications sections for further clarification
5 End of study date changed
Following a discussion with our funding agency, the NIHR HTA programme, on 6 April 2016 we were
granted a 3-month no-cost extension to allow for the timely write-up of the study. Our end of study date
was therefore 31 October 2015
5 Follow-ups
Most patients had an 8-month follow-up, but given that our primary outcome is obtained at 5 months,
we have agreed with the HTA programme that, for the final nine patients recruited to the study, a final
follow-up data collection will only be done at 5 months. For these nine patients, we will not have
8-month data
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Appendix 13 Standard operating procedure for
cardiac rehabilitation nurses: assessing, reporting and
monitoring risk of self-harm and suicide
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Appendix 14 Patient and public involvement
commentary
Our PPI representatives actively contributed to many of the key discussions that took place during thelifetime of the project. They regularly attended project management meetings and also met separately
to discuss important issues, often in preparation for a team meeting.
The PPI group were very supportive of the idea of providing EPC to cardiac patients, given the patchiness
of existing psychological input in cardiac rehabilitation and the lack of availability of this in many cases.
However, the PPI group raised several issues in their discussions.
Context of patients’ lives
One of the issues that was raised by the PPI group was the importance of seeing the relationship between
a patient’s cardiac event and depression in the wider context of their lives, for example, the social support
available to them and other stressful events that they may be experiencing. The group also pointed out
that depressive symptoms might be accompanied by other symptoms, such as those associated with
post-traumatic stress. This comment appears to be supported by some of the evidence in the qualitative
research, where patients report feelings of being, ‘shell shocked’ and suffering from panic attacks.
Given that the cardiac nurses in the trial made the initial assessment of ‘new onset depression’ the group
wondered if the limited training given to the cardiac nurses would allow them to recognise and deal with
these issues. The PPI group thought that the timing of the intervention and the level of depression that
would be used as a recruitment criterion were important to maximising the benefit to patients.
Behavioural activation
The group felt very strongly that the results of the work carried out and the qualitative interview results
supported the supposition that cardiac patients would benefit from EPC, but it was difficult to comment
on the specific effectiveness of BA. This was attributable to the small number of people involved in
the trial.
Patient and public involvement group members noted that the results from the qualitative study indicated
that having someone to talk to about their psychological problems was important to patients. The value
of the ‘listening ear’, as one interviewee put it, should not be underestimated. The findings from the
qualitative work highlight the importance of the nurse/patient relationship. This may have been enhanced
by the nurse training in BA and the addition of extra ‘listening time’ given to the patient. The group felt
that the available evidence suggested that this was beneficial to patients.
An issue raised by one of our PPI members, which may need to be taken into account in future, is the fact
that many medications prescribed to cardiac patients may have significant side effects that may impair a
patient’s ability to engage with BA. Such medications can contribute to a general feeling of being ‘ill’ and/or
fatigued. There was concern that this might have a negative impact on people’s ability to successfully
undertake BA, given the central focus on activity and that this is an issue which needs further exploration.
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Cardiac nurses
The PPI group felt that it could see a clear benefit to the initial support being provided by cardiac nurses
rather than requiring a referral to another service, although this option should be available if a patient
needs more specialist help.
The group noted that the BA training that the nurses received appeared to enhance their knowledge and
skills, giving them greater confidence with which to explore and discuss the wider psychological impact of
a cardiac event. This suggests that psychological training of nurses could improve psychological outcomes
for patients.
Resources
The PPI group were concerned about the lack of resources to deliver BA, both in terms of the lack of an
appropriate room to carry out BA and the workload of the nurses. They were concerned that these factors
might significantly impair the effectiveness of the intervention. The change from a nurse-led intervention in
the feasibility study to a patient-led intervention in the pilot study was carried out for several reasons, but a
key one was the finding from the feasibility study that nurses were struggling to deliver the intervention.
The PPI group expressed initial concerns that this change may place more of a burden on patients who are
already struggling to cope with a traumatic event. However, the group felt happy with the changes that
were eventually made, and did not feel that they affected patients adversely.
Concluding comments
The group was mindful of the provisional nature of the findings from the study. However, the following
points were emphasised as key messages in reporting this work from a patient perspective:
l There is clearly a need for psychological support to be offered to patients as part of routine
cardiac rehabilitation.
l It was seen as beneficial that initial support can be provided by cardiac nurses, rather than requiring a
referral to another service. However, having trained psychological counsellors based within rehabilitation
teams would also achieve this effect, and may deal with the issues of training and workload for nurses.
l The opportunity to share experiences between patients was clearly valuable.
l The ability to spend time talking one to one with someone about the psychological consequences of a
cardiac event was something that patients valued.
l The need to be able to get back in touch with someone if problems arose later on is important
(e.g. being given some contact numbers on completing the rehabilitation).
l Behavioural activation seems to be a promising approach to meeting patient needs for
psychological support.
l The need to provide nurses with adequate training, time, resources and support in order to carry out
this role was also something that the group felt was very important.
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Appendix 15 Sample size calculation for a
definitive trial
The table below summarises the sample size calculations for a definitive cluster randomised trial.Estimates are based on different assumed true values of the mean and SD of the BDI-II measure for the
control group at 8 months.
Scenario
BDI-II score Clinically meaningful effect (MCID)
Required total sample size (n)Mean (SD) BDI-II score Effect size Cardiac teams
1 6 (3) 1.05 0.35 54 702
2 6 (3.5) 1.05 0.3 72 936
3 6 (5) 1.05 0.21 148 1924
4 7 (3) 1.225 0.41 40 520
5 7 (3.5) 1.225 0.35 54 702
6 7 (5) 1.225 0.25 104 1352
7 8 (3) 1.4 0.47 30 390
8 8 (3.5) 1.4 0.4 42 546
9 8 (5) 1.4 0.28 84 1092
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